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PDGF platelet-derived growth factor 
P K A cAMP dependent protein kinase 
P K C protein kinase C 
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S.D. standard deviation of mean 
S D S - P A G E SDS-polyacrylamide gel electrophoresis 
S.E.M. standard error of mean 
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TMB-8 hydrochloride 8-(diethylamino)octyl 3,4,5-trimethoxybenzoate 
hydrochloride 
TNF tumor necrosis factor 





Biochemical changes, especially those involved in signaling pathways in L-929 cells 
treated with recombinant human tumor necrosis factor (liiTNF) were studied. The 
present study can be classified into two main groups: one is the signal transduction 
provoked by rhTNF treatment on L-929 cells, and the other is the events induced 
in L-929 cells by rhTNF that is related to the death of L-929 cells. 
Translocation of nucleophosmin, a nucleolar protein, is observed in L-929 cells ‘ 
treated with rhTNF. Nucleophosmin translocation has been shown to be a good 
parameter for screening of anti-tumor agents. The results indicate that the nucleus 
may be one of the affected area involved in rliTNF-mediated cytotoxicity in L-929 
cells. It has also been shown that actinomycin D, an inhibitor of RNA synthesis, 
can enhance the ability of rliTNF in inducing nucleophosmin translocation. 
Actinomycin D can also enhance the sensitivity of L-929 cells towards rhTNF. It 
was found that translocation of nucleophosmin induced by rhTNF takes place 
before cell death and is not a result of nucleus destruction. Considering the known 
functions of nucleophosmin, rhTNF may affect ribosome structure, cell 
proliferation and stability of RNA in L-929 cells. 
We have also studied the role of free radicals on the cytotoxic effect of rhTNF on 
L-929 cells. We have found that some antioxidants, such as superoxide dismutase 
and cysteine, are capable of suppressing the cytotoxic effect of rhTNF on L-929 
cells. These results give indirect evidence that the killing of L-929 cells by rhTNF 
involves free radicals; at least superoxide anion radical production. However, it 
was found that a polar derivative of vitamin E, trolox, gives no protection of L-
V 
929 cells from rhTNF treatment. This may be due to its poor aqueous solubility 
and no effective dosage was obtained in our experiment. 
We observed that rhTNF fails to induce cAMP accumulation in L-929 cells. By 
using two commonly used bacterial toxin, we found that rhTNF-mediated 
cytotoxicity in L-929 cells is mediated through a pertussis toxin-sensitive pathway 
but not through a cholera toxin-sensitive pathway. The role of cAMP and cAMP-
dependent protein kinase (PICA) in rhTNF-mediated cytotoxicity has also been ^ 
studied. By using Sp-cAMPS (a cAMP analog) and Rp-cAMPS (a cAMP 
antagonist), we observed that cAMP exhibits little effect on rhTNF-mediated 
cytotoxicity on L-929 cells. However, we cannot eliminate the possibility of 
secondary involvement of cAMP in the cytotoxic effect of rhTNF on L-929 cells. 
By the use of various PICA inhibitors, namely H-8 and H-9, we could not find any 
difference in the cytotoxicity of rhTNF on L-929 cells with or without these 
inhibitors. These results indicate that PKA is unlikely to be involved in the 
cytotoxicity of rhTNF on L-929 cells. 
The ability of rhTNF to induce change in intracellular free calcium ion level was 
investigated in this system. By using fluorescence technique, it was found that ‘ 
rhTNF could not demonstrate change in cytosolic free calcium ion level in L-929 
cells treated with rhTNF, both in cell suspension system and in single cell 
measurement. However, change in cytosolic free calcium was observed by using 
both fluorescence technique and by the use of radioactive calcium-45 in L-929 cells 
treated with rhTNF for a long period of time. Change in cytosolic free calcium ion 
level was demonstrated after rhTNF administered for 2 to 6 hours. By using single 
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cell measurement technique, we found that the free calcium ion level near nucleus 
accumulates when L-929 cells are treated with rhTNF. However, there is no direct 
evidence that the accumulation of calcium ion near the nucleus is directly related to 
the cytotoxic effect of rhTNF on L-929 cells. 
Three specific L-type calcium ion channel blockers, namely diltiazen, nifedipine and 
verapamil, were shown to suppress the cytotoxic effect of rhTNF on L-929 cells. 
Another non-specific calcium ion channel blocker, cinnarizine, also gave similar — 
result. This indicates that by preventing the entry of external calcium ions, the 
cytotoxic effect of rhTNF on L-929 can be suppressed. This means that we have 
shown, indirectly, that rhTNF-mediated cytotoxicity in L-929 cells involves an 
uptake of external calcium ions. 
The role of some calcium-dependent kinases in rhTNF-mediated cytotoxicity has 
also studied. By using fluorescence dye and monoclonal antibody, it have been 
demonstrated that protein kinase C is activated upon rhTNF treatment in L-929 
cells. It was also demonstrated that by suppressing the protein kinase C activity 
with staurosporine, the cytotoxic effect of rhTNF on L-929 cells is also 
suppressed. The result indicates that protein kinase C is not only activated by 
rhTNF treatment in L-929 cells but this activation is also involved in the killing 
mechanism. 
The present study cannot demonstrate the involvement of another calcium 
dependent kinase, namely the calmodulin related kinase, in rhTNF-mediated 
cytotoxicity on L-929 cells. The effect of two calmodulin inliibitors, W-7 and 
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TMB-8, on rhTNF-mediated cytotoxicity on L-929 cells was also studied. It is 
found that there is no difference in the cytotoxicity pattern in rhTNF treated L-929 
cells in the presence or absence of these inhibitors. This gives strong evidence that 
calmodulin related kinase does not take part in cytotoxic effect of liiTNF on L-929 
cells. 
The role of inositol tiisphosphate and tyrosine kinase in ihTNF-mediated 
cytotoxicity in L-929 cells were also studied. We have demonstrated that rhTNF ' 
can induce synthesis of inositol trisphosphate but this response is not very effective. 
By the use of fluorescence staining, we found that tyrosine kinase activity increases 
in L-929 cells after treatment with rhTNF. Tyrosine kinase inhibitor, genistein, is 
very effective in suppressing the cytotoxic effect of rhTNF on L-929 cells. 
We postulated that rhTNF mediated cytotoxicity is mediated through a pertussis 
toxin-sensitive pathway in which tyrosine kinase may also be involved. The 
tyrosine kinase induces inositol trisphosphate synthesis. The inositol trisphosphate 
has been shown to elevate cytosolic calcium ion level which ends up in activation 
of other calcium dependent response with protein kinase C being one of them. 
The role of membrane potential in rhTNF-mediated cytotoxicity on L-929 cells was 
also studied. By using both fluorescence technique and whole cell patch clamp 
technique, we found that rhTNF cannot alter the membrane potential of L-929 cells 
upon rhTNF treatment. By altering the membrane potential of L-929 cells, we also 
found that membrane potential does not play a role in rhTNF-mecliateci cytotoxic 
effect on L-929 cells. However, by using potassium ionophores (namely nigercin), 
v i i i 
we demonstrated the relation between intracellular pH and susceptibility of L-929 
cells towards rhTNF. Agents that prevent the entry of sodium ion and thus 
maintain a lower intracellular pH were shown to suppress the cytotoxic effect of 
rhTNF on L-929 cells. However, we could not demonstrate a change in 
intracellular pH in L-929 cells treated with rhTNF. It seems that rhTNF is unable 
to induce a rapid change in the internal pH of L-929 cells. However, the cytotoxic 
cascade it induces seems to be a pH-dependent process. 
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Chapter 1. Biochemistry of Tumor Necrosis Factor (TNF) 
1. Introduction 
1.1 The Discovery of Tumor necrosis factor (TNF): 
Treatment of cancer has puzzled scientists ever since the notice of cancer. A wide 
spectrum of drugs have been developed for the cure of cancer. Unfortunately, most of 
these drugs are also highly toxic to normal cells since they cannot distinguish between 
normal and cancer cells. This limits the use of these cytotoxic agents as anti-cancer 
drugs. 
The spontaneous regression of tumor in patients after high grade fever had been 
observed for quite a long time but no explanation was found. It was postulated that 
the fever induced the body to produce 'something' that killed the tumor. It was not 
until the later half of 19th century, William Coley, a surgeon in New York, investigated 
this phenomenon. Though he did not give a clear explanation, he was the first to 
induce hemorrhagic necrosis of tumor with therapeutic intent (see review by Old 1988; 
Malik et a l , 1992). The patients were injected with the 'Coley's toxins, which was a 
mixture of gram-negative, gram-positive bacteria and their products. In some cases, 
regression of tumor was observed. However, the side effects of this 'Coley's toxin' 
were unacceptable, and soon this sort of treatment was stopped. 
A bacterial polysaccharide was later isolated from 'Coley's toxin�. It was the main 
component that contributes to the biological effect of 'Coley's toxin'. This compound 
was identified as the same molecule isolated from gram-negative bacterial culture and 
is named lipopolysaccharide (LPS). LPS isolated from bacteria was shown to induce 
hemorrhagic necrosis of transplantable tumor in mice. Unfortunately, the toxic effects 
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of LPS were so strong that it was impossible to use for therapeutic purpose (Old, 
1988). In 1962, 0 'Mai lay el al showed that the serum of a LPS-treated animal 
contained some endogenous factors that could cause hemorrhagic necrosis of 
transplant tumor in other animals that had not been exposed to LPS (O'Mallay et a l 
1962). Later in 1975，Cars we II et al showed that mice pre treated with Bacillus 
Calmette-Guerin (BCG) could produce a factor when challenged with LPS (Carswell 
et a l 1975). This factor could cause hemorrhagic necrosis of Meth A sarcoma in the 
skin of recipient mice. This factor not only caused hemorrhagic necrosis of tumor in • 
vivo, but was also toxic to some tumor cell lines in vitro (Helier et al 1975), and 
hence, this factor was named as 'tumor necrosis factor' (TNF). T N F was believed at 
that time to be effective in suppressing the growth of many forms of neoplastic 
diseases and that it was nontoxic and highly specific. 
In the meantime, another group of investigators working independently on cachexia in 
animals under chronic disease reported that they had found a factor in the serum of the 
experimental animals that can cause wasting and they named it 'cachectin' (Rouzer et 
a l 1980). Cachexia is common in animals affected by cancer and various infectious 
diseases and is associated with profound anorexia and inappropriate hypermetabolic 
state, leading to consumption of lipid and protein resources. In 1981, Kawakami and 
Cerami reported that cachexia was found in mice after LPS injection (Kawakami and 
Cerami 1981): the animals developed hypertriglyceridemia, and suppression of 
lipoprotein lipase activity in adipocytes was observed. They also found that 
macrophages when treated with LPS in vitro could also produce the factor that cause 
cachexia. In 1985, the amino acid sequences of cachectin and T N F were compared 
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and it was found that the two factors were actually the same molecule (Beutler el al 
1985). 
Furthermore, another cytokine was later isolated after stimulation of lymphocytes 
.(Ruddle et a l 1967; 1968). It was designated as Lymphotoxin. Since its amino acid 
sequence has some similarities with TNF, it was also called TNF-p. Accordingly, TNF 
was renamed as TNF-a or TNF-a/Cachectin. For simplicity, TNF-a/cachectin will be 
called TNF within this thesis. ‘ 
1.2 T N F as an antitumor agent 
There were four observations that many investigators graded TNF as an anti-tumor 
agent. Firstly, the hemorrhage necrosis of transplantable tumor from both mice and 
human were seen in a wide variety of experiments (Carswel! et al 1975, Haranaka et al 
1984). Secondly, TNF induce both cytotoxic and cytostatic effects in many human 
tumor cell lines in vitro, but is non-toxic to most normal cells (the reasons are still 
unknown) (Helson et al 1975, Haranaka et al 1981, Williamson et al 1983, Yamamoto 
et a l 1985, Sugarman el al 1985, Fransen et al 1986); and thirdly, the synergistic 
cytotoxic effect of TNF and other cytokines, especially interferon-y was observed in 
many tumor cell lines in vitro (Williamson et al 1983, Sugarman et al 1985, Fransen et 
al 1986). Finally, it seems that TNF is the main mediator of activated macrophage 
related cytotoxic effects on tumors in vivo (Urban et al 1986, Philip et al 1986, 
Ziegler-Heitbrock et al 1986, Nissen-Meyer et al 1987, Feinman et al 1987). These 
observations rendered TNF a new hope in tumor therapy despite that TNF causes a 
wide range of side effects and even death in experimental animals receiving over-
dosage of TNF. 
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1.3 Production o f T N F 
Traditionally, it was thought that TNF was produced only in macrophages both in vivo 
and in vitro (Stein et al 1991, Mannel et al 1980, Matthews 1981, Zacharchuk et al 
1983, Wozencraft el al 1984，Wood and Clerk 1984, Bloksma et al 1984). However, 
it was later found that a wide variety of cells can produce TNF. These include natural 
killer cells (NK cells) and lymphokine-activated killer cells (LAK cells) (Gemlo et al 
1988), T-lymphocytes (Sung et al 1988, Steffen et al 1988) and mast cells (Gordon 
and Galli 1990). Even L-929 cells, when transformed to TNF-resistant cell lines, can 
also produce TNF (Rubin et al 1986). This phenomenon was also observed in many 
human tumor cells (Spriggs el al 1987). It seems that many cell types, besides 
macrophage, can also produce TNF but the amount is not so abundant as 
macrophages. 
The production and release of TNF depends on the presence of inducer. LPS is the 
most potent inducer so far identified. LPS can induce activated macrophages to 
produce 10 times more TNF than resident macrophages (Stein el al 1991). Other 
inducers include zymosan and opsonized red blood cells but they were 10 times less ‘ 
effective than LPS. Red blood cells from malaria infected individuals (Kwiatkowsky et 
a l 1989) and viral DNA (Aderka et al 1986) were also potent inducers of TNF 
production from macrophages. This explains the importance of TNF in parasitic and 
viral infections. A large number of cytokines are also inducers of TNF, among them, 
the most important one is interferon^ (IFN7). IFN-y can stimulate TNF production 
even in the absence of LPS. I FN � can enhance the transcription of TNF mRNA 
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(Collart et al 1990). However, other inducers seems to be needed for effective 
translation. Besides IFN-y, TNF itself can also stimulate macrophages to produce 
TNF (Philip et al 1986) and enhance TNF inRNA transcription (Descoteaux et al 
1990). Other cytokines that can induce TNF production include IL-2 (Economou et al 
1989), GM-CSF (Cannistra et al 1987) and CSF-1 (Warren and Ralph 1986). 
A membrane-bound form of TNF exists in some macrophages. It has a molecular 
weight of 28 KD (Kriegler et al 1988). It seems to be the precursor of the soluble 
form of TNF. However, these macrophages are only present in some strongly 
stimulated tissues and represent only a small percentage of the total macrophages. 
1.4 Structure of T N F 
In 1984, the cDNA of human TNF was cloned (Pennica et al 1984). This made a great 
step forward in the basic and clinical research in TNF. Later, many recombinant TNFs 
were available commercially. 
TNF is encoded within the major histocompatibility complex in chromsome 6 in man 
(Nedwin et al 1985, Spies et al 1986) and chromosome 17 in mouse (Nedospasov et al 
1986). The human TNF gene contains three in Irons with 3 kb long. In human TNF, it 
is produced as a protein consists of 233 amino acids in which the 76 amino acids at the 
amino end is cut off before secretion. The mature human TNF consists of 157-
residues and contains one intrachain disiilphide bond. In mouse, the propeptide 
consists of 79 amino acids long. When the TNF troni human and mouse were 
compared, it was found that this amino acid sequence is highly conserved. There is a 
79% conservation in the mature protein and in the propeptide segment, and up to 86% 
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of the amino acid sequence are the same. The function of the propeptide was still not 
clear as it does not show any classical signal sequences. One possible function was 
that this sequence is important for membrane anchor (Hung et al 1990). 
When TNF is isolated, they are easily aggregated to form TNF polymers. Dimers, 
trimers and even higher order polymers had been reported. However, the most stable 
polymer form in normal physiological condition is the trimeric form. This had been 
confirmed by a wide variety of techniques such as gel filtration, zonal sedimentation 
and crosslinking (Smith et al 1987), ultracentrifugation (Wingfield et al 1987), small-
angle scattering (Lewit-Bentley et al 1988 ) � a n d gel electrophoresis (Eck et al 1988 ). 
It was widely accepted that the trimeric form of TNF was the active form. By X-ray 
crystallography, it was found that there was an extensive ^-sheet content exists in the 
molecule (Hsu et al 1986, Davis et al 1987). Once TNF is secreted, it has a circulating 
half-life of 14-18 min. in humans. 
1.5 T N F receptors 
Like other cytokines, the biological response triggered by TNF is mediated by the 
activation of specific receptors on target cell surfoce. TNF receptors (TNF-R) were 
first isolated in urine as soluble TNF receptor (Olsson el al 1989, Engelmann et al 
1989, 1990a, Seckinger et al 1989). Soluble TNF receptors were commonly found in 
human urine. In healthy individuals, the amounts are small. However, in those with 
malignancies, tumors, autoimmune disease or inflammatory disorders, there might be a 
much higher level of soluble TNF receptors. The sequence of this soluble TNF 
receptor is identical to that of the receptors found on cell surtace especially for the 
cysteine-rich extracellular domain (Nophar cl al 1990). Whether the soluble form of 
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TNF-R is a result of cleavage from the cell surface or as a clue to additional cleavage 
process from TNF-R synthesis is unknown. Lymphotoxin, which binds to the same 
receptor on cell surface, exhibits a much lower affinity to the soluble TNF-R 
(Engelmann et a l 1989, 1990a, Seckinger et a l 1989). This implies that lymphotoxin 
and T N F might have different binding sites on the TNF-R. This also explains why 
these two cytokines bind to the same receptor, but give different responses. 
As TNF can cause a wide range of actions, it is not surprised that TNF-Rs are present 
in nearly all cells, with a few exception such as erythrocytes (Shalaby el a l 1987)， 
resting �- lymphocytes (Munker et a l 1987, Scheurich et a l 1987) and some 
transformed B-cells (Scheiuich et a l 1986, Yoshie el a l 1986, Digel et a l 1990). T w o 
distinct TNF-Rs are found. They differ not only in molecular weight but also in ligand 
binding affinity, glycosylation, immunoreactivity and proteolytic fragments (Hohnmann 
et a l 1989), and more significantly, they have different transmembrane and 
intracytoplasmic domains (Loetscher et a l 1990a, Lewis el a l 1991). This indicates 
that they should have different functional aspect in TNF signaling. Antibodies raised 
against these two TNF-Rs show no cross-reactivity against one another in both binding 
inhibition and flow cytometry studies (Brockhaus el a l 1990). As determined by SDS-
PAGE, one of the receptors was found to have a molecular weight of 55 KD (named -
as TNF-Rp) while the other was found to have a molecular weight of 75 K D (named 
as TNF-Ra) (Loetscher et a l 1990a; 1990b, Smith et a l 1990, Kohno et a l 1990, 
Helier et a l 1990). These two TNF receptors are expressed in different cells in various 
amounts under different situations (Hohnmann et a l 1990, Thorn a et a l 1990, 
Brockhaus et a l 1990, Shalaby et a l 1990). In general, the number of TNF-R is low, 
with typical values ranging from a few hundred to a few thousands per cell (Scheurich 
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et a l 1986, Yoshie el a l 1986, Creasy el a l 1987). The K^ of TNF-R/5 for T N F was 
found to be 2-5 x whereas the K j of TNF-Ra for T N F was found to had a 
higher affinity at a value of 3 - 7 x l O ' ^ ^ M (Scheurich el a l 1987). 
The organization of TNF/TNF-receptor complex had been studied. It had been 
suggested that T N F might mediate its biological effect by crosslinking the receptors on 
the cell surface (Eck et a l 1989). Receptor crosslinking may be induced by a 
multivalent trimer that binds to the membrane receptors. By making mutants of TNF, 
it was found that TNF lacking up to 9 residues from the NH2- terminus is still effective 
in killing tumor cells as compared to the normal TNF (Carlino et a l 1987，Sid ho et a l 
1989). This indicates that the NH2-terminus is not involved in the cytotoxicity of TNF. 
In mutants of T N F that have a higher basicity of the NH2-terminus, the cytotoxicity 
towards tumor cells is higher than that of normal TNF (Soma at a l 1987). From these 
observations, it seems that the NH2.terminus of TNF is not required for receptor 
binding, but may modulate or interfere with the interaction between T N F and T N F 
receptors. 
Using similar techniques, mutants having modified C-term in us had been made. It was . 
found that mutants lacking 2 to 10 residues tiom the C-term in us loss its biological 
activities (Sidho et a l 1989, Kobayashi el a l 1986). The truncation of those amino acid 
residues interferes the forming of the /?-sheet, and hence no trimeric polymer can be 
formed. Also, the amino acid residues at the C-term in us is important in stabilizing the 
charges in the C-terminus. By removing the few amino acid residues at the C-
terminus, the C-terminus becomes highly positively charged and affects the stability of 
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the trimerc structure of TNF. This might give an explanation to the importance of the 
C-terminus in the biological activity of TNF. 
The amino acid residues which are responsible for TNF cytotoxicity had been defined. 
They are found to be located at residues 30-34, 79-87 and 143-149 (Yamashima et a l 
1990, Van Ostade el a l 1991). Residues from these three regions are exposed in the 
trimeric form and are solvent accessible. These residues are all located at the base of 
the trimeic form of TNF and it is suggested that they may bind to the TNF-receptor on 
the target cells (Van Ostade et al 1991). 
Other approaches have been employed to locate the residues in TNF molecule which 
are responsible for binding to TNF receptors. Using site-directed mutagenesis, 
glycosylation at particular site is possible (Leung et al 1990). The glycosylation affects 
the binding of the TNF molecules to the TNF receptors. Glycosylation at amino acid 
residues described above, or at the base of the trimeric form of TNF diminishes the 
binding of TNF to TNF receptors. These findings are consistent with the requirement 
an inter-subunit binding site and the observations that the basal region of TNF trimer is 
important in the TNF molecule when it interacts with its receptors (Eck ct a l 1989). 
The crosslink of TNF receptor is also important for the biological effect of TNF as 
demonstrated by using multivalent antibody against TNF receptors. It has been 
reported that when this antibody was added to L-929 cells, it induced the aggregation 
of TNF receptors and caused cell death (Engelmann et a l 1990b). Aggregation of 
T N F receptors by other means also induced TNF-like response. These observations 
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indicate that TNF trimers bind to at least two TNF receptors and that the crosslinking 
of the TNF receptors is critical to the biological activities of TNF. 
However, it is also widely accepted that TNF binding to its receptors is necessary but 
not sufficient for TNF to express its biological effects. Some mutant TNF that binds to 
the TNF receptors as normal but do not induce cell death in L-929 cells (Yamagishi et 
a l 1990). Another group of investigators has also found thai a monoclonal antibody 
that interferes with the binding of TNF to its receptors does not alter the cytotoxicity 
of TNF to L-929 cells (Rathgen et al 1990). It was suggested that this might be a 
result of binding of TNF to different TNF receptors which have different functions in 
the target cells. 
Internalization of ligand-receptor complex followed by receptor recycling is common 
in ligand induced response. However, in the case of TNF, the recycling of receptor 
was only observed in some cell lines. For example, in MCF-7 cells, recycling of 
receptor occurs and it was noticed that over 95% of the TNF-R involved are TNF-R-^ 
type (Vuk-Pavlovic and Kovach 1989). The receptor might be subjected to 
intracellular degradation after ligand binding in those cells that do not recycle the 
receptors to the cell surftice (Tsujimoto el a I 1986, Watanabe ct a I 1988a, Gullberg el ‘ 
a11986). This suggests that the two types of TNF-R are differentially processed inside 
the cell after ligand binding. 
1.6 Biological activities of TNF: 
Though the amino acid sequences of TNF isolated from different animals share high 
degree of homology; species specificity does exist in TNF actions. Mouse TNF 
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appears fully active in human cells but human TNF is only active in some aspects 
towards different murine tumor cells. This can be explained simply by receptor binding 
study that shows that mouse TNF and human TNF have a comparable affinity towards 
human TNF-R (Smith et al 1986). Recombinant human TNF (rhTNF) and murine cell 
line L-929 are used in this study because rhTNF has been proved to be effective in 
killing L-929 cells. (Meager et al 1989). For other cellular responses such as TNF 
mediated growth enhancement of interleuk:in-2-de|3endent T-cell lines, great species 
specificity's are found (Ranges et al 1989). 
The target cells of TNF are found all over the body as TNF-Rs are present in nearly all 
types of cell. In monocytes and macrophages, TNF causes a marked activation and 
differentiation response especially in the presence of IFN-y. As TNF is chemotactic 
for monocytes and macrophages (Wang el al 1990), the local induction of TNF by any 
inducing agent ends up in a self-amplifying reaction. TNF can also trigger the 
macrophages to produce superoxide and nitric oxide (Ding et al 1988). The products 
are highly reactive and are effective in eliminating of foreign particles such as bacteria, 
virus infected cells and parasites though TNF is not so potent than I F N � in this 
function. However, TNF has shown to reduce MHC class II antigens on the 
membrane of macrophages (Watanabe et al 1991). This seems to be a control ‘ 
mechanism to prevent tissue damage from continuous self-amplification induced by 
TNF and macrophages. 
TNF has no effect on resting T-lymphocytes because they have no TNF-R. However, 
in activated T-lymphocytes, TNF can increase membrane IL-2 receptors (Scheurich el 
a l 1987). In mixed lymphocyte cultures, TNF has been shown to enhance the 
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population of cytotoxic T-lymphocytes (Shalaby el al 1988). TNF can also activate a 
wide variety of immunocytes such as NK cells, L A K cells (Ostensen et al 1987), B-
lymphocytes (Jelinek and Lipsky 1987) and polymorphonuclear leucocytes (PMN). 
TNF enhances phagocytosis, degranulation, and superoxide production in PMN 
(Schleiffenbaum and Fehr 1990). TNF can cause damage to endothelial cells by 
inducing adhesion of neutrophils and eosinophils to the endothelial cells (Lo et al 
1989, Slungaard et a l 1990). 
As mentioned previously, TNF is also known as cachectin (Beutler et a l 1985). 
Cachexia is a term to describe the wasting phenomena in individuals with infectious 
disease or cachexia. The best studied target for cachexia induced by TNF is adipose 
tissue (Spiegeiman and Hotamisligil, 1993). TNF can suppress expression of 
lipoprotein lipase (LPL), enhance glycerol release in cultured fat cells (Kawakami et a l 
1987, Torti et al 1985), suppressing adipose differentiation (Torti el al 1985), and 
suppress the expression of a wide variety of adipose tissue specific proteins at a 
transcription level. These proteins included adipsin which is a serine protease (Min et 
a l 1986), glycerolphosphate dehydrogenase, fatty acid binding protein (Torti et a I 
1985). TNF also antagonizes the lipogenic effect of insulin (Hotamisligil et a l 1993). 
TNF has been shown to play a direct role in obesity-linked insulin resistance . 
(Hotamisligil et a l 1993). Other investigators reported that there is an immediate 
acceleration in glycogenolysis in TNF-treated cells and thus eliciting a sharp increase in 
fructose-2,6-bipliosphate levels, glycogen depletion and increased lactate production in 
host suffering from cachexia (Lee et a1 1987). 
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TNF not only affect energy metabolism experimentally in vitro but also in vivo. 
Administration of TNF to animals results in elevation of plasma triglyceride, 
suppression of LPL and resorption of fat. When human TNF secreting tumor cells 
were implanted into nude mice, the animals produce low but detectable level of human 
TNF in their circulation and they also develop a severe wasting condition as cancer 
patients do (01 iff e/ a l 1987). TNF is also responsible for bone resorption (Bertolini el 
all9S6). 
Beside cachexia, TNF is also responsible for septic shock induced by bacterial infection 
or more specifically by LPS. Mice injected with rhTNF develop piloerection of hair, 
diarrhea, a withdrawn, unkempt appearance and die if sufficient amount of rhTNF is 
given. Rats become mildly hypotensive, tachypenic and die of sudden respiratory 
arrest (Tracey et a l 1986). After injection of TNF, the animals develop a severe 
acidosis, hemoconcentration, and biphasic changes in blood glucose level. All the 
observed events are mimic to the condition of animals after the administration of LPS. 
In all cases, the mentioned events can be prevented by prior administration of anti-
human-TNF antibody. High grade fever is common in animals administered with LPS. 
This is also observed in those injected with TNF. TNF elicits the response by direct 
interactions on the hypothalmus where it increases prostanglanclin E2 just as IL-1 does. -
Followed by this phase of fever, TNF provokes another phase of fever by inducing IL-
1 secretion. It seems that the toxicity of LPS is mainly due to the endogenous TNF. 
Thus, not only anti-TNF can prevent the death of animals under septic shock, other 
agents that can interrupt the cascade can also work. These agents include lL-1-
receptor antagonist, cyclooxygenase inhibitors and other anticoagulation agents 
(Taylor et a l 1987). In a study concerning the serum TNF level and degree of septic 
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shock, it was found that patients with serum TNF level exceeding 440 U/ml invariably 
die (Waage etall9Sl). 
1.7 Anti-tumor activities of T N F 
TNF mediates cytotoxic and cytolytic activity on tumor cells. In vitro studies indicated 
that TNF inhibits growth of many tumor cell lines (Malik el a l , 1992). The exact 
mechanisms for TNF anti-tumor action in vitro and in vivo are not very clear, 
however, five non-mutually exclusive theories are widely accepted. They account for 
different observations in different cell types. 
1.7.1 In vitro studies 
1.7.1.1 Synertiistic effect of other cytokines: 
The first one and most probably the inarguably theory is that TNF must bind to its 
specific receptors on the target cells though the target cells may not be the tumor. 
This is a universally accepted mechanism for protein mediators to exert its effect on 
target cells. However, in the case of TNF, it is believed that other unclearly 
determining factors are needed for the maximal activity of TNF. Most of these factors 
are cytokines, and interferon�(IFN-y) is the most widely studied cytokine that works 
together with TNF (Palombella el al 1988). IFN^ has been shown to increase the -
number of TNF receptors in tumor cells (Tsujimoto et al 1986) and makes the cells 
more susceptible to the cytotoxic effect of TNF both in vivo and in vitro. Activated 
macrophages have been shown to secrete interleukin-l (IL-1) which further activates 
T-lymphocytes to produce interleuk:in-2 (IL-2). IL-2 is well known for its ability to 
activate macrophages. Besides the mentioned phenomenon, TNF has been 
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demonstrated for its autocrine action, thus it is not surprise that TNF is not working 
alone in in vivo system. 
1.7.1.2 DNA damages: 
The second theory suggests that TNF attacks the nucleus and causes fragmentation of 
the tumor cell DNA. This killing pattern is similar to that induced by T-cytotoxic cells 
but not to that mediated by humoral immunity. This suggests that TNF may not cause 
lesion on the cell membrane but affect intracellular enzyme activity. TNF may affect 
the enzymes and proteins related to the nucleus. Upon TNF treatment of tumor cells 
in vitro, it was found that the DNA synthesis ceases which is followed by the death of 
the tumor cells. Although there are no evidence showing direct activation of 
intracellular endonuclease by TNF, TNF cytotoxicity can be abrogated by Zn""^  (Malik 
et a l , 1992), which is an inhibitor of endonuclease. It has also been shown that TNF 
can synergistically enhance the toxicity of anti-cancer drugs targeted at DNA 
topoisomerase II (Alexander et al 1987). Though there is solid evidence that TNF 
affects the nucleus, the mechanisms or the target site of DNA damage is still not very 
clear. 
1.7.1.3 Free Radicals generation: 
The findings that TNF treatment affects the metabolism of the pathways of 
polyunsaturated fatty acids to prostaglandin form the basis of the third theory. It is 
postulated that during the conversion of arachidonic acid to prostaglandin, free radicals 
are produced as by-products. The highly reactive free radicals may be responsible for 
the cell damage (Kettelhui el al 1987) which may include the fragmentation of DNA 
and mitochondrial RNA (Schulze-Osthoffe/ a l , 1992). It has been found that hydroxy 1 
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radicals are involved in TNF-mediated cytotoxicity in TNF-sensitive but not in TNF-
resistant cells (Adamson el a I , 1992). Since reduced form of glutathione can scavenge 
oxyradical, treatment of cells with inhibitors of reduced glutathione biosynthesis can 
enhance the cytotoxicity of TNF on cells (Adamson el a I , 1992). Some TNF-resistant 
tumor cells can over-express manga no us superoxide dismutase (Mn-SOD) in the 
mitochondria when treated with TNF (Wong and Goedclel 1988). Mn-SOD is an 
antioxidant enzyme which can catalyze dismutation of superoxide radicals. 
1.7.1.4 Utilization of ATP: 
Another theory suggests that under the influence of TNF, the susceptible tumor cells 
carry out a futile energy cycle. Large amounts of ATP are hydrolyzed and the energy 
store is released in the form of heat. It is believed that this heat energy is responsible 
for the killing of tumor cells. This theory seems to provide an explanation of ability of 
TNF to distinguish between normal cells and tumor cells because the later have a 
higher metabolic rate and ATP level. It lias been shown that exogenous ATP level can 
alter the cytotoxic activity of TNF (Stanislaw el al 1992, Lendann et al 1990). 
Alteration of energy pool is also noticed in increased mobilization of glycogen storage 
in cells after TNF treatment. This may also cause an over-production of lactate which 
may further cause a drop in intracellular pH and induce irreversible damage to the cells. ‘ 
In this futile cycle, fructose 2,6-biphosphate is produced instead of fructose 1,6-
biphosphate as in normal energy metabolism. Fructose 2,6-biphosphate is reported to 
have a stimulatory effect on fructose-6-phospliate kinase. The activation of this kinase 
may cause a further utilization of the energy pool and speed up the death of the cell. 
Not only the energy pool in the cell is affected, the energy storage in other tissues are 
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affected. This hypothesis provides a reasonable explanation to the wasting effect of 
TNF on animals injected with TNF. 
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1.7.1.5 Phosp ho lipase A^ activation; 
Upon TNF treatment, the phospholipase A! (PLA2) will be released that mediate 
membrane lipid peroxidation of the tumor cells (Neale et a l , 1988). TNF cytotoxicity 
can be abrogated by PLA2 inhibitor, e.g., quinacrine. Most recently Kolesnick and 
Golde (1994) suggested that TNF employs the sphingomyelin pathway (Liscovitch and 
Cantley, 1994) to effect signal transduction by its receptors. This pathway is initiated 
by hydrolysis of plasma membrane sphingomyelin to ceramide by the action of 
sphingo-myelinase. Ceramide serves as a second messenger which stimulates a 
serine/threonine ceramicie-activated protein kinase to tranduce the TNF signal. The 
extent of this pathway being used in cytotoxicity of TNF is not known. 
1.7.2 !n vivo studies: 
In the in vivo situation, the killing mechanisms of TNF on tumor cells should be far 
more complicated. Besides the direct action on the tumor cells, TNF has been shown 
to express multifunctional immunoregulatory activities such as activation of neutrophils 
and macrophages (Urban et al 1986). TNF can stimulate the expression of adhesion 
proteins, E-selectin and intracellular adhesion molecule-1 by endothelial cells. These 
proteins have chemotactic activities to attract the neutrophils emigration to the tumor 
sites. At these sites TNF enhances neutrophil adhesion to endothelium. Neutrophils 
then exert their respiratory burst response to release free radicals to kill the tumor cells 
(Zhang et a l , 1992). 
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It has been known that solid tumors can secrete growth factors that stimulate the 
growth of blood vessels towards them and supply the tumor with nutrients. TNF has 
been shown to suppress the endothelial cells to respond to these growth factors. In 
tumors with developed blood vessel systems, TNF can cause necrosis of the blood 
vessels by activating the neutrophils. It seems that TNF is not only responsible for 
tumor rejection but also as a cytokine in control of the defense system. 
1.8 Clinical trials 
Phase I and phase II clinical trials have been done all over the world as large amount of 
rhTNF can be synthesized by recombinant technique. Unfortunately, large number of 
patients with advanced tumor treated with rhTNF got no major therapeutic result after 
rhTNF treatment and more disappointed, these patients suffered from a wide range of 
side effects (reviews see Taguchi et a I , 1992; Schiller el a l , 1992). Patients treated 
with rhTNF developed a transient period of hypertension, decrease in cardiac output 
(Natanson et a l 1989), followed by hypotension in 2 to 12 hours (Creaven et a l 1987, 
1989, Spriggs et a l 1988). The hypotension can be reversed by administration of 
arginine metabolic inhibitors indicated that the hypotension induced by TNF was nitric 
oxide (NO) related (Kilbourn el al 1990). Elevated S C O T level was found in patients . 
receiving daily injection of rhTNF at a dose higher than 100 //g/nr (Creaven et a l 
1987，Jakubowski el a l 1989). The serum cholesterol and high-density lipoprotein 
(HDL) decreased significantly (Spriggs el al 1988) while the turnover rate of glycerol 
and free fatty acid increased after rhTNF treatment (Bartsch el a l 1988). Other side 
effects included thrombocytopenia, drop in total leukocyte count, fever, chills, 
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myalgias, nausea, vomiting and fatigue. Some of the side effects, however, are not 
dose dependent. 
As TNF shows synergistic effect with other cytokines in vitro, combined application of 
TNF with other cytokines in tumor therapy has been done. In phase I clinical trial of 
combined TNF and I F N � treatment, much better result was obtained. It was found 
that I F N � reduce the maximal tolerated dose of TNF by 2 to 5 fold. Anti-tumor 
activity was found in patients with biliary cancer, pancreatic cancer and sarcoma when 
treated with rhTNF and IFN-y. 
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Chapter 2. Materials and Methods 
2.1. Materials 
Recombinant human tumor necrosis factor and all analogs and antagonists were 
purchased from CaliBiochem. The EC50 of the rhTNF is 20-50 pg/ml as measured 
in a cytotoxicity assay with the TNF-susceptible murine L-929 cell line in the 
presence of actinomycin D (described by CaliBiochem). Fetal calf serum was 
purchased from Gibco. All fluorescence probes were from Molecular Probes. 
Monoclonal antibodies against protein kinase A and phosphotyrosine were 
purchased from Boehringer Mannheim Biochemica. Radioactive materials were 
purchased from Amersham and other chemicals from Sigma. 
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2.2 Solution commonly used 
1. R P M M 6 4 0 
RPMI-1640 was purchased from Sigma as powder. The powder was dissolved in 
double distilled water. The solution was then filter-sterilized by passing through a 
0.22 fxm membrane filter using positive pressure generated from a nitrogen gas 
cylinder. The RPMI-1640 medium was supplemented with fetal calf serum (FCS) 
(percentage used was adjusted according to the cell type), 5 U/ml penicillin and 5 
f-ig/ml streptomycin. 
2. Phosphate butTered Saline (PBS) 
PBS was used as a general washing buffer. It consists of 140 mM NaCl, 2.7 mM 
KCl, 1.5 mM KH2PO4 and 9.1 mM Na2 HPO4. The pH is adjusted to 7.4 at room 
temperature. 
3. Phosphate Buffered Saline used in uerforining B23 experiments (PBS-B23) 
Phosphate buffered saline used in performing B23 nucleolar protein experiments 
has a unique composition. It consists of 145 mM NaCI, 1.6 mM NaHaPO^ and 8.45 
mM Na2HP04. The pH is adjusted to 7.2. 
4. Sodium-HEPES solution (Na-HEPES) 
Na-HEPES was used as a medium for fluorescence experiments in the present 
study. It can maintain the viability of the cell for a few hours even in the absence of 
FCS. It consists of 140 mM NaCl, 5 mM KCl, 1 mM CaCb, I mM MgCb, 10 mM 
glucose and 10 mM HEPES. The pH is adjusted to 7.4 unless otherwise stated. 
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5. Neutral red solution 
Neutral red solution was used to measure the viability of cells after TNF treatment. 
It consists of 5% neutral red in 0.9% saline. The constituents were well mixed and 
stored for at least 2 days followed by filtering through Whatman number 1 filter 
paper. It was prepared at least 1 week before use. 
6. Scintillation cocktail 
Scintillation cocktail was used when performing experiments involving ^H and ''^ Ca 
labeled compounds. It consists of 12 g PPO, 1.2g POPOP, 2.0 L toluene and 1 L 
of Triton x-100. The constituents were mixed and stirred overnight. The 
completely dissolved solution was kept in dark. 
7. Other liquid media 
The composition of other liquid media will be described in the text. 
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2.3 Methods and Procedure 
2.3.1 Culture of L-929 cells 
L-929 cell line (ATCC CCL 1，NCTC clone 929, strain L) was purchased from the 
American Type Culture Collection (ATCC). L-929 was a fibroblast cell line 
derived from normal subcutaneous aveolar and adipose tissue of a 100-day male 
C3H/An mouse. As they are fibroblasts in origin, they are grown on the surface of 
the culture flask. Clone 929 of the L-cell (L-929) was established from the 95th 
subculture generation of the parent strain. 
Because L-929 is highly susceptible to rhTNF (Malik et al 1992), it was used for 
the measurement of TNF titer by different workers in TNF studies. L-929 was 
thus used as the main cell line in this study. 
L-929 cells were cultured in RPMI-1640 medium supplemented with 5 % FCS, 5 
U/ml penicillin, 5 "g/ml streptomycin and kept at 3 T C in a 5 % CO2 incubator. 
Cells were passed when the cells in the culture flask were grown to confluence. 
Cells were then harvested by using 2 nil of trypsin/EDTA (0.25% trypsin-1 mM 
EDTA-4 Na) in each 75-cm^ flask. The detached cells were washed twice with 
PBS (pH 7.4) and about 5% of the total cell number were seeded in each of the -
flasks with culture medium mentioned above. 
2.3.2 Trypan Blue Exclusion Test 
For all experiments, cells harvested from tissue culture flask were examined for 
viability by trypan blue exclusion test. Cells was diluted and well mixed with 9 
volumes of PBS and further mixed with an equal volume of 2% trypan blue in PBS. 
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The viability of cell was determined by means of haemocytometer under a light 
microscope. The exclusion of trypan blue is an energy dependent process and 
hence dead cells were stained blue. Only cell suspensions with a viability of over 
98% were used for further experiments. 
2.3.3 Detennination of viability of L-929 cells upon rhTNF treatment 
Viability of L-929 cells after rhTNF treatment (with or without other drugs) was 
measured by the neutral red up-take method. About 3x10" L-929 cells per well 
were seeded in a 96-well plate in 100 "1 volume and incubated at 37°C in a CO2 
incubator overnight. The culture medium was then replaced by RPMI-1640 
medium with the appropriated dilution of rhTNF alone or in combinations of 
different drugs. The medium used in the assay was similar to that of normal culture 
except that the serum was heat inactivated. Heat inactivated serum was used to 
avoid the action of complement mediated cytotoxicity. After further incubation for 
20 to 24 hours at 37°C in the CO2 incubator, the medium was removed and 50"1 
of neutral red (0.5% in normal saline) was added to each well. The cells were 
allowed to actively up-take the neutral red for 1 hour at 37°C. The plate was then 
washed gently with PBS for three times before dried in a 60°C oven. One hundred 
jul of 1 % SDS was added to each well to dissolve the neutral red and the plate was 
read by plate reader at a wavelength of 540 nm. The reading (in term of optical 
density (O.D.) was a reflection of the viable cells at the end of incubation. Result 
was expressed by subtracting the O.D. of control well (no cell seeded) from the 
O.D. of individual well. Each treatment consists of at least five determinations and 
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each experiment was repeated for at least three times with slight difference in cell 
number. 
In the assay for the study of the effect of membrane potential on rhTNF mediated 
cytotoxicity, high potassium level medium was used. In this case, RPMI-1640 was 
not used as the assay medium, instead, Na-Hanks solution and K-Hanks solution 
were used to make dilutions of rhTNF. This was because it was difficult to control 
the Na+ and K+ levels in the RPMI-1640 medium. Also, in experiments that study 
the effect of external pH on rhTNF mediated cytotoxicity on L-929 cells, 5% heat 
inactivated FCS in Na-HEPES solution was used to make dilution of rhTNF and 
the plates were kept in normal incubator at 37°C without supplementary CO2 
supply to avoid the changes of pH due to the CO2 in the incubator. 
2.3.4 Determination of Cellular cAMP level 
L-929 cells were cultured as usual and harvested 2 hours before assay. 1 x 10^ 
cells in 1 ml volume of Na-HEPES buffer (pH 7.4) were used for each sample. 
Cells were incubated with either 50 ng/ml rhTNF or 1 //g/ml CTX for various time 
intervals. After incubation, cAMP was extracted twice by using 65% ice-cold -
ethanol. The clear supernatants were collected and all cell debris were removed by 
centrifugation. The samples were than dried by speedvac. The amount of cAMP 
was determined by using cAMP assay kit purchased from Amershani (code 
TRK.432). 
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Briefly, this assay was based on the competition between unlabeled cAMP in the 
sample and a fixed amount of tritium labeled cAMP for binding to a specific cAMP 
binding protein isolated from calf thymus. Fifty jA of fixed amount of ^H-labeled 
cAMP and 50 "1 of sample were mixed with 100 " � of binding protein and kept at 
4°C overnight. The cAMP will bind to the binding protein and the amount of H-
labeled cAMP bound depends on the amount of normal cAMP. The higher the 
cAMP level in the sample, the lesser amount of ^H-labeled cAMP binds to the 
binding protein. After incubation, 100"1 of activated charcoal was added and well 
mixed. All the free cAMP, both labeled and unlabeled, were removed by absorbing 
onto the coat of charcoal. The reaction mixture was then centrifuged to separate 
the charcoal. The labeled cAMP in the solution was counted by liquid scintillation 
counter. The amount of cAMP in the sample was calculated from a linear standard 
curve. This standard curve was prepared by serial dilution of a known standard 
and the diluted standard undergoing the same treatment as normal samples. 
2.3.5 Determination of Inositol Phosphate Turnover 
Inositol phosphate turnover of L-929 cells was measured as described byBerridge 
and Irvine, 1984. L-929 cells were grown in culture flask as usual until confluence. . 
The culture medium was removed and replaced with plain RPMI 1640 containing 
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4/^Ci/ml H-myo-inositol for 18-24 hours at 3 7 � C in a 5% CO2 incubator. After 
incubation, cells were harvested and washed 3 times with Na-HEPES solution (pH 
7.4). For each sample, 1 x 10^ cells in 1 ml volume of Na-HEPES were used. The 
cell suspension was treated with 10 mM LiCl for 15 minute before addition of 
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rhTNF to amplify the signal as Li+ could inhibit the hydrolysis of IP3. The 
reaction was stopped at various time intervals by adding 1 ml of ice-cold 5 % 
perchloric acid (HCIO4) followed by keeping at 4°C for 30 minutes. The 
suspension was then transferred to a glass tube and the HCIO4 was then extracted 
with 1 ml of mixture of trichlorotrifluoroethane and tri-n-octylamine (in 1:1，v:v 
ratio) and 100/^1 of 100 mM EDTA. The mixture was then vortexed vigorously 
for at least 5 minutes. The mixture was then centrifuged for 5 minutes at 2000 
rpm. The upper phase was transferred to a test tube containing 5 ml of distilled 
water. The pH of the solution should be about 7.0. In case the pH is lower than 
6.0，50 mM NaOH should be used to bring the pH to about 7.0. 
To separate the various fractions of inositol phosphate, the extracts were subjected 
to ion-exchange chromatography using Dowex l-x8 anion exchange resin in 
foi-mate form. Dowex resin (Biorad A G l-x8，formate form, 200-400 mesh) was 
immersed in distilled water overnight at room temperature and washed at least 5 
times with distilled water. 1.5 ml of the resin was applied to the micro-column and 
washed with 10 ml of distilled water. The column was then ready for use. After 
separation, the column could be regenerated by using 5 ml of 1 M NaOH followed 
by 5 ml of 1 M formic acid. The column was then washed with distilled water until 
pH of the elutent return to 7. The column was then completely regenerated. 
Solutions of different ionic strength was used to elute different members of the 
inositol phosphate family. Ten ml of the following solutions was added in 
sequence and every 2 ml was collected as one fraction. Distilled water was used to 
28 
elute free inositol; 60 mM ammonium formate/5 mM disodium tetraborate was 
used to elute deacylated inositol lipids; 200 mM ammonium formate/100 mM 
formic acid was used to elute inositol monophosphate; 400 mM ammonium 
formate/100 mM formic acid was used to elute inositol bis-phosphate; 800 mM 
ammonium formate/100 mM formic acid was used to elute inositol tris-phosphate. 
From each fraction, 500 was taken out and well mixed with 5 ml of scintillation 
cocktail and radioactivity was determined by liquid scintillation counting. 
2.3.6 Use of Fluorescence Probe in the study of rhTNF mediated killing 
The method of Tsien (1981) was followed. The use of fluorescence probes in the 
study of rhTNF mediated biochemical events were done by using either ion probes 
or by FITC-labeled antibody directed against specific structure. In the former case, 
specially designed ion probes were used. The probes are usually polar 
carboxylates and are impermeable to cell membrane. They are purchased in 
acetoxymethyl (AM) ester form of the probes. Upon incubation, the probe can go 
into the cells and the ester form is hydrolysed by intracellular esterases to 
regenerate the active ion probe (Tsien 1981). A real time tracing of the changes of 
the free ions concentration was done. In case of FlTC-labeled antibody, only the 
structure or location of special proteins can be studied and fixation process is ‘ 
needed before using the antibody. Usually, the FITC-labeled antibody is used as 
secondary antibody to detect the monoclonal antibody directed against special 
. protein or structure. 
Detection of fluorescence signals were done in two ways, either by direct 
measurement of the fluorescence intensity or by counting the photon generated 
‘ from the sample by a photomultiplier tube. The electronic signal was then 
converted to give a 2-D image and a pseudo-color image was developed by 
computer software. In the former case, calibration was possible by changing the 
environment of the sample, and a standard fluorescence reading was obtained. 
2.3.6.1 Determination of changes in internal nH of L-929 cells 
The internal pH was determined by fluourecent probe as described else where 
(Grinstein et a I , 1984 ). L-929 cells were harvested and the cell concentration was 
adjusted to 2 x lO^nl. To each ml of the cell suspension, 2 f i \ of BCECF-AM (1 
mg/ml in DMSO) were added and incubated at 37°C for 30 minutes. The cells 
were washed twice with Na-HEPES and suspended in 2 ml of Na-HEPES (pH 
7.4). The sample was examined by a Perkin-Elmer Luminescence 
Spectrophotometer LS50B with excitation wavelength at 488 nm (5 nm slit) and 
emission wavelength at 530 nm (5 nm slit). The slit size used in this combination 
would give a fluorescence intensity around 500. The cell suspension was stirred in 
a ‘slow’ mode by the stirrer in the spectrophotometer. When the tracing was 
stable, rhTNF was added and the changes in the internal pH of the cells was 
determined. 
At the end of the experiment, of 1 % SDS was added to lyse all the cells and a 
fluorescence reading corresponding to pH 7.4 was obtained. Afterwards, acidic 
solution was added to bring the reaction medium to acidic condition and another 
reading was obtained. The pH of the medium was then measured by a pH meter 
and used to calibrate the tracing, assuming that the changes in fluorescence 
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intensity is in a linear relation with the pH at that range. The experiment was done 
at room temperature to avoid changes in voltage across the membrane of the 
electrode during pH measurement as temperature could affect the reading. To 
determine the internal pH of L-929 cells after rhTNF treatment for several hours, it 
is impossible to hold the cell in the fluorescence spectrophotometer for such a long 
time. Instead, rhTNF was added and BCECF-AM was added just half hour before 
the end of incubation. The internal pH was determined similarly as mentioned 
above. 
2.3.6.2 Deterinillation of intracellular calcium level in L-929 cells 
The method as described by Nasmith and Grinstein et al (1987) was used. To 
determine the free calcium level in the cell, Fura-2 AM was used. Fura-2 A M was 
sensitive to free calcium level. As Fura-2 can be excited at two wavelengths and 
each wavelength gives different response to calcium level, the ratio of the two 
readings can give a more sensitive detection of the change in calcium level. 
Basically, 2 excitation wavelengths were applied to the sample alternatively within 
second. The detector was synchronized to detect the emission from different 
excitation wavelengths and a ratio of two readings were calculated and displayed. 
In this experiment, 2x10^ L-929 cells in 1 ml Na-HEPES were loaded with 2/il 
Fura-2 (1 mg/ml in DMSO) for 30 minutes at 3 7 ° C Cells were washed twice with 
Na-HEPES and suspended in 2 ml of Na-HEPES before applied to a fluorescence 
spectrophotometer. A program designed for this experiment, namely, 'Intracellular 
Biochem’ (Perkin Elmer), was used with two excitation wavelengths of 340 nm 
and 380 nm (8 nm slit) and emission wavelength at 510 nm (10 nm slit). A graph 
of 340/380 ratio was plotted to show the changes in fluorescence ratio. At the end 
of experiment, 10/^1 of 1 mg/ml ionomycin was added to equilibrate the external 
and internal calcium level and a F,„ax value was obtained. The zero calcium level 
was obtained by adding 20 /A of 0.5M MnSO^ and a F ,„ i„ value was obtained. 
Mn2+ displaced the calcium ions from Fura-2 and the Fura-2-Mn^"'" complex 
exhibited no fluorescence at the above setting of wavelengths. 
The intracellular free calcium level is then calculated according to the following 
formula: 
[Ca2>224(F-F …� „)/(F � - F ) 
where 224 (nM) is the apparent Kd of Ca"^-Fura-2 complex at cytoplasmic 
condition; F is the fluorescence reading of the fluorescence probes measured and 
the determination of and Fn“„ are as described above. 
2.3.6.3 Determination of Calcium Mobilization in L-929 cells hy Con Focal 
Microscopy 
Calcium level in L-929 cells was determined as described else where (Eberhard and 
Erne 1991). 1x10^ L-929 cells were seeded onto a 35 mm culture disk containing ‘ 
a circular cover slip and incubated overnight in a moist 5% CO2 incubator at 3 7 � C . 
The cover slip was then washed briefly with Na-HEPES (pH 7.4) and incubated 
with the fluorescence probe, namely, calcium green-AM-1/AM, at a final 
concentration of 2 /^ g/ml in Na-HEPES (pH 7.4) for 1 hour at 3 7 � C . The cover 
slip was then washed briefly in Na-HEPES and put in a special designed stainless 
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steel holder and examined under con focal microscopy (Molecular Dynamic). 500 
"I of Na-HEPES was added onto the cover slip to maintain the cell in viable stage. 
After selecting a cell or a group of cells, rhTNF was added to the surface of the 
buffer without disturbing the position of the cell(s) selected. The fluorescence 
images were captured and analysed by the software 'image space'. A laser of 488 
nm was used for excitation and emission signal at 510 nm was detected. The 
energy of the laser and sensitivity of the detector was kept constant throughout the 
experiment. 
2.3.6.4 Determination of Membrane potential by Fluorescence Probes 
The methods of Grinstein et a l . (1984) and Rink et al (1981) was followed. 5x10^ 
L-929 cells were incubated with 75 nM bis-oxonol (Grinstein el a l , 1984) at 3 7 � C 
for 30 minutes in Na-HEPES buffer (pH 7.2). After incubation, the cells were 
observed under a Perkin-Elmer Luminescence Spectrophotometer LS50B and the 
fluorescence tracing was monitored with at an excitation wavelength of 540 nm (3 
nm slit) and an emission wavelength of 580 nm (8 nm slit). After establishing a 
stable fluorescence tracing, various agents were added. Positive control was made 
by adding gramicidin (0.1 "g/ml). 
Another fluorescence probe, diS-C3-(5) (Rink et al, 1981) was also used to study 
the changes in membrane potential in L-929 cells. The procedure was similar to 
that of bis-oxonol except that the concentration used was 50 nM, the excitation 
wavelength used was 620 nm (5 nm slit), the emission wavelength used was 660 
nm (10 nm slit) and that the positive control used was 1 " M valinomycin. 
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2.3.6.5 Translocation of Nucleolar protein, luicleonhosmin (B23), in L-929 
cells 
The method as described by Chan el a l . (1987) was used. 1x10^ L-929 cells in 
complete RPMI-1640 medium were seeded onto a 35 mm culture disk containing a 
circular cover slip (Fisher 25mm circular microscope cover slip) and incubated 
overnight at 37°C in a moist CO2 incubator. The medium was then replaced with 
5 % heat-inactivated FCS in RPMI-1640 medium containing various concentrations 
and composition of drugs and further incubated for various time intervals. After 
incubation, the cells were fixed by immersing in 2% /?-tbrmaldehyde in PBS which 
were specifically prepared for B23 experiments (B23-PBS) for 20 minutes 
followed by 3 washes in B23-PBS with gentle shaking for 5 minutes each. The 
cells were then dehydrated in acetone at -20�C for 3 minutes. The cells were then 
rinsed briefly in B23-PBS for 4 times and then blown dry with cool air. 
Nucleolar protein B23 was detected by a monoclonal antibody directed against 
B23 nucleolar protein (anti-B23 monoclonal antibody was kindly provided by Dr. 
P.K.Chan, Baylor Medical College, TX, USA). This antibody was raised against 
B23 nucleolar protein isolated from human He La cell and belonged to a mouse IgG 
subclass. The antibody was diluted 1:20 (v:v) with B23-PBS. To each cover slip, . 
100 of the diluted antibody was added and kept overnight at 4°C in a moist 
chamber. The cover slips were then washed with B23-PBS 4 times with gentle 
shaking for 15 minutes/wash. After washing, the cover slips were blown dry with 
cool air. 
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To locate the anti-B23 antibody, 100 "1 of FITC-labeled goat anti-mouse IgG at a 
dilution of 1:200 in B23-PBS was added and incubated in a moist chamber at room 
temperature for one hour in the dark. After incubation, the cover slips were 
washed briefly in B23-PBS 4 times and examined under con focal microscopy. 
2.3.6.6 Determination of Protein Kinase C and Phospho-tyrosine Kinase in L-
929 cells 
1x10^ L-929 cells were seeded onto a 35 mm culture dish containing a circular 
cover slip and incubated overnight at 37°C in a CO2 incubator. The culture 
medium was removed, washed with Na-HEPES (pH 7.4) and replaced with 1 ml of 
Na-HEPES (pH 7.4) solution containing various amounts of rhTNF. After 
incubation for various time intervals, the cells were fixed with 5% acetic acid in 
methanol for 30 seconds. The sample was then immersed in ice-cold methanol for 
20 minutes followed by washing briefly in Na-HEPES (pH 7.4) solution. The cells 
were then immersed in 1%FCS in Na-HEPES to block the nonspecific binding. 
100 fiX of diluted first antibody (anti-PKC, or anti-phospho-tyrosine kinase,), at a 
dilution of 1:500 in Na-HEPES (pH 7.4) was added to each cover slip and kept 
overnight at 4°C. The cells were then washed 4 times in Na-HEPES with gentle 
shaking for 20 minutes during each wash. 
In case of staining of phospho-tyrosine kinase, the cells were ready for direct 
immunofluorscence study. For the cells stained with anti-PKC, an indirect 
immunofloursence study was employed. Briefly, 100 "1 of FITC-labeled anti-
mouse IgM at a dilution of 1:200 with Na-HEPES (pH 7.4) was added and further 
incubated for 1 hour at room temperature in darkness. The cells were ready for 
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immuno-fluorescence study after washing briefly 4 times with Na-HEPES (pH 
7.4). Immuno-fluorscence was studied by using a con focal laser microscopy. 
2.3.7 Uptake of 4Sca++ in L-929 cells 
5 X 10^ L-929 cells in 1 ml volume of culture medium were seeded into wells of 24 
well plate and incubated overnight at 37°C in a moist CO2 incubator. The culture 
medium was replaced with Na-HEPES (pH 7.4) supplemented with 5 % FCS 
containing various concentrations of rhTNF for different time intervals. 1.57 //Ci 
of in 50 "1 volume was added at 15 minutes before the end of incubation. 
After incubation, the cells were washed 3 times with ice-cold PBS. Afterwards, 
0.5 ml of IM NaOH was added to lyze the cells. The lysate was mixed with 
scintillation cocktail and radioactivity was determined by scintillation counter. 
2.3.8 Measurement of Meinhrane Potential hy Patch-clamp Assay 
The membrane potential of L-929 cells was determined by patch-champ as 
described else where (Huang el al 1993). IxlO^ L-929 cells were seeded onto 
culture dish and allowed to grow to subconfluent. The culture medium was then 
replaced with Na-HEPES (pH 7.4). Single isolated cells were selected for patch 
clamping. The patching was done inside the culture dish which worked like a 
reaction bath. The borosilicate glass patch pipette was pulled by a two-stage 
vertical pipette puller (Vitrex, Modo-johm, I/S). The pipette was further polished 
by an integrated coater-polisher (L/M-CPZ-101, List-Electronic). Before clamping 
the cell, the pipette was filled with filling solution which was similar in composition 
to norma! Na-HEPES except that the calcium ion concentration was adjusted to 
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120 nM. An agar salt bridge was used to connect the reference Ag-AgCl electrode 
to the reaction bath. The whole cell ionic current was recorded by a patch-clamp 
amplifier (Axopatch-ID, Axon Instrument). After forming whole cell 
configuration, the series resistance and cell capacitance were compensated. rhTNF 
was then added and the changes in membrane potential upon rhTNF treatment was 
then recorded by a IBM-AT compatible computer with an interface (TL-1-125, 
Axon Instruments) and analysed by using the software pClamp 5.5.1 (Axon 
Instruments). 
2.3.9 Determination of tyrosine kinase activation by Western blotting 
L-929 cells treated with or without rhTNF were harvested by low speed 
centrifugation to form the cell pellet. 1 ml of ice-cold suspension buffer (0.1 M 
NaCl, 10 mM Tris-HCl/pH 7.6，1 mM EDTA, 1 "g/ml DTT) was added to the cell 
pellet and mixed well. An equal volume of 2-fold SDS gel loading buffer (100 
mM Tris-HCl/pH 6.8, 200 mM DTT, 4% SDS, 0.2% bromophenol blue, 20% 
glycerol) was then added. The sample was placed in boiling water-bath for 10 
minutes. The sample was subjected to 1 minute sonication after cooling from 
boiling temperature. The sonicated sample was then centrifuged at 13,000x g for 
15 minutes and supernatant was collected and stored at -4°C for later use. ‘ 
The SDS-PAGE was performed as follows: The separating gel solution was 
prepared by mixing 3 ml of running gel buffer (1.5 M Tris-HCI, 0.4% SDS, pH 
8.8); 3.5 ml of acrylamide solution containing 0.3 g/ml acrylamide and 8 mg/ml 
N,N'-methylene bisacrylamide; 6 of TEMED; and 40 "1 of 10% ammonium 
persulfate. Distilled water was added to make up the final volume to 12 ml. The 
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well-mixed separating gel was added to the mini-gel apparatus (Bio-Rad) before 
polymerization. After the separating gel was formed, stacking was loaded on top 
of the separating gel with insertion of comb which was removed after the gel had 
been set. The stacking gel was composed of: 1 ml stacking buffer (0.5 M Tris-
HCl, 0.4% SDS, pH 6.8); 0.5 ml acrylamide solution; 6//I TEMED; 1 0 " 1 of 10% 
ammonium persulfate; and 2.7 ml distilled water. 20 "1 of sample was loaded into 
the wells and electrophoresis was run at lOOV with electrophoresis buffer (25 mM 
Tris, 1 % SDS, 0.193 M glycine, pH 8.3) until the the tracking dye migrated to the 
edge of the gel. 
The Western blotting was performed as follows: Six pieces of Whatman 3MM 
filter paper and one piece of nitrocellulose filter were cut to the exact size of the 
SDS-gel. The nitrocellulose filter was soaked with distilled water for at least 5 
minutes. The 3MM filter paper was soaked with transfer buffer (39 mM glycine, 
4.8 mM Tris, 0.037% SDS, 20% methanol, pH 8.3). The nitrocellulose filter, the 
SDS-gel and 3MM filter paper were placed into the blotter in the following 
sequence: three pieces 3MM papers, nitrocellulose filter, SDS-PAGE and finally 
three pieces 3MM filter papers. It should be noticed that the nitrocellulose filter 
was placed near the anode and that all air bubbles must be removed. The system -
was then allowed to run for 2 hours with a current of 66 mA. 
The nitrocellulose filter was then placed in T B S T blocking solution (10 mM Tris-
HCl, 150 mM NaCl, 0.05% Tween 20, 1%BSA, pH 8.0) for at least 30 minutes, 
the blocking solution was replaced by T B S T containing anti-tyrosine kinase 
antibody (1:10,000) and further incubated for 30 minutes. The filler was washed 
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with TBST 3 times and further incubated in TEST containing alkaline phosphatase-
linked second antibody for 30 minutes. The filter was washed again for 3 times 
and transferred to developing bath containing 0.66% NBT (v:v) and 0.33% BCIP 
(v:v) in alkaline phosphatase buffer (100 mM NaCl, 5 mM MgCl2-6H20, 100 mM 
Tris, ph 9.8). The coloration development was stopped by rinsing the filter in 
distilled water and stored in humidified plastic bag. 
2.3.10 Statistical analysis 
All results were expressed as the arithmetic mean � standard deviation (S.D.). 
Student's t-test was used to determine the confidendce limits in group 
comparisons. In most graphs, standard error of mean (S.E.M.) or standard 
derivation (S.D.) was plotted as error bar. Normally, p<0.05 is regarded as 
significant difference. 
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Chapter 3. Effect of rhTNF treatment on niicleopliosinin translocation in L-
929 cells 
3.1 Introduction 
Nucleophosmin, formerly known as nucleolar protein B23, is a nucleolar 
phosphoprotein which is more abundant in tumor cells and growing cells than in 
normal resting cells (Olson et a I , 1974, Prestayko el a l , 1974, Busch et a I , 1984). 
There are 2 forms of nucleophosmin in the nucleolus, namely the monomelic form 
(37 Kda), which consists of equimolar a monomer and p monomer; and the 
hexameric form (230 Kda), which consists of a and p monomers in a ratio of 2:1. 
It is suggested that the hexameric form is the biological active form while the 
monomelic form serves as a pool for the assembly of hexameric form (Yung and 
Chan, 1987). B-lymphocytes stimulated with mitogens give a 5- to 20-fold 
increases in nucleophosmin synthesis (Feuerstein et a l , 1987a; 1987b). 
The cDNA of nucleophosmin had been cloned. This cDNA encodes a protein of 
294 amino acids. By using this cDNA as probe, it was found that the quantity of 
nucleophosmin mRNA is 50-fold higher in Novikoff hepatoma and 5-fold higher in 
hypertrophic rat liver cells when compared to normal rat liver cells (Chan el a I , 
1989). When the level of nucleophosmin mRNA and the nucleophosmin molecule 
were compared in tumor cells, it seems that a translational control mechanism is 
involved in the expression of nucleophosmin. 
Even though the exact function of nucleophosmin is still uncertain, there is ample 
evidence suggesting that nucleophosmin is involved in the assembly of ribosomes 
(Schmidt-Zachmann et al，1987, Yung et a l , 1985a, Spectar et a I , 1987, Yung and 
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Chan, 1987). The location of nucleophosmin had been studied by electron 
microscopy and was found to concentrate in the granular region of the nucleolus 
where ribosome assembly occurs. Nucleophosmin had been found to be associated 
with 60S and 80S preribosomal particles in the nucleolus (Prestayko et a l , 1974， 
Yung et a l , 1985a). The antigenic site and phosphorylation site of humans, rats, 
and Xenopus laevis are highly conserved (Schmidt-Zachmann et al, 1987, Chan et 
a l 1986a, 1986b, Dingwall et al 1987). The amino acid sequence of 
nucleophosmin isolated from different animal sources shows high degree of 
homology, indicated that the nucleophosmin had been well conserved during 
evolution and might play an important role in some critical function in the cell. 
Possible function of nucleophosmin may include the transport of ribosomal 
subunits in the nucleus. It has been suggested that nucleophosmin is responsible 
for assisting ribosomal protein assembly in pre-ribosomal particles (Earnshaw et 
a l , 1980; Laskey et a l , 1987). 
Nucleophosmin translocation from the nucleolus to the nucleoplasm had been 
observed in tumor cells under serum starvation (Chan el a I , 1985) or treated with 
various anti-tumor agents such as actinomycin D (Yung et a I , 1985b), toyocamycin 
(Yung el a l , 1985a), luzopeptin (Huang et a l , 1983, Huang et a l , 1985, Yung et a l , 
1986), doxorubicin (Chan el a I , 1987) and mitomycin C (Chan et a l , 1988). The 
phenomenon of ‘nucleophosmin translocation' correlates with rRNA synthesis and 
processing. Inhibition of protein synthesis had no effect on nucleophosmin 
translocation (Chan et a l , 1985, Yung et a l 1985b). Experiments using luzopeptin 
analogues ( B B M 928 A, B, C, and D) (Huang et a l , 1983, Huang et a l , 1985) with 
different anti-tumor activities showed that translocation of nucleophosmin and 
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inhibition of RNA synthesis correlated with anti-tumor activities of luzopeptin 
(Yung el a l , 1986). 
It has been shown that nucleophosmin binds to certain elements in the nucleus, 
such as pre-rRNA, protein and matrix structures, and plays a role in RNA synthesis 
(Yung et a I , 1985a; Yung et a I , 1986). It seems reasonable to suggest that 
nucleophosmin translocation induced by anti-tumor agents may give rise to 
inhibition of rRNA synthesis and riboniicleoprotein particles processing. The anti-
tumor agents may either alter or destroy the binding sites of nucleophosmin in the 
nucleolus and hence the nucleophosmin losses its binding targets in the nucleolus 
and diffuses into the nucleoplasm giving the observed translocation pattern. Fields 
el a l (1986) found that nucleophosmin is associated with internal nuclear matrix in 
rat liver cells. Both the 60S and 80S riboniicleoprotein particles were found to be 
associated with nucleophosmin and that 60S riboniicleoprotein particle is the 
precursor of the large ribosomal subunits. It is conceivable that nucleophosmin may 
be involved in the transport of large ribosomal particles to the nucleoplasm through 
the internal nuclear matrix system. 
In another study of the function of nucleophosmin, another anti-tumor agent, 
nitrogen mustard was used. Nitrogen mustard was known to induce D N A inter-
strand cross-link resulting in the death of the tumor cell. It has been shown that 
the difference between nitrogen mustard-sensitive and nitrogen mustard-resistant 
cells resides within the nuclear matrix phosphoproteins (Moy and Tew, 1986). 
This study indicates the importance of interactions between nitrogen mustard and 
nuclear phosphoproteins. It also suggests that cross-link of nuclear 
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phosphoprotein may cause cell death in tumor cells. When nitrogen mustard at a 
therapeutic range was applied to tumor cells, a dose-dependent cross-link of 
nucleophosmin was observed (Chan, 1989). Considering the fact that tumor cells 
and proliferating cells are more susceptible to nitrogen mustard than normal resting 
cells, it seems that there are some relations between nucleophosmin cross-linking 
and cell death induced by nitrogen mustard. However, the reason for a high degree 
of nucleophosmin cross-linking in tumor cells induced by nitrogen mustard is not 
known. The large amount of nucleophosmin in tumor cells is unlikely to be the 
only factor for the high degree of cross-linking as no cross-linking is observed in 
normal cells. One possible explanation of the functions of nucleophosmin deduced 
from this study was that the nucleophosmin may provide initiation sites and induce 
proper conformation for iRNA synthesis (Chan et a I , 1990). 
Recently, workers in our laboratory (Lui et a I , 1993) found that hyperthermia at 
41°C and 43°C can enhance the translocation of nucleophosmin in Ehiiich ascites 
tumor cells, U-87 MG glioblastoma and U-373 MG glioblastoma. 
It should be noted that other nucleolar proteins, such as protein C23 and fibrillarin, 
do not translocate under treatments by anti-tumor agents (Chan et a l , 1985). 
Translocation of nucleophosmin may represent a special response of the tumor 
cells towards the anti-tumor drugs or hyperthermic treatment. However, no 
concrete relationship between nucleophosmin translocation and cell death has been 
proved. In this chapter, we studied the effect of rhTNF treatment on 
nucleophosmin in L-929 cells using an immuno-fluorescent technique. 
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3.2 Results 
We studied the effect of rhTNF treatment on nucleophosmin in L-929 cells using 
immuno-fluorescent technique as described in 'Materials and Methods'. 
Monoclonal antibody against nucleophosmin was kindly provided by Dr. P.K. Chan 
of Baylor Medical College (Houston, USA). This antibody recognizes only 
nucleophosmin with no cross-reaction against other nucleoproteins. 
3.2.1 Effect of T N F (in the presence or absence of actinomycin D) on the 
nucleophosmin translocation in L-929 cells : 
As actinomycin D has been shown to be a potent inducer of nucleophosmin 
translocation in tumor cells, actinomycin D was used as a control. Fig 3.1 shows 
the immunofluoresence micrographs taken from control L-929 cells and L-929 
cells treated with rhTNF with or without actinomycin D. 
In the figure, the pattern of nucleophosmin distribution can be classified into 3 
groups. Firstly, those with no translocation shows 5 to 7 very bright spots 
indicated that nucleophosmin are highly condensed in the nucleolus (pattern A). 
Secondly, those cells that show fluorescence all over the nucleus and in some 
cases, uneven distribution of the fluorescence occurs. The diffused fluorescence 
indicated that nucleophosmin is translocated all over the nucleus, presumably, into 
the nucleoplasm (pattern C). The third pattern showed fluorescence pattern 
between the first and second patterns. In this case, fluorescence spots are still 
found in the nucleolus, however, the whole nucleus shows deem fluorescence. 
This implies that, the nucleophosmin started to move away from nucleolus and 
move to the nucleoplasm (pattern B). 
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Fig. 3.1 Immunofluorescence imagegraph of nucleophosmin. L-929 cells were 
treated with rhTNF with or without actinomycin D or actinomycin D alone for 
various time intervals. L-929 cells were fixed and stained after treatment as 
described in 'Materials and Methods'. Panel A shows the result of L-929 cells not 
treated with any drugs. The fluorescence pattern is a taken as ‘pattern A � . Panel B 
shows the immuno-fluorescence imagegraph of L-929 cells treated with 1 //g/ml 
actinomycin D. Immuno-fluorescence imagegraph was taken at different time 
intervals. Upper left: 1 hour; upper right: 2 hours; lower left: 3 hours; lower right: 
4 hours. The fluorescence imagegraph taken from L-929 cells treated with 1 /�g/ml 
actinomycin D is a typical example of 'pattern C . Panel C shows the immuno-
fluorescence imagegraph of L-929 cells treated with 50 ng/ml rhTNF for various 
time interval. The imagegraphs were taken at various time intervals and they 
follow the same arrangement as described in panel B. L-929 cells treated with 50 
ng/ml rhTNF for 3 hours is a typical ‘pattern B � f luorescence imagegraph of 
nucleophosmin translocation. Panel D shows the fluorescence imagegraph of L-
929 cells treated with 50 ng/ml rhTNF and 1 "g/ml actinomycin D. Fluorescence 
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Fig. 3.1 Continuous. Panel C. 
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Fig. 3.1 Continuous. Panel A. 
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In the presence of 1 "g/ml actinomycin D, translocation of nucleophosmin 
occurred within one hour (pattern C) and the degree of translocation increased as 
the time of treatment increased. When 50 ng/ml rhTNF was administered alone for 
two to three hours, translocation of nucleophosmin also occurred (pattern B) but 
not so extensive as those treated with 1 /^ g/ml actinomycin D. The location of 
fluorescence diffused out to the nucleoplasm instead of condensing to give spots of 
highly fluorescent regions. This indicates that nucleophosmin started to translocate 
into the nucleoplasm. However, complete translocation (pattern C) was not 
observed after 4 hour treatment. When 50 ng/ml rhTNF and 1 //g/ml actinomycin 
D were applied to the cells, complete translocation of nucleophosmin (pattern C) 
was observed within two hours. Cells treated with a combination of 50 ng/ml 
rhTNF and 1 "g/ml actinomycin D gave a more extensive translocation even in 
samples treated for one hour. The whole nucleus was stained with fluorescence 
probe and with only a few areas showing higher fluorescence intensity. After 
treated for 4 hours, an evenly stained nucleus was observed in the cells. 
A dose-dependent translocation of nucleophosmin was also observed in another 
experiment. Fig. 3.2 shows the fluorescence images taken from L-929 cells treated 
with various amounts of rhTNF for 4 hours and stained for nucleophosmin. From 
the images, it can be found that translocation of nucleophosmin (pattern B) can be 
found in L-929 cells treated with 25 ng/ml rhTNF for 4 hours and the degree of 
translocation decreased as the dosage of rhTNF decreased. No translocation of 
nucleophosmin (pattern C) could be found when the concentration of rhTNF 
reached 0.8 ng/ml. 
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Fig. 3.2. Immunofluorescence imagegraph stained with anti-nucleoplasmin as first 
antibody in L-929 cells treated with various concentrations of rhTNF. L-929 cells 
were treated with rhTNF ranging from 25 to 0.4 ng/ml rhTNF in two-fold serial 
dilution for 4 hours. The L-929 cells were fixed and stained as described in 
'Materials and Methods'. Position of immuno-fluorescence imagegraphs of L-929 
cells treated with various concentrations of rhTNF are: left side, from top to 
bottom: 25 ng/ml; 12.5 ng/ml; 6.25 ng/ml and 3.125 ng/ml and right side, from top 
to bottom: 1.6 ng/ml, 0.8 ng/ml and 0.4 ng/ml. 
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In another experiment, nucleophosmin translocation in L-929 cells treated with 
rhTNF with or without actinomycin D was examined under a traditional 
fluorescence microscope. The number of rhTNF-treated L-929 cells that shows 
different translocation patterns were counted and the result showed on table 3.1. It 
was found that 1 "g/ml actinomycin D can induce complete translocation of 
nucleophosmin (pattern C) in 80% of the L-929 cells when treated for 3 hours. 
When 25 ng/ml rhTNF was used as a stimulator, about 25% of the treated L-929 
cells showed pattern C translocation. When L-929 cells were treated with 1 "g /ml 
actinomycin D and 25 ng/ml rhTNF together, complete translocation (pattern C) 
was observed in all L-929 cells. Fig. 3.3 shows the image taken from the 
fluorescence microscope showing typical view of the L-929 cells treated with 
various combination of drugs. 
3.2.2 Effect of actinomycin D on the TNF-mecliated cytotoxicity on L-929 
cells: 
Actinomycin D is known to be cytotoxic to tumor cells. In L-929 cells treated 
with rhTNF, actinomycin D suppressed the percentage survival in a dose 
dependent manner. Fig. 3.4 shows the result of a typical experiment in which L-
929 were treated with rhTNF together with various amount of actinomycin D. 
From the graph, it seems that actinomycin D was highly toxic to L-929 cells. At a 
concentration of 0.26 ng/ml rhTNF, rhTNF alone gave only a slight decrease of 
survival in L-929 cells, but in the presence of 0.5 //g/mI actinomycin D, the 
percentage survival dropped to 70%, indicating that actinomycin D was highly 
toxic to L-929 cells. In another experiment, L-929 cells were treated with rhTNF 
52 
Pattern A Pattern B Pattern C 
"control 100 Ol 0 
25 ng/ml rhTNF 0 74.3 25.7 
1 //g/ml act. D 0 19.0 81.0 
25 ng/ml rhTNF + 0 0 100.0 
J "g /ml act. D 
Table 3.1 Table showing the percentage of ceils with different patterns of 
nucleophosmin translocation in L-929 cells treated with or without rhTNF and 
actinomycin D (act. D) for 3 hours. For the description of the patterns of 
translocation of nucleophosmin, please refer to the text. The percentage of 
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Fig. 3.3 Immunofluorescence staining of nucleophosmin in L-929 cells treated 
with rhTNF with or without actinomycin D for 3 hours. The imagegraphs were 
taken under a fluorescence microscope. Treatment of the cells are described as: 
upper left: control; upper right 25 ng/ml rhTNF; lower left: 1 //g/ml actinomycin D 
and lower right: 1 "g/ml actinomycin D and 25 ng/ml rhTNF. 
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Fig. 3.4 Effect of actinomycin D on rhTNF mediated cytotoxicity on L-929 cells. 
4 
L-929 cells at a population of 4x10 /well were seeded to wells of 96-well plate and 
incubated overnight at 37°C in a moisten CO2 incubator. The culture medium was 
replaced with various dilutions of rhTNF with no actinomycin D ( • ) � 0.5 "g/ml 
actinomycin D (〇�or 1 "g/ml actinomycin D (V) and further incubated at 37°C in 
a moisten CO2 incubator for 20 hours. After incubation, viability was determined 
by neutral red uptake assay. Percentage survival was defined as the percentage 
ratio of O.D. 540 nm reading of individual well treated with rhTNF compared to 
the wells treated with medium. Results were means of six individual readings and 
S.E.M. of the readings were plotted as the error bars in the graph. 
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with/without 1 "g/ml actinomycin D for either 6 or 20 hours. Fig. 3.5 shows the 
result of this experiment. From the graph, it can be found that L-929 cells treated 
for 20 hours with different combination of drugs gave similar result as the former 
experiment. However, in L-929 cells treated for 6 hours with the cytotoxic agents, 
the cells remained alive and gave no difference comparing to the control. It seems 
that destruction of the cells does not occur within 6 hours after administration of 
rhTNF and/or actinomycin D. Taking together with the results concerning the 
fluorescence images after drug treatments, it seems that the translocation of 
nucleophosmin is not a result of cell death. However it may probably be one of the 
initial steps which leads to cell death in a later stage. 
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Fig. 3.5 Effect of actinomycin D on rhTNF mediated cytotoxicity on L-929 cells. 
L-929 cells at a population of 4 x 1 0 V e i l were seeded to wells of 96-well plate and 
incubated overnight at 37。C in a moisten CO2 incubator. The culture medium was ‘ 
replaced with various dilutions of rhTNF with or without actinomycin D and 
further incubated at 37°C in a moisten CO2 incubator. After incubation, viability 
was determinate by neutral red uptake assay. Percentage survival was defined as 
the percentage ratio of O.D. 540 nm reading of individual well treated with rhTNF 
compared to the wells treated with medium. The graph showed the results of 
various treatments: 1，treated with rhTNF only for 6 hours (〇)，2，Treated with 
rhTNF in medium containing 1 "g/ml actinomycin D for 6 hours (A), 3，treated 
with rhTNF only for 20 hours (•)，and 4，treated with rhTNF in medium 
containing 1 "g /ml actinomycin D for 20 hours ( • ) . Results were means of six 




In this study, the effects of rhTNF treatment on nucleophosmin in L-929 cells were 
investigated. Many anti-tumor drugs have been reported to induce nucleophosmin 
translocation in human HeLa cells (Yung et al, 1985c; Yung et a I , 1986; Yung et 
al, 1985b; Chan etal, 1985)，in rat Novikoff hepatoma cells (Chan et al, 1987) and 
in mouse leukemia cells (Chan el a I , 1987). This protein binds to certain 
element(s) in the nucleolus and plays an essential role in ribosome synthesis in 
tumor cells (Yung et al, 1986; Yung el al, 1985b). 
Translocations were followed using an immuno-fluorescence technique in present 
study. The decrease in nucleolar fluorescence in L-929 cells after rhTNF treatment 
is dose dependent. rhTNF at dosage smaller than 0.8 ng/ml did not exhibit any 
effect on the nucleolar fluorescence. The translocation of nucleophosmin in L-929 
cells in response to rhTNF is also time-dependent. When L-929 cells were treated 
with 50 ng/ml rhTNF, translocation was apparent after 2 to 3 hr. and complete 
translocation was observed only after 4h. The decrease in nucleolar fluorescence 
did not associate with any decrease in viability of L-929 cells treated with rhTNF. 
Treatment of rhTNF at 50 ng/ml for 6 h did not exhibit any decrease in viability 
(Fig 3.5). This phenomenon implies that nucleophosmin translocation is not 
directly linked to immediate cytotoxicity of rhTNF on L-929 cells. This situation 
/ 
also occurred when L-929 cells were treated with 1 ^g/ml actinomycin D. 
Translocation was observed as early as after 1 hr of treatment whereas treatment of 
this concentration of actinomycin D even combines with 50 ng/ml rhTNF could not 
cause any death of L-929 cells after 6 hr (Fig. 3.5). 
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The translocation could be accelerated by combining treatment of rhTNF and 
actinomycin D. As shown in Fig 3.1，when 50 ng/ml rhTNF and 1 ng/ml 
actinomycin was applied to the cells, complete translocation was observed within 2 
hours. The addition of actinomycin D (0.5 to 1 "g /ml) could also enhance the 
cytotoxic effect of rhTNF (0.26 to 33.3 ng/ml) on L-929 (Fig. 3.4 and Fig. 3.5). 
However, this combined treatment could not give any cytotoxic effect on L-929 
cells after 6 hr incubation. Only significant decrease in cell survival ( 〜 7 0 % 
decrease comparing with no treatment control) was observed after 20-24 hr 
incubation. 
The mechanism of the effect of rhTNF on the nucleophosmin translocation is not 
clear. Nucleophosmin is found to be a non-histone protein which is involved in 
ribosome synthesis (Schmidt-Eachmann et a I, 1987). Translocation of 
nucleophosmin may cause disruption of ribosome synthesis, as indicated in 
situations such as tumor cells treated with various anti-tumor agents (e.g. Chan el 
a I 1987). Whether rhTNF treatment on L-929 cells can cause suppression of 
ribosome synthesis via nucleophosmin translocation is of interest to study. It is also 
of therapeutically importance to investigate the association between the 
translocation and the cell survival during rhTNF treatment in the presence or 
absence of actinomycin D. 
59 
Chanter 4. Changes in membrane potential and intracellular pH in rhTNF-
mediated cytotoxicity in L-929 cells 
4.1 Introduction 
TNF induces a multitude of activities in different cell types. Each of which could be 
mediated through a variety of complex signal transduction mechanisms. Addition of 
rhTNF to a R12 neuron in the Aplysia Rurodai causes a decrease K+ conductance 
(Sawada et al 1990). TNF alters membrane permeability and causes a rapid decrease 
in resting membrane potential in skeletal muscle (Tracey et al 1986). Recently, it has 
been demonstrated that TNF trimer itself interacts with the lipid bilayer directly to 
form a Na+-like ion channel (Kagan et al 1992). Data also indicates that addition of 
TNF to human U937 cells increases ^^Na^ uptake by 3-fold (Kagan et al 1992). 
These observations suggest that change of membrane potential may be required for 
TNF-mediated cytotoxicity. To address this question, we tested the relationship 
between the membrane potential (Em) of L-929 cells and TNF-mediated cytotoxicity. 
In our experiments, Em of L-929 cells were measured by two fluorescent probes, bis-
(l,3-diethyl-thio-barbituric)-tri-methineoxonol (bis-oxonol) and 3,3'-
dipropylthiadicarbocyanine [dis-C3-(5)]. The Em of the cells were monitored by 
gramicidin and valinomycin. Cells were also clamped at lO-equilibrium potential or 
depolarized by gramicidin or high K+ buffer and tested for TNF cytotoxicity. Besides 
using fluorescent probes, we also employed patch-clamp technique to monitor the Em 
> 
of L-929 cells during TNF treatment. 
Vanhasesbroeclc et al (1990) reported that cytotoxic activity of TNF on L-cells is 
inhibited by amiloride derivatives without involvement of the Na+/H+ antiporter. 
Amiloride is an inhibitor of Na7H+ antiporter, L-929 cells treated with amiloride may 
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result in changes in intracellular pH. In present study, we also examined the 
relationship of intracellular pH and the TNF-mediated cytotoxicity. Since the transport 
in the cells is also controlled by Na+ and K+ transport (which are dependent on Na+/K+-
ATPase) we also employed K+ ionophore (nigercin), Na+ channel blocker 
(tetrodotoxin) and NaVK+-ATPase inhibitor (ouabain) to facilitate the change of 
intracellular pH and tested their effects on TNF-mediated cytotoxicity. We have also 
directly measured the change of intracellular pH of L-929 cells before and after rhTNF 
treatment. In this aspect, a pH sensitive fluorescent dye, [2��7 '-bis-(carboxyethyl)-




4.2.1 Effect of rhTNF on the membrane potential of L-929 cells determined by 
niiorescence method 
The effect of membrane depolarization on the rhTNF-mediated cytotoxicity was 
studied. Exogenous imposed membrane depolarization was produced by incubating L -
929 cells in K^-Hank's buffer solution (the final IC+ concentration was 75 mM). As 
shown in Fig. 4.1, addition of various concentrations of rhTNF which was diluted in 
Na+-Hank，s or K+-Hank’s buffer (also used as incubation buffer) showed similar 
cytotoxic pattern. No significant alteration of the EC50 of rhTNF was obtained in the 
neutral red uptake assay. Fig. 4.2a showed the normal morphology of the L-929 cells. 
These cells formed a uniform monolayer and exhibit well-defined cytoplasm and 
nucleus. In the control experiments, L-929 cells cultured in Na'-Hank's or K^-Hank's 
buffer did not show any differences in the morphology (Fig.4.2a, b). Challenge of cells 
with rhTNF (0.1-10 ng/ml) in Na^-Hank's or iC-Hank's induced similar killing pattern 
(Fig. 4.2c-f). It seems likely that no cell killing was observed in Na+-Hank，s or 
Hank's buffer when the concentration of rhTNF was 0.01 ng/ml in our system (Fig. 
4.2g，h). These findings suggested that exogenously imposed membrane 
depolarization by high buffer did not kill the L-929 cells nor affect the rhTNF 
mediated cytotoxicity. 
1 
The effects of rhTNF on the membrane potential (Em) of L-929 cells was determined 
by using two fluorescence probes, bis-oxonol and cliS-C3-(5). It has been reported 
that，under certain situations, diS-C3-(5) accumulates in mitochondria and inhibits the 
cellular metabolism (Grinstein and Dixon, 1989). It was therefore essential to validate 
the Em by using a negatively charged Em probe, bis-oxonol. As shown in Fig. 4.3， 
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Fig. 4.1 Effect of high on the rhTNF-media ted cytotoxicity on L-929 cells. One 
hundred of L-929 cells of density AxloVml suspended in 5% FCS supplemented 
RPMI-1640 medium were seeded in 96-well plate at 37。C，5%C02 for 24 hours. 
After incubation, 1 0 0 o f various concentrations of rhTNF diluted with Na'-Hank's 
buffer (o) or iC-Hank's buffer ( • ) was added. After 20 to 24 hours, the amount of 
neutral red uptake by viable cells were then measured. Results are mean � S.D. of at 
least 5 determinations. 
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〔 ig. 4.2 Effects of rhTNF on the morphology of L-929 cells in the high K'-Hank's 
buffer. L-929 cells were seeded in 96-well plates with 5% FCS-supplemented RPMI-
1640 medium at 37。C，5% CO2 for 24 hours. L-929 cells were then incubated with 
� r i o u s concentrations of rhTNF in Na'-Hank's buffer (a,c,e,g) or K^-Hank's buffer 
(M，f，h) 
as indicated in Fig. 4.1. for 24 hours at 37 5% CO2. Cells were then stained 
with neutral red for 1 hour. Results are representative for at least two experiments. 
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Fig, 4.3 Effects of rhTNF on the membrane potential of L-929 cells. Experimental 
procedure was described in 'Materials and Methods'. L-929 cells were incubated with 
75 nM bis-oxonol (first and second tracing) or 50nM diS-C3-(5) (third and fourth 
tracing). When the baseline fluorescence has been established, gramicidin (0.1 "g/ml), 
rhTNF (2 ng/ml or 20 ng/ml), or valinomycin (1 /<M) was added as indicated, tracings 
are representive of at least three experiments. 
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exposure of L-929 cells to rhTNF (2 ng/ml) did not alter the Em as measured by bis-
oxonol (second tracing). At the end of experiment, addition of monovalent cation 
ionophore, gramicidin, caused an increase of the fluorescence indicating a 
depolarization of the membrane. In addition, challenge of cells with rhTNF, which had 
been treated with gramicidin, did not produce any change of Em (Fig. 4.3，first 
tracing). Similar results were observed when the Em was determined by diS-C3-(5). 
As shown in Fig. 4.3 (third tracing), concentration of rhTNF up to 20 ng/ml did not 
cause any change of Em but membrane hyperpolarization could be obtained when cells 
were treated with valinomycin, a K+ ionophores. On the other hand, rhTNF also had 
no effect on the Em of the valinomycin-pretreated L-929 cells (Fig.4.3, fourth tracing). 
These results suggest that addition of rhTNF alone to L-929 cells did not change the 
membrane potential. The unresponsiveness was not due to the impairment of cells 
since gramicidin or valinomycin induced changes of Em. 
1-2.2 Effect of rhTNF on the memhraiie potential of L-929 cells determined by 
jjjUch clamp technique 
The effect of rhTNF on membrane potential of L-929 cells was also measured by 
patch-clamp technique. A whole cell patch was made and the membrane potential was 
measured as described in 'materials and methods'. Fifty ng/ml (final concentration) 
rhTNF was mixed with 5 ml of Na-HEPES buffer. The cells were perfused with this 
solution at a rate of 10 ml/minute by a perfusion pump. The data was analyzed by the 
software ‘pClamp�and the result was shown in Fig. 4.4. The X-intercept in the graph 
showed the membrane potential measured and the slope of the curve showed the 
conductance of the cell membrane. From the graph, it can be seen that there is only 
slight change ifi membrane potential when 50 ng/ml rhTNF was administered to the L -
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Fig. 4.4 Membrane potential of L-929 cells treated with rhTNF recorded by patch 
clamp technique. The graph showed the current-voltage relationship obtained from the 
same cell. A. Control, in which the resting potential was recorded; B. the same L-929 
cell treated with 50 ng/ml rhTNF; C. the same L-929 cell treated with 2 /^M 
ionomycin. 
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929 cells. However, 2 " M of ionomycin was effective in inducing a change in 
membrane potential. The patch clamp method was a more sensitive method when 
compared to the fluorescence assay and the results of the two assays indicate the same 
fact that rhTNF is unlikely to induce changes in membrane potential of L-929 cells. 
Results in Fig. 4.5 shows a dose-dependent cytotoxic effect of rhTNF on L-929 cells. 
The spectrum of effective dose of rhTNF was relatively broad and the EC50 was about 
0.1 ng/ml. To investigate whether the Em plays a role in the rhTNF mediated 
cytotoxicity, L-929 cells were stimulated under conditions in which the Em was held 
constant. When the Em was clamped at the K+ equilibrium potential by treating the 
cells with valinomycin, addition of rhTNF does not cause any changes in the EC50 of 
rhTNF with or without valinomycin treatment (Fig.4.5a). Similarly, cells pre treated 
with gramicidin for the membrane depolarization did not show any effect on rhTNF 
mediated cytotoxicity (Fig.4.5b). In another experiment, L-929 cells were treated with 
various concentrations of valinomycin for 4 hours before the cells were exposed to 
rhTNF. Fig. 4.5c shows that rhTNF mediated cytotoxicity was not affected in L-929 
cells when the membrane potential was clamped by valinomycin for 4 hours. These 
results further indicate that change of Em was not a necessary event for the rhTNF 
iTiediated cytotoxic action. 
1 2 . 3 Effect of K+, Na+ and pH on the rhTNF-mediated cytotoxicity on L-929 cells 
One of the factors that control the membrane potential is the distribution of alkaline 
metal ions, of which the most important ions are sodium and potassium ions. In 
normal cells, movement of these ions across membrane would induce changes in 
membrane potential. The movement of these ions was accompanied by a counterflow 
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Fif. 4.5 (a-c). Effect of Gramicidin and valinomycin on the rhTNF-mediated 
cytotoxicity on L-929 cells. One hundred "1 of L-929 cells at a density of 4xl0Vml 
(a) and 2xl0Vml (b) in 5% supplemented RPMI-1640 were seeded in 96-well plate at 
370c ,5% CO2 for 24 hours. After incubation, various concentrations of rhTNF were 
added in the absence (o) or presence ( • ) of 1 juU valinomycin (a) or 0.1 "g /ml 
gramicin (b). After 20 hours, the amount of neutral red uptake by the viable cells were 
then measured. Results are mean ± S.D. of at least 4 determinations. 
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Fig. 4.5 Continus. (c) Effect of valinomycin on rhTNF mediated cytotoxicity on L-
929 cells. L-929 cells at a population of 4xlo'^/well were seeded on wells of 96-
well plate. The cells were treated with 5 nM valinomycin (〇)�50 nM valinomycin 
( • ) and culture medium without valinomycin ( • ) for 4 hours before the 
administration of rhTNF. rhTNF at a concentration of 33.3 ng/ml to 0.26 ng/ml in 
two-fold serial dilutions were added and further incubated at 37。C in a humidified 
CO2 incubator for 20 hours. Viability of cells was determined by neutral red 
uptake assay. Percentage survival was defined as the percentage ratio of O.D. 540 
nm reading of individual well treated with rhTNF compared to the wells treated 
with medium. Results were means of six individual readings and S.E.M. of the 
readings were plotted as the error bars in the graph. 
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of other positive ions, such as H+ ion. Changes in the intracellular pH was measured in 
L-929 cells upon stimulation with various monovalent ion ionophorCvS and their ability 
to affect rhTNF mediated cytotoxicity was studied. The changes in intracellular pH 
was determined by using BCECF, a pH sensitive fluorescence dye, loaded into L-929 
cells and examined under a fluorescence spectrophotometer. Fig. 4.6 shows the 
changes in intracellular pH in L-929 cells treated with valinomycin. Valinomycin was 
able to decrease the intracellular pH from 7.16±0.01 to 6.99�c!!oi (n=4). However, 
the concentration needed was 500 nM, which is 100 to 500 times more concentrated 
than that used in cytotoxicity assay. When L-929 cells was treated with 1 " M 
valinomycin, no change in intracellular pH was observed (data not shown). 
Another potassium ionophore, nigercin, was employed to study its effect on rhTNF 
mediated cytotoxicity. Nigercin was applied to L-929 cells either before rhTNF 
treatment or together with rhTNF. Fig. 4.7 shows the result of rhTNF mediated 
cytotoxicity of L-929 cells pretreated with nigercin and Fig. 4.8 shows the result of 
similar experiment in which nigercin was administered together with rhTNF. From the 
result，it was found that this potassium ionophore enhanced the survival of L-929 cells 
exposed to rhTNF. When nigercin was administered together with rhTNF, the effect 
^vas more promising, nearly 30% increase in survival was observed at a dose of 33.3 
ng/ml rhTNF. In Fig.4.7, it was showed that nigercin at 1, 10 and 20 ng/ml gave 
similar enhancement in survival percentage, indicated that 1 ng/ml nigercin should be 
enough to give maximal inhibition in cytotoxicity induced by rhTNF on L-929 cells. 
When 1 ng/ml (final concentration) nigercin was applied to L-929 cells, the internal pH 
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Fig.4.6 Changes in fluorescence intensity in BCECF-AM loaded L-929 cells after 
valinomycin treatment. 1x10^ L-929 cells in 1 ml of Na-HEPES buffer (pH 7.4) 
were loaded with BCECF-AM as described for 30 minutes. The fluorescence 
intensity of the cells was monitored by fluorescence spectrophotometry and the 
recorded data was calculated as described in 'materials and methods'. Valinomycin 
was added to the cells to give a final concentration of 500 and 1000 nM when the 
fluorescence tracing was stable. The graph showed the tracing of one typical 
experiment. The calculated intracellular pH values of the cells with S.D. in this 
graph was obtained from 4 individual experiments. 
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Fig. 4.7 Effect of nigercin on rhTNF mediated cytotoxicity on L-929 cells. L-929 
.ce l ls at a population of 4xlo'^/well were seeded on wells of 96-well plate. The 
cells were treated with 1 //g/ml nigercin (〇)�10 "g/ml nigercin ( • ) � 2 0 / � / n i l 
nigercin ( • ) and culture medium without nigercin ( • ) for 4 hours before the 
administration of rhTNF. rhTNF at a concentration of 33.3 ng/ml to 0.26 ng/ml in 
two-fold serial dilutions were added and further incubated at 37°C in a humidified 
CO2 incubator for 20 hours. Viability of cells was determined by neutral red 
uptake assay. Percentage survival was defined as the percentage ratio of O.D. 540 
nm reading of individual well treated with rhTNF compared to the wells treated 
with medium containing only nigercin. Results were means of six individual 
readings and S.E.M. of the readings were plotted as the error bars in the graph. 
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Fig. 4.8 Effect of nigercin on the rhTNF mediated cytotoxicity on L-929 cells. L-
929 cells at a population of 4xlo'^/welI were seeded on wells of 96-well plate for 
the assay. RhTNF at a range of 33.3 ng/ml to 0.26 ng/ml in two-fold serial 
dilutions in medium containing 1 "g/ml nigercin (〇)’ 10 //g/ml nigercin ( • ) � 2 0 
"g/ml nigercin ( • ) and no nigercin ( • ) . Viability of L-929 cells was determined by 
neutral red uptake assay. Percentage survival was defined as the ratio of O.D. 540 
nm reading of individual well treated with rhTNF compared with the wells treated 
with no rhTNF but only culture medium or culture medium containing nigercin. 
Results are means of at least six individual measurements and S.E.M. of the 
measurements are plotted as error bar in the graph. 
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Fig.4.9 Changes in fluorescence intensity in BCECF-AM loaded L-929 cells 
treated with nigercin. 1x10^ L-929 cells in 1 ml of Na-HEPES buffer (pH 7.4) 
were loaded with BCECF-AM as described for 30 minutes. The fluorescence 
intensity of the cells was monitored by fluorescence spectrophotometry and the 
recorded data was calculated as described in 'materials and methods'. A final 
concentration of 1 ng/ml nigercin was added to the cells when the fluorescence 
tracing was stable. The tracing was obtained from one typical experiment. The 
calculated intracellular pH values of the cells was expressed with S.D. in this graph 
and the value was obtained by 4 individual experiments. 
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Nigercin is a potassium ionophore which stimulates the exchange of intracellular 
potassium ions with extracellular H+ ion. the changes in cellular H+ ion in a ratio of 1:1. 
However, the concentration of potassium ion inside the cell is about 140mM, an 
exchange of H+ that brings along a change of 0.5 unit pH (about 7% in case of 1 ng/ml 
nigercin on L-929 cells) would be insignificant compared to the change in percentage 
of potassium ion. Hence, it seems reasonable to believe that the enhancement of 
survival in nigercin treated L-929 cells was a result of changes in intracellular pH but 
not a change in potassium ion or membrane potential. 
As the exchange of H+ across the membrane is not only associated with potassium ion 
but also with sodium ion, sodium ion channel blocker was also used for the study of 
the effect of intracellular pH on rhTNF mediated cytotoxicity. Tetrodotoxin (TTX), 
isolated from ovaries of Japanese puffer fish, is a highly selective sodium channel 
blocker and was used to block the sodium channels on L-929 cells. The cytotoxicity of 
rhTNF on L-929 cells under the influence of TTX was studied and the result was 
shown in Fig. 4.10 and Fig. 4.11. In Fig. 4.10, the dose-dependent cytotoxic effect of 
rhTNF on L-929 cells pretreated with TTX was shown. There was a small but 
significant increase in survival percentage in these TTX-pretreated L-929 cells exposed . 
to rhTNF. In another experiment in which TTX was added to L-929 cells together 
with rhTNF, the enhancement was much more significant and promising. Fig. 4.11 
shows the result of this experiment, about 30% increase in survival percentage was 
observed when rhTNF at a dose of 33.3 ng/ml was used. 
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Fig. 4.10 Effect of TTX on rhTNF mediated cytotoxicity on L-929 cells. L-929 
4 
cells at a population of 1x10 /well were seeded on wells of 96-well plate. L-929 
cells were treated with 30 nM TTX (〇)�300 nM TTX ( • ) and culture medium 
containing no TTX ( • ) for 4 hours before the administration of rhTNF. The cells 
were incubated for a further 20 hours at 3TC in a humidified CO2 incubator. 
Viability was determined by neutral red uptake assay. Percentage survival was 
defined as the percentage ratio of O.D. 540 nm reading of individual well 
compared to the wells treated with medium containg TTX only but not with 
rhTNF. Results were means of six individual readings and S.D. of the readings 
were plotted as the error bars in the graph. 
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Fig. 4.11 Effect of TTX on rhTNF mediated cytotoxicity on L-929 cells. L-929 
cells were treated with rhTNF ranging from 33.3 ng/ml to 0.26 ng/ml in two-fold 
serial dilutions in the present of 30 nM TTX (〇)�100 nM TTX ( • ) and no TTX 
( • ) . Viability of L-929 cells was determined by neutral red uptake assay. 
Percentage survival was a percentage ratio obtained by comparing the O.D. 540 
nm reading of individual well with well containing no TNF but only TTX or culture 
medium. Result was obtained from at least six individual measurements and 
S.E.M. was plotted as error bar in the graph. 
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One of the factors that control the exchange of monovalent ion across the membrane is 
) 
t 
NaVK+-ATPase. This enzyme regulates the movement of N a + � I C by an energy 
dependent process. This Na+/K+-ATPase can be inhibited by using the drug, ouabain. 
Ouabain is not very effective in altering the intracellular pH as shown in Fig. 4.12. The 
pH value dropped about 0.1 unit when 100 [aM ouabain was applied to L-929 cells. 
When it was added to L-929 cells for pretreatment, it offered no significant protection 
to the L-929 cells when the cells were exposed to rhTNF treatment. Fig, 4.13 shows 
that L-929 cells pretreated with 10，50 and 100 " M ouabain for 4 hours gave similar 
killing pattern when exposed to rhTNF compared with control. Fig. 4.14 shows that 
the survival curve of L-929 cells treated with rhTNF together with 10，50,100 / i M 
ouabain shifted a little to the right. In the graph, it can also be found that there is no 
dose-dependent effect of enhancement in survival of L-929 cells treated with various 
concentrations of ouabain. This indicates that NaVK7ATPase may only play a minor 
role in the mechanism of rhTNF mediated cytotoxicity of L-929 cells. 
Another mechanism that control the flow of monovalent ion is Na7H+ antiporter 
inhibitor. NaVH+ antiporter is responsible for the exchange of Na+ and H+ ions across 
cell membrane. Amiloride is a NaVH+ antiporter inhibitor that has no affinity for 
potassium ion and when low dosage of amiloride is used, it functions as specific 
inhibitor for transmembrane Na+ entry (Sariban-Sotorabay and Benos, 1988). The 
effect of amiloride on rhTNF mediated cytotoxicity on L-929 cells was investigated 
and the result shown on Fig. 4.15. From the graph, it can be seen that there was a 
close-dependent increase in survival induced by amiloride on rhTNF cytotoxicity on L-
929 cells. Fig.4.16 shows the results of experiment in which L-929 cells were 
pretreated with amiloride for 4 hours before the administration of rhTNF. An 
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Fig. 4.12 Changes in fluorescence intensity in BCECF-AM loaded L-929 cells 
treated with ouabain. 1x10^ L-929 cells in 1 ml of Na-HEPES buffer (pH 7.4) 
were loaded with BCECF-AM as described in 'materials and Methods' for 30 
minutes. The fluorescence intensity of the cells was monitored by fluorescence 
spectrophotometry and the recorded data was calculated as described in 'materials 
and methods'. Ouabain was added to the cells to give a final concentrations of 50 
/^M and 100/^M when the fluorescence tracing was stable. The graph showed the 
tracing obtained from one typical experiment. The calculated intracellular pH 
values of the cells with S.D. in this graph was obtained from 4 individual 
experiments. 
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Fig. 4.13 Effect of ouabain on rhTNF mediated cytotoxicity on L-929 cells. L-
4 
929 cells at a population of 1x10 /well were seeded on wells of 96-well plate. L-
929 cells were treated with 10 /^M ouabain (〇)�50 juM ouabain ( • ) � 1 0 0 /iM 
ouabain ( • ) and culture medium containing no ouabain ( • ) for 4 hours before the 
administration of rhTNF. The cells were incubated for further 20 hours at 37°C in 
a humidified CO2 incubator. Viability was determined by neutral red uptake assay. 
Percentage survival was defined as the percentage ratio of O.D. 540 nm reading of 
individual well compared to the wells treated with medium without or ouabain 
only. Results were means of six individual readings and S.D. of the readings were 
plotted as the error bars in the graph. 
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Fig. 4.14 Effect of ouabain on the rhTNF mediated cytotoxicity on L-929 cells. L-
929 cells at a population of 4xloVvel l were seeded on wells of 96-well plate for 
the assay. RhTNF at a range of 33.3 ng/ml to 0.26 ng/ml in two-fold serial 
dilutions in medium containing 10/^M ouabain (〇)�50 /^M ouabain ( • ) � 1 0 0 / ^ M 
ouabain ( • ) and no ouabain ( • ) was added to the cells and incubated for 20 hours.. 
Viability of L-929 cells were determined by neutral red uptake assay. Percentage 
survival was defined as the ratio of O.D. 540 nm reading of individual well 
compared with the wells treated with no rhTNF but only culture medium or culture 
nieclium containing ouabain. Results were means of at least six individual 
measurements and S.D. of the measurements were plotted as error bars in the 
graph. 
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Fig. 4.15 Effect of amiloride on rhTNF mediated cytotoxicity on L-929 cells. L-
929 cells were treated with rhTNF ranging from 33.3 ng/ml to 0.26 ng/ml in two-
fold serial dilution in the presence of 1 0 a m i l o r i d e (〇)�50 " M amiloride (V) 
and no amiloride ( • ) . Viability of L-929 cells was determined by neutral red 
uptake assay. Percentage survival was a percentage ratio obtained by comparing 
the O.D. 540 nm reading of individual well with well containing no TNF but only 
amiloride or culture medium. Result was obtained from at least six individual 
measurements and S.E.M. was plotted as error bar in the graph. 
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Fig. 4.16 Effect of amiloride on rhTNF mediated cytotoxicity on L-929 cells. L-
4 
929 cells at a population of 1x10 /well were seeded on wells of 96-well plate. L-
929 cells were treated with 10//M amiloride (〇)�50/^M amiloride (V) and culture 
medium containing no amiloride ( • ) for 4 hours before the administration of 
rhTNF. The cells were incubated for a further 20 hours at 3 T C in a humidified 
CO2 incubator. Viability was determined by neutral red uptake assay. Percentage 
survival was defined as the percentage ratio of O.D. 540 nm reading of individual 
well compared to the wells treated with medium containing amiloride but not 
rhTNF. Results were means of six individual readings and S.E.M. of the readings 
were plotted as the error bars in the graph. 
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enhancement of survival in the present of 50 " M amiloride was observed. From the 
results of Fig. 4，;:]5 and Fig, 4.16，it is conceivable that sodium entry may play a role 
in rhTNF mediated cytotoxicity on L-929 cells. As an entry of sodium is accompanied 
by a out-flux of H+�and thus an increase in intracellular pH, the role of intracellular pH 
on rhTNF mediated cytotoxicity should further be studied. 
Changes in intracellular pH of L-929 cells upon rhTNF stimulation was investigated by 
using the pH-sensitive dye, BCECF as described in 'Materials and Methods'. BCECF-
AM was loaded into the L-929 cells before experiment as described in 'materials and 
methods'. A typical fluorescence tracing was shown on Fig. 4.17, from this graph, it 
can be noted that there were no significant change in intracellular pH when L-929 cells 
were stimulated by a very high dose of rhTNF (100 ng/ml). Table 4.1 shows the 
intracellular pH values of L-929 cells treated with or without various concentrations of 
rhTNF. No significant change in intracellular pH was found after li iTNF treatment. 
In another experiment, the intracellular pH of L-929 cells treated with rhTNF was 
measured at different time intervals. The result was plotted on Fig. 4.18. The 
intracellular pH remained stable for the first 3 hours but start to drop after 4 hours of 
treatment. However, the changes in pH was only about 0.05 units. The effect of pH 
on rhTNF mediated cytotoxicity was also investigated. RPMI-1640 medium was 
replaced with Na-HEPES buffer supplemented with 5%FCS with different pH values. 
Cells were kept in CO2- free air incubator to avoid changes in pH due to 
COz/bicarbonate buffering. One j jM digitonin was added to equilibrate the internal 
and external pH. Fig. 4.19 shows the result of this experiment. From the graph, it can 
be found that within pH value of 7.0 to 7.6’ the survival percentage increased with a 
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Fig. 4.17 A typical fluorescence tracing of BCECF-loaded L-929 cells treated with 
rhTNF. L-929 cells were loaded with BCECF-AM as described in 'material and 
methods�. After washing with Na-HEPES (pH 7.4), the fluorescence intensity of 
the cells was recorded as described in 'materials and Methods'. In this tracing 100 
ng/ml rhTNF was added. The pH values at different points were calculated as 
described and indicated on the graph. 
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rhTNF (ng/ml) Before addition of After addition of Different 
rhTNF rhTNF 
12.5 r i 6 ~ ^ ^ 
25 7.145 7.15 0.005 
100 7.16 7.155 -0.005 
175 7.15 7.17 0.02 
Table. 4.1 Intracellular pH vaules in L-929 cells treated with rhTNF for 5 minutes. 
1x10 L-929 cells in 1 ml Na-HEPES were loaded with BCECF-AM for 30 
minutes and subjected to spectrophotometer as described. Various amounts of 
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Fig. 4.18 Changes in intracellular pH of L-929 cells treated with rhTNF. 1x10^ L-
929 cells in 1 ml of Na-HEPES buffer were treated with 100 ng/ml rhTNF and 
incubated at 3 T C for various periods of time. BCECF-AM was loaded half hour 
before the end of incubation and the intracellular pH was determined as described 
in 'materials and methods'. The graph showed the result of a typical experiment. 
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Fig. 4.19 Effect of pH on rhTNF mediated cytotoxicity on L-929 cells. L-929 cells 
diluted at a population of 4xlo'^/well in culture medium were seeded onto wells of 
96-well plate and incubated overnight at 37。C in a humidified C02 incubator. The 
culture medium was replaced with rhTNF ranged from 33.3 ng/ml to 0.26 ng/ml in 
Na-HEPES solutions containing 1 juM digitonin with pH adjusted to 7.0 (A), 7.2 
(〇)�7.4 ( • ) and 7.6 ( • ) • The cells were kept at 3TC in a C02 free incubator for 
24 hours. The viability of the cells was determined by neutral red uptake assay. 
Percentage survival was a percentage ratio obtained by comparing the O.D. 540 
nm reading of individual well with well containing no TNF but only Na-HEPES 
buffer at different pH. Result was obtained from at least six individual 
measurements and S.E.M. was plotted as error bar in the graph. 
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decrease in pH. From the results of the above experiments (Fig. 4.19)，there are 
implications that pH plays a role in rhTNF mediated cytotoxicity on L-929 cells. 
However, when L-929 cells were treated with rhTNF, there are no transient change in 
intracellular pH. The pH of L-929 cells treated with rhTNF for 4 hours shows a drop 
of intracellular pH. This drop of intracellular pH may not be a direct effect of rhTNF 
treatment because the drop of pH is only 0.05 units and occurs 4.5 hours after 
administration of rhTNF (Fig. 4.18). It was postulated that rhTNF does not induce 
changes in internal pH as a means of signal transduction, but the events following 




In the present study, it has been illustrated that membrane potential (Em) does not play 
any role in rhTNF-mediated cytotoxicity in L-929 cells. This conclusion is based on 
our observations (1) TNF did not induce any changes of Em of L-929 cells but 
gramicidin and valinomycin produced positive responses as measured by two 
fluorescent probes bis-oxonol and dis-C3-(5) or by patch-clamp technique; (2) 
exogenously imposed membrane depolarization by gramicidin or high K+ buffer did not 
attenuate the TNF-mediated cytotoxicity in L-929 cells. (3) when the Em of L-929 
cells were clamped at K^-equilibrium potential, TNF showed a dose-dependent 
cytotoxicity which was very similar to the normal TNF cytotoxic action. Our results 
are consistent with those of Yuo et al (1989) who showed that TNF-induced 
superoxide production in human granulocytes is not accompanied with membrane 
depolarization. However, the TNF effect may vary in different cell types. 
We also found that rhTNF could not affect the intracellular pH of L-929 cells. 
However, lowering the intracellular pH in L-929 cells could result in inhibition of 
cytotoxicity of rhTNF on the cells. In our experiments, intracellular pH was 
decreased by using K+ ionophore (nigercin) to remove intracellular K+ in exchange of 
H + � o r by employing sodium ion channel blocker (TTX) to block Na+ channel and 
preserving intracellular H + � and by Na+/H+ antiporter inhibitor (amiloride) to inhibit 
transmembrane Na+ entry and preserved intracellular H+. We speculate that the event 
after TNF- treatment may be a pH-dependent process which may he activated (in term 
of cytotoxicity) under higher pH (i.e. at alkaline condition). Our findings that 
amiloride could inhibit the cytotoxic activity of TNF on L-929 cells are consistent with 
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the results reported by Van Haesebroeck el al (1990). However, more experiments 
are needed to determine whether Na+/H+ antiporter or other transporters may take part 
in rhTNF -mediated cytotoxicity in L-929 and other tumor cell lines. 
Recently, our colleague had demonstrated that the intracellular pH of L-929 cells could 
be affected by rhTNF. Under confocal microscopy, L-929 cells developed a sharp 
drop in intracellular pH when rhTNF was added. The drop of intracellular pH resumed 
back to normal level within seconds (personal communication). The recovery was 
delayed by the add it ion of nigercin. This changes in intracellular pH was not observed 
y 
in U-87MG cells which was a rliTNF-resistance cell line. The sensitivity of normal 
fluorescence spectrophotometer may not be good enough to capture the changes 
within such a short time and this explains why we cannot detect any changes in 
intracellular pH in L-929 cells treated with rhTNF by using a fluorescence 
spectrophotometer. Taking together with this finding, it seems that the intracellular 
pH plays a major role in rhTNF-mediated cytotoxicity in L-929 cells. 
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Chapter 5. Effect of intracellular cAMP and cAMP-dependent protein kinase 
(protein kinase A) on the rhTNF mediated cytotoxicity on L-929 cells 
5.1 Introduction 
5.1.1 GTP-hinding protein (G-proteiii), cAMP and protein kinase A (PKA) 
The guanine nucleotide-binding proteins (G-proteins) serve as membrane-bound 
transduction of chemically and physically coded information. They function as 
intermediates in transmembrane signaling pathways that consist of three proteins: 
receptors, G-proteins and effectors. The nature of G-proteins have been 
extensively reviewed (Iyengar, 1990; Oilman, 1987; 1989; Ross, 1988; Brass, 
1988; Neer and Clapham, 1988; Allende, 1988; Weiss et al, 1988; Micheael and 
Simon, 1988). Besides signal transduction across cell membrane, G-proteins also 
take parts in control of ion channels across membrane (Brown and Birnhaumer, 
1988; Brown et al, 1988; Rosenthal et al, 1988)，secretion (Cockcroft et al, 1987)， 
microtubule assembly (Cassmeris et al, 1987)，protein synthesis (Moldave, 1985) 
and intracellular transport (Seger et a I , 1988) 
The G-proteins are heterotrimers and consists of 3 subunits designated as a, p and 
Y in order of decreasing molecular weight. The a subunits differ among the 
members and define the action and property of individual G-protein. Some of the 
a subunits share one common feature in that they are substrates for ADP-
ribosylation catalyzed by bacterial toxins. This feature is important in the study of 
G-protein as bacterial toxins are commonly available. GTP binding site was found 
on the subunits and was responsible for the interactions of G-protein-effector arm 
of the system. Common p and 丫 subunits share among a subunits to form the 
specific trimers. 
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Some of the G-protein related receptors have been studied and defined. They 
shared some degree of amino acid sequence similarity (-25%) and a similar 
transmembrane structure. These receptors are believed to span the plasma 
membrane several times with hydrophilic loops based on hydrophobic plots. The 
hydrophilic loops are believed to interact with the G-proteins. 
The function of G-proteins is regulated cyclically by dissociation of GDP and 
association of GTP with the a subunit followed by hydrolysis of GTP to GDP and 
phosphate group (Pi). Dissociation of GDP from a subunit is triggered by the 
binding of ligand to the receptors and seems to be the rate limiting step in the 
receptor-G-protein-effector system. Binding of GTP is closely associated with the 
activation of the G-protein and regulation of the effector system. The binding of 
GTP also dissociates the a subunit from the p-丫 subunits. The dissociated a 
subunit is believed to be responsible for the transduction of signal to the effector 
system. Deactivation of G-proteins is related to the hydrolysis of GTP to GDP by 
endogenous GTPase activity of the a subunit. This deactivated a subunit then 
reassociates with the p-y subunit to form the heterotrimer and is ready for next 
stimulation. As one ligand-receptor complex can activate about ten G-protein ‘ 
systems over a period of a few seconds, this system can amplify the signal across 
the cell membrane. The interactions of the three subunits of G-protein also 
provides a mean for the control of inhibitory and stimulatory inputs and cross-
interact for various second messenger systems. 
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The multiplicity and heterogeneity of the enzymes controlling the synthesis and 
metabolism of second messengers appear to be the key mechanism in achieving 
specific effects by the primary agents. There are several molecular species of G-
proteins, mainly based on different a subunits, as well as effector enzymes linked to 
the G-proteins. These enzymes determine the outcome of the reactions of the cells 
towards the binding of the primary agents to its receptors. These enzymes include 
adenylyl cyclase, phosphodiesterase, protein kinases and phospholipase. 
Several classes of G-proteins are defined by their a subunits. They are the Gs, G[, 
Gt and Gq. The Gs was first defined by its ability to activate adenylyl cyclase and 
consisted of a mixture of 5 oligomers with different a subunits. Two of them are 
well studied and the molecular weights of the a subunits were found to be 52 and 
45 Kda respectively as determined by SDS-polyacrylamide gel electrophoresis. 
The relative concentrations of the two forms of Gs vary among cells and tissues. 
Different types of Gs differ in their stability of their activated states and their 
sensitivities towards receptors. By studying their mRNA sequence of their a 
subunits，they are believed to arise from a single gene of a subunits by alternative 
splicing of internal exons (Robishaw el a l , 1987). Gs is also responsible for the 
control of C a " channels (Vantani el a l , 1988) and inhibits Mg2+ and glucose 
uptake (Iyengar, 1990). 
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The a subunit of Gj was first visualized as a 41 Kda substrate for ADP-ribosylation 
by pertussis toxin. There are at least 4 types of Gj purified from different animal 
and tissue sources. They were first known for their ability to inhibit adenylate 
cyclase. Gj was ten times more abundant than Gs in plasma membrane (Oilman, 
1987). The amount of Gj has been proved to be related to aging (Green and 
Johnson, 1989). This gives an explanation to the changes in sensitivity of cells 
isolated from aged animals in response to various drugs. Gj is also responsible for 
the control of K+ ion (lyenger, 1990; Vantani et al, 1988) and glucose movement 
across membrane and regulation of phospholipase A2 and phospholipase C 
(Crouch and Lapetina, 1988). One of the members of the G[ is Gp which activates 
phosphoinositol-specific phospholipase C (PLC) (Litosch and Fain, 1986). 
The Gt of G-proteins, purified at about the same time as Gg, is found strictly in 
retina and is also named as transducin. It consists of two members, one found in 
the rod cells (the a subunit consists of 350 amino acids) and the other in the cone 
cells (the a subunit consists of 354 amino acids) of the retina. They couple -
rhodopsin to a cGMP phosphodiesterase to the rod/cone cells. They are involved 
in visual transduction (Iyengar, 1990; Chabre and Deterre, 1989). Another 
member of the G-protein is the G。. It is mainly found in the brain and consists of 
2-3 members. The a subunits of Gq has a molecular weight of 33 Kda and is 
pertussis toxin sensitive. It can stimulate phospholipase C (Iyengar, 1990) and 
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regulate Ca^"^ and K:+ channels (VanDonggen et a I , 1988). There is still one new 
member in the G-protein family，the G^, which functions as a nuclear effector 
(Iyengar, 1990). 
5.1.2 Role of cAMP as second messenger 
Of all the known signal transduction system, cAMP and cAMP-dependent protein 
kinase system is the most well studied. The role of cAMP as a second messenger 
in hormonal response was first suggested in 1958 (Sutherland et al 1960). 
However, it was later found that cAMP did not take part directly in the response 
but only affect the next member of the signal transduction cascade, the cAMP-
dependent protein kinase. This cAMP-dependent protein kinase was responsible 
for the phosphorylation and hence the modulation of enzymes in the target cells to 
give the appropriate response. A wide range of metabolic responses, such as 
hormonal and neurotransmitter responses, interferon action and susceptibility to 
viral infection，growth stimulation by polypeptide growth factors, viral cell 
transformation, chemical tumor promotion, DNA transcription and repair, protein 
synthesis, energy metabolism, and muscle contraction, have been shown to be 
controlled by this cyclic nucleotide cascade system. Together with allosteric 
regulation and control of enzyme levels through differential rates of protein 
synthesis and degradation, cyclic nucleotide cascade system maintain the living cell 
in a responsive, highly regulated state. The cAMP cascade consists of adenylate 
cyclase，cyclic nucleotide phosphodiesterases, cAMP-dependent protein kinase, 
several phosphoprotein phosphatases, and numerous inter-convertible proteins and 
allosteric effectors involved in many metabolic pathways. 
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Activation of the cAMP cascade starts when ligand binds to its specific receptors 
which are linked with G-protein. The binding changes the conformation of the 
receptor and giving a ligand-receptor complex which can further activate the G-
protein by accelerating the exchange of the bound GDP with GTP. The GTP-
bound G-protein becomes activated and interacts with adenylate cyclases, resulting 
in the activation of the enzyme. The activated adenylate cyclase hydrolyzes ATP 
to give cAMP. The activated G-protein is inactivated by the hydrolysis of the GTP . 
back to GDP. The activity of adenylate cyclases, which is a key factor that affect 
the level of intracellular cAMP, thus is controlled by the balance between the 
amount of GTP-bound G-proteins and GDP-bound G-proteins. Upon stimulation 
by the ligand, the intracellular cAMP level rises and causes the activation of the 
third messengers. The turnoff of the third messengers can be achieved by down-
regulating the cAMP level. In intact cells, the cAMP is hydrolysed to 5 '-AMP by 
phosphodiesterases. Several types of phosphodiesterases are involved and their 
activity depends on the cAMP levels. Some of the intracellular cAMP move out of 
the cell and goes to the extracellular space and this is a main source of serum 
cAMP. 
The activation of third messenger by cAMP has been well studied. In intact cells, 
cAMP activates the cAMP-dependent protein kinase A by binding to regulatory 
subunits of an enzyme complex, resulting in the release and activation of the 
catalytic subunits of protein kinase A. The catalytic subunit can phosphorylate 
cellular proteins in the presence of ATP. Protein kinase A can also phosphorylate 
another inter-convertible enzyme which further transmits and amplifies the signal in 
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this cAMP cascade. Activated protein kinase A can be deactivated by specific 
phosphoprotein phosphatases. Thus, the level of phosphorylated target proteins 
can be regulated by the activities of the protein kinase A and phosphoprotein 
phosphatases. 
In the cAMP cascade system, the signal generated by ligand binding to the 
receptors on the cell surface can be transmitted into the cell and during the 
transmission, the signal can be amplified. Indeed, it has been postulated that there . 
may be an amplification of several orders of magnitude. Another advantage of this 
cascade system is that such a system presents numerous possibilities to be 
modulated by allosteric factors, since each component, hence each kinetic 
parameter, may be modulated, allowing for an efficient control of the 
responsiveness of the system to the primary stimulus. 
5.1.3 Bacterial toxin used For study of G-protein 
Some of the a subunits of G-proteins contain recognition site that allow ADP-
ribosylation by bacterial toxin. This provides an easy and convenient means to 
study the G-proteins. Cholera toxin is one of the most widely studied bacterial 
toxin that can affect G-protein activity. Cholera toxin (CTX) is an extracellular -
secreted protein produced by toxicogenic strains of Vibrio cholerae. Cholera toxin 
is composed of two subunits, subunit A (Molecular weight 27 Kda) and subunit B 
(molecular weight 11.6 Kda). The subunit A consists of 2 peptides, A l and A2, 
linked together by disulfide bonds. The B subunit is responsible for the binding of 
the toxin to the target receptor while the A2 peptide can go into the cells and 
catalyses ADP ribosylation of the a subunit of the membrane-associated G-protein. 
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They affect mainly the Gs and Gt. ADP-ribosylated G-protein is resistant to the 
hydrolysis of GTP bound on the a subunit and hence causes persistent activation. 
Another toxin is the pertussis toxin (PTX) isolated from Bordetella pertussis. The 
toxin consists of two components, the A protomer and the B oligomer. It is the A 
protomer that has the ADP-ribosylation activity. It attacks a cysteine residue near 
the carboxyl terminus of Gj, Gi and G(). As this cysteine residue is absent in G^, 
pertussis toxin has no effect on Gg. Pertussis toxin has been shown to inactivate 
the GTP-binding protein receptor (the a receptor) by ADP-ribosylation. Pertussis 
toxin can also induce a slow influx of that in turn activates adenylate cyclase 
and increase intracellular cAMP level. 
5.1.4 Effect orcAMP on rhTNF cytotoxicity 
Not many experiments have been performed to elucidate the relationship between 
cAMP, protein kinase A (PICA) and the cytotoxic effect of rhTNF on tumor cells. 
Early observations indicated that TNF can increase cAMP level in normal cultured 
mesangial cell (Baud et a I , 1988). TNF can increase both cAMP level and PKA 
activity in human fibroblasts (Zhang el a I , 1988). To our knowledge, there are no 
report on the effect of rhTNF on the change of cAMP in experimental tumor cells 
in vitro. Concerning the effect of intracellular cAMP on the cytotoxicity of rhTNF, 
Chun and Hoffmann (1987) reported that increase of the intracellular cAMP 
concentration by dibutyryl cAMP (which is resistant to phosphodiesterase in the 
cells), or by forskolin can enhance the sensitivity of L-cells to rhTNF. Recently, 
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Branellec et al (1993) reported that the potentiating effect of cAMP-inducing 
agents, such as forskolin, on TNF-mediated cytotoxicity on MCF-7 cells (humans 
breast tumor cell line), is not mainly due to cAMP but is associated with an 
increase in the DNA fragmenting capacity on TNF by this agent. 
In the present study, we first determined whether rhTNF could increase the 
intracellular cAMP level in L-929 cells. We then examined whether increasing or 
decreasing the intracellular cAMP concentration could affect the rhTNF's -
cytotoxicity. Since it has been reported that some of the actions of dibutyryl 
cAMP are mediated by butyrate in many tumor cells (Yusta et al, 1988; Gross et 
a I , 1988; Ryan et a I , 1987), we decided not to use dibutyryl cAMP as the cAMP 
source in our experiments. Instead, we have employed a newly developed cAMP 
analog, namely Sp-cAMPS which is an agonist of cAMP dependent protein kinase 
(Rothermel et a I , 1988) thus mimicking the effects of natural cAMP without other 
side-effects, and has drastically improved stability towards cyclic nucleotide 
phosphodiesterase (Braumann el al, 1986) in our study. We have also tested the 
effect of a competitive antagonist for cAMP signal pathway, namely Rp-cAMPS 
which is a cyclic nucleotide inhibitor of cAMP-dependent protein kinase (Van 
Hasstert el al, 1987) in our study. Both Sp-cAMPS and Rp-cAMPS have -
enhanced lipophilicity resulting in good cell membrane permeability (Braumann et 
a I, 1985). Since they are chemically stable with excellent aqueous solubility, 
concentrations up to 10 /^M have been used in our experiments. 
Two toxins, cholera toxin (CTX) and pertussis toxin (PTX), which can stimulate 
intracellular cAMP levels have also been used in our study. Chun and Hoffmann 
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(1987) reported that CTX at 1-10 ng/ml could potentate the cytotoxic effect of 
rhTNF on L-cells under 48 hours of co-treatment. The L-cells which they used 
were very sensitive to rhTNF. In their assay, TNF at 10'^  ng/ml suppressed 50% of 
the cell viability. In our assay system, we will test the effect of CTX and PTX on 
the change of sensitivity of L-929 cells towards rhTNF. 
5.1.5 Effect of cAMP-dependent protein kinase (PKA) on rhTNF cytotoxicity 
We further examine the effect of the inhibitors of cAMP-dependent protein kinase, ^ 
namely H-8 and H-9, on the rhTNF mediated cytotoxicity on L-929 cells. H-8 (N-
[2-(methylamino)-ethyI]-5-isoquinolinesuIfonamide, HCl), has Ki=1.2 f j M on 
cAMP-dependent kinase (i.e. protein kinase A) (Hidaka et al, 1984). H-9 (N-(2-
aminoethyl)-5-isoqiiinolinosulfonamide, HCl) has structure closely similar to that 
of H-8 and has similar inhibition potency as H-8 on protein kinase A, namely 
Ki=1.9 juM (Inagaki el al, 1985). H-8 and H-9 are highly specific inhibitors 
towards protein kinase A because they only atYect the ATP-binding site of protein 
kinase A but not other protein kinases (Hagiwara et a I, 1987). 
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5-2 Results 
5.2.1 Cvclic-AMP (cAMP) level in rhTNF-treated L-929 cells 
cAMP levels in L-929 cells were measured by using cAMP kit purchased from 
Amersham. As shown in Fig. 5.1, during a time period of 210 minutes, there were 
no significant changes in the intracellular cAMP level in the L-929 cells treated 
with 50 ng/ml rhTNF. The changes in the cAMP measurement were found to be 
insignificant, as determined by student's T-test, comparing with that of the zero 
time control. In this experiment, cholera toxin (CTX) was used as a control system 
as CTX is one of the most potent stimulators for intracellular cAMP level. CTX 
catalyzes the transfer of an ADP-ribosyi group from endogenous group to the G^-
subunit of G-protein. This ADP-ribosylation of Gs-subunit is stable and has a 
persistent activation of the Gs-subunit. This ends up with a persistent activation of 
adenylate cyclase and accumulation of intracellular cAMP level. CTX was used as 
control just to make sure that our experimental protocol (i.e. time of treatment, 
etc.) worked well in L-929 cells and that the extraction method we used was 
adequate. 
As shown in Fig. 5.1, the intracellular cAMP level in L-929 cells raised rapidly 
when stimulated with CTX, this indicates that L-929 cells is responsive to CTX 
which activates the Gs-subunit of G-protein. Results in Fig. 5.1 suggest that upon 
treatment with rhTNF (50 ng/ml) for 210 minutes, the intracellular cAMP level of 
L-929 cells did not change, and that cAMP-dependent pathways seems not to be 
involved in the secondary signal transduction provoked by rhTNF. As 50 ng/ml 
103 
2 . 0 - 1 
1 . 5 -
f / 
广 / . 
0 . 5 一 y f 
0 5 0 1 0 0 1 5 0 2 0 0 2 5 0 
Time /min. 
Fig. 5.1. Changes in cAMP level in L-929 cells upon stimulation with 50 ng/ml 
rhTNF (O) and 1 /vg/ml CTX (•). 1x10^ L-929 cells in 1 ml volume of Na-HEPES 
(pH 7.4) were used in each sample. The cAMP was extracted with 65% ice-cold 
ethanol. cAMP level was measured by using cAMP assay kit purchased from 
Amersham. CTX was used as a control as it is a potent stimulator of intracellular 
cAMP. Each point represents at least 3 measurements of different samples and 
S.D. was plotted as the error bar of the measurements. The clianges in intracellular 
cAMP level stimulated by rhTNF was found to be insignificant by student's t-test. 
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rhTNF was a rather high dosage in cytotoxicity assay, and 210 minutes treatment 
period covers the time needed for cAMP stimulation and demonstrated by the 
increased cAMP by CTX stimulation (Fig. 5.1)，we have not tried on higher rhTNF 
dose or longer incubation period. In the experiment, Na-HEPES (pH 7.4) without 
serum was used as a reaction medium because there are growth factors in the 
serum that may stimulate cAMP production in the cells and may interfere with the 
results. 
5.2.2 Effect of iiitraceliiiiar cAMP level on rhTNF mediated cytotoxicity hi L-
929 cells 
Though there are no significant change in intracellular cAMP level in L-929 cells 
treated with rhTNF, whether cAMP plays any role in rhTNF mediated cytotoxicity 
in these cells has to be tested. Two toxins, CTX and PTX, were used to study the 
effect of intracellular cAMP level on rhTNF-mediated killing in L-929 cells. Fig. 
5.2 shows the survival curves of L-929 cells treated with CTX and rhTNF for 20 
hours. The curves showed that there was no significant difference in the survival 
curves with or without CTX. A concentration of 1 "g/ml CTX is effective in 
raising very high intracellular cAMP level (Fig. 5.1) but still no effect on rhTNF 
cytotoxicity can be found. 
Another toxin, pertussis toxin (PTX), was also used to study the effect of cAMP 
level in rhTNF-mediated killing in L-929 cells. Fig. 5.3 shows the result of the 
effect of PTX on rhTNF-mediated killing in L-929 cells. The results indicate that 
L-929 cells treated with PTX were more sensitive toward rhTNF-mediated killing 
despite a dose dependent manner could not be found at this range of PTX (20 to 
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Fig. 5.2 Effect of CTX on rhTNF-mediated cytotoxicity on L-929 cells. Different 
dilutions of rhTNF were prepared without CTX (•)�0.1 /^g/ml CTX (A), 0.5 //.g/ml 
CTX (•) and 1 //g/ml CTX ( • ) . L-929 cells were treated with different 
combinations of rhTNF and CTX for 20 hours in wells of 96-well plate. Viable 
cells after treatment were stained with neutral red. To each assay well, 100 of 
1% SDS was added to dissolve the neutral red. The amount of neutral red was 
measured with 96-well plate reader at a wavelength of 540 nm. The viability was 
expressed in term of percentage survival which is a percentage ratio of the O.D. 
540 nm reading of the well compared to the reading of the well with no rhTNF but 
only CTX. The data was presented as the mean of six measurements from different 
wells and enw bar was plotted to show the S.E.M. of the readings 
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Fig. 5.3 Effect of PTX on rhTNF-mediated cytotoxicity on L-929 cells. Different 
dilutions of rhTNF were prepared without PTX (•), 20 ng/ml PTX (A), 50 ng/ml 
PTX (•) and 100 ng/ml PTX ( • ) . L-929 cells were treated with different 
combinations of rhTNF and PTX for 20 hours in wells of 96-well plate. Viable 
cells after treatment were stained with neutral red. To each assay well, 100 of 
1% SDS was added to dissolve the neutral red. The amount of neutral red was 
measured with 96-well plate reader at a wavelength of 540 nm. The viability was 
expressed in term of percentage survival which is a percentage ratio of the O.D. 
540 nm reading of the well compared to the reading of the well with no rhTNF but 
only PTX. The data was presented as the mean of six measurements from different 
wells and error bar was plotted to show the S.E.M. of the readings 
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100 ng/ml). PTX, like CTX, can induce elevated cAMP level in cells but with a 
different mechanism. PTX consists of two subunits, the A protomer has ADP-
ribosyltransferase activity and the B oligomer which mediates the binding of toxin 
to the target cells. The A protomer can cause ADP-ribosylation of the Gj-subunit 
of the G-protein. PTX attacks a cysteine residue near the carboxyl terminus of Gi-
subunit. As other subunits of G-protein do not have this cysteine residue near their 
carboxyl terminus, they are insensitive towards PTX. ADP-ribosylation induced by 
PTX does not inhibit GTP hydrolysis nor does it appreciably alter the G-protein's ‘ 
response to GTP. However, the PTX treated G-protein becomes insensitive to 
receptor coupling. PTX has also been shown to induce a slow Ca++ influx which 
further activated cyclase cascade and cause an increase in cAMP level. Lower 
concentrations of PTX and shorter incubation time are expected to provoke larger 
elevation of intracellular cAMP level in L-929 cells comparing to the conditions 
using CTX in our system. 
5.2.3 Effect of agonist and inhibitor of cAMP dependent n rote in kinase 
(protein kinase A) on rhTNF-mediated cytotoxicity on L-929 cell 
To have a better understanding of the role played by cAMP in our system, two 
derivatives of cAMP are used to study the effect of intracellular cAMP level in -
rhTNF mediated killing. Sp-cAMPS is a cAMP analog that is resistant to cyclic 
nucleotide phosphodiesterases. It is the Sp-diastereomer of cAMP and is 
permeable to cell membrane. Sp-cAMPS is a very potent analog of cAMP and can 
activate protein kinase A response and thus mimics the effect of cAMP as second 
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Fig. 5.4 Effect of Sp-cAMPS on rhTNF-mediated cytotoxicity on L-929 cells. 
Different dilutions of rhTNF were prepared without Sp-cAMPS ( • ) , ! juM Sp- ‘ 
cAMPS (A), 5 " M Sp-cAMPS (•) and 10/^M Sp-cAMPS ( • ) . L-929 cells were 
treated with different combinations of rhTNF and Sp-cAMP for 20 hours in wells 
of 96-well plate. Viable cells after treatment were stained with neutral red. To 
each assay well, 100 ju\ of 1% SDS was added to dissolve the neutral red. The 
amount of neutral red was measured with 96-well plate reader at a wavelength of 
540 nm. The viability was expressed in term of percentage survival which is a 
percentage ratio of the O.D. 540 nm reading of the well compared to the reading of 
the well with no rhTNF but only Sp-cAMPS. The data was presented as the mean 
of six measurements from different wells and error bar was plotted to show the 
S.E.M. of the readings 
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rhTNF for 20 hours in the presence of various concentration of Sp-cAMPS. Three 
concentrations of Sp-cAMPS were used. At a concentration of 1 / � ’ 5 " M Sp-
cAMPS, there were no significant difference when compared to the control. 
However, Sp-cAMPS at 10/^M could potentate the cytotoxic effect of rhTNF on 
L-929 cells (Fig. 5.4) 
Another cAMP derivative, Rp-cAMPS, was also employed to study the effect of 
intracellular cAMP level in rhTNF-mediated killing in L-929 cells. Rp-cAMPS is ‘ 
the Rp-diastereomer of cAMP and is permeable to cell membrane. Its action is 
opposite to that of Sp-cAMPS. Rp-cAMPS is a competitive membrane permeable 
cAMP antagonist that inhibits protein kinase A activities. Rp-cAMPS binds to the 
regulatory subunits of the protein kinase A complex with an apparent affinity of 8 
/"M. Upon binding, the Rp-cAMPS is also resistant to the hydrolysis of 
phosphodiesterases and it does not induce the dissociation of the catalytic subunit 
from the complex. This results in a decreases in the effective concentration of 
cAMP in the cell. Rp-cAMPS is one of the most potent inhibitor that directly 
affect the protein kinase A system. Fig. 5.5 shows the effect of Rp-cAMPS on the 
rhTNF-mediated killing in L-929 ceils indicating that 10 /^M Rp-cAMPS, a 
sufficiently high level of Rp-cAMPS that can render Rp-cAMPS to bind on the ‘ 
regulatory subunits of cAMP-dependent protein kinase activities, could increase 
the survival of L-929 cells (i.e. suppressing the cytotoxic effect of rhTNF). Cells 
treated with 1 f M and 5 //M of Rp-cAMPS showed little effect. 
Taking together the two survival curves of 10 jj.U Sp-cAMPS and 10 f M Rp-
cAMPS from Fig. 5.4 and Fig. 5.5 respectively, we found that the survival curve 
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Fig. 5.5 Effect of Rp-cAMPS on rhTNF-mediated cytotoxicity on L-929 cells. 
Different dilutions of rhTNF were prepared without Rp-cAMPS ( • ) , ! jlM Rp- -
cAMPS (A), 5 juM Rp-cAMPS (•) and 10 Rp-cAMPS ( • ) . L-929 cells were 
treated with different combinations of rhTNF and Rp-cAMPS for 20 hours in wells 
of 96-well plate. Viable cells after treatment were stained with neutral red. To 
each assay well, 100 "1 of 1% SDS was added to dissolve the neutral red. The 
amount of neutral red was measured with 96-well plate reader at a wavelength of 
540 nm. The viability was expressed in term of percentage survival which is a 
percentage ratio of the O.D. 540 nm reading of the well compared to the reading of 
the well with no rhTNF but only Rp-cAMPS. The data was presented as the mean 
of six measurements from different wells and error bar was plotted to show the 
S.E.M. of the readings 
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of cells under rhTNF action treated with 10 j tM Rp-cAMP is up-shifted than that 
of control while the curve with 1 0 " M Sp-cAMP is down-shifted than that of the 
control curve. This shifting is more significant when rhTNF dosages ranging from 
2 to 20 ng/ml were used (Fig. 5.6). From this data, it is reasonable to suggest that 
cAMP play a role in rhTNF-mediated killing, at least through an indirect manner. 
5.2.4 Effect of protein kinase A inhibitors on rhTNF-mediated cytotoxicity on 
L-929 cells 
The role of protein kinase A in rhTNF mediated killing in L-929 cells were also 
investigated by using inhibitors of Protein kinase A. Figure 5.7 and Fig. 5.8 show 
the survival curves of L-929 cells when cultured with rhTNF for 20 hours in the 
presence of various amount of H-8 and H-9 respectively. H-8 and H-9 are 
effective protein kinase A inhibitors with Kj value of ] .2 / M for H-8 (Hidaka et a I , 
1984) and kj value of 1.9 /^M for H-9 (Inagaki et al, 1985). At the experimental 
dosage (1 to 20 " M ) � H - 8 and H-9 should effectively inhibit the protein kinase A 
activity. The results from this two graphs indicate that protein kinase A was 
unlikely to be involved in rhTNF mediated killing in L-929 cells. In another 
experiment, H-8 and H-9 were pre-loaded in cell with an attempt to inactivate the 
protein kinase A before administration of rhTNF. Fig. 5.9 and Fig. 5.10 show the 
results of pretreating the L-929 cells with H-8 and H-9 for 4 hours before the 
administration of rhTNF respectively. The results also show that there was no 
significant difference between the cells in sensitivity towards rhTNF treated or not 
treated with these protein kinase A inhibitors. The direct measurement of protein 
kinase A activities upon rhTNF treatment was not done as it seems that even if 
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Fig. 5.6 Changes in survival percentage of L-929 cells treated with rhTNF with K) 
/ /M Rp-cAMPS ( • ) and 10//MSp-cAMPS (〇).Changes of survival percentage 
was calculated by comparing the survival percentage of the survival curve with the 
control curve (the dot-line). Data was based on Fig. 5.4 and Fig. 5.5. 
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Fig. 5.7 Effect of H-8 on rhTNF-mediated cytotoxicity on L-929 cells. Various 
dilutions of rhTNF were prepared without H-8 (•)，1 H-8 (A), 5 /^M H-8 (•) 
and 10 /^M H-8 ( • ) . L-929 cells were treated with different combinations of 
rhTNF and H-8 for 20 hours in wells of 96-well plate. Viable cells after treatment 
were stained with neutral red. To each assay well, 100 fi\ of 1% SDS was added 
to dissolve the neutral red. The amount of neutral red was measured with 96-well 
plate reader at a wavelength of 540 nm. The viability was expressed in term of 
percentage survival which is a percentage ratio of the O.D. 540 nm reading of the 
well compared to the reading of the well with no rhTNF but only H-8. The data 
was presented as the mean of six measurements from different wells and error bar 
was plotted to show the S.E.M. of the readings. 
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Fig. 5.8 Effect of H-9 on rhTNF-mediated cytotoxicity on L-929 cells. Various 
dilutions of rhTNF were prepared without H-9 (•)，2 H-9 (A), 10 " M H-9 (•) 
and 20 juM H-9 ( • ) . L-929 cells were treated with different combinations of 
rhTNF and H-9 for 20 hours in wells of 96-well plate. Viable cells after treatment 
were stained with neutral red. To each assay well, 100 //I of 1% SDS was added 
to dissolve the neutral red. The amount of neutral red was measured with 96-well • 
plate reader at a wavelength of 540 nm. The viability was expressed in term of 
percentage survival which is a percentage ratio of the O.D. 540 nm reading of the 
well compared to the reading of the well with no rhTNF but only H-9. The data 
was presented as the mean of six measurements from different wells and error bar 
was plotted to show the S.E.M. of the readings. 
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Fig. 5.9 Effect of H-8 on rhTNF-mediated cytotoxicity on L-929 ceils. 4x10"^ L -
929 cells were seeded in wells of 96-well plate and incubated overnight at 37°C in . 
a moisten 5% CO2 incubator. The cells were treated without H-8 (•) , 1 ^ M H-8 
(A)，5 " M H-8 (•) and 10/ /M H-8 ( • ) for 4 hours before rhTNF treatment. The 
cells were incubated in the present of rhTNF for 20 hours before the viability of the 
L-929 cells was measured. Viable cells after treatment were stained with neutral 
red. To each assay well, 100/fl of 1% SDS was added to dissolve the neutral red. 
The amount of neutral red was measured with 96-well plate reader at a wavelength 
of 540 nm. The viability was expressed in term of percentage survival which is a 
percentage ratio of the O.D. 540 nm reading of the well compared to the reading of 
the well with 
no rhTNF but only H-8. The data was presented as the mean of six 
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Fig. 5.10 Effect of H-9 on rhTNF-mediated cytotoxicity on L-929 cells. 4x10"^ L-
929 cells were seeded in wells of 96-well plate and incubated overnight at 37°C in , 
a moisten 5% CO2 incubator. The cells were treated without H-9 (•)，2 ^ M H-9 
(A), 1 0 " M H-9 (•) and 20/ /M H-9 ( • ) for 4 hours before rhTNF treatment. The 
cells were incubated in the present of rhTNF for 20 hours before the viability of the 
L-929 cells was measured. Viable cells after treatment were stained with neutral 
red. To each assay well, 100//I of 1% SDS was added to dissolve the neutral red. 
The amount of neutral red was measured with 96-well plate reader at a wavelength . 
of 540 nm. The viability was expressed in term of percentage survival which is a 
percentage ratio of the O.D. 540 nm reading of the well compared to the reading of 
the well with no rhTNF but only H-9. The data was presented as the mean of six 
measurements from different wells and error bar was plotted to show the S.E.M. of 
the readings. 
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there are changes in the activities of protein kinase A, the part induced by rhTNF 
should be undetectable when compared to the stimulatory effect arising from 
growth factors in the serum. 
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5.3 Discussion 
Early observations on TNF action indicated that TNF increases cAMP level in rat 
mesangial cells (Baud et al, 1988) and human fibroblasts (Zhang et al, 1988). 
However, in our present study, we found that rhTNF does not exert any changes in 
cAMP content in TNF-sensitive L-929 cells (Fig. 5.1). rhTNF can suppress 
growth in L-929 cells but it displays proliferative effect towards normal human 
fibroblasts (Palombella et al, 1988). Whether the difference in activation of cAMP 
levels of L-929 cells and fibroblasts in responding to TNF action account for their 
opposite responses towards the cytotoxic effect of TNF remains to be investigated. 
In TNF-sensitive cell lines, (e.g. L-929 cells and human breast tumor cell line, 
MCF7)，increasing intracellular cAMP levels of cAMP always results in 
potentiation of cytotoxicity of rhTNF (Chun and Hoffmann, 1987; Branellec et al’ 
1993). Using some newly developed cAMP analogs, we have verified the above 
findings. Early experiments performed for the studying the exogenous cAMP 
effect, workers used dibutyryl cAMP to mimic the action of endogenous cAMP. 
However, it has been later found that 'butyrate effect' may occur in cells by the 
dibutyryl derivatives of cAMP (please see the introduction section in this chapter). 
Instead, we used a specific cAMP analog, namely Sp-cAMPS, to study the effect 
of cAMP on rhTNF-mediated cytotoxicity of L-929 cells. We found that 10 /乂M 
Sp-cAMPS can potentiate the cytotoxic effect of TNF (Fig. 5.6). In contrast, 10 
/^M Rp-cAMPS which is the specific antagonist of cAMP, can suppress the 
cytotoxicity of rhTNF on L-929 cells. This result clearly demonstrates that 
although rhTNF cannot induce cAMP accumulation in L-929 cells, intracellular 
cAMP level definitely play a role in rhTNF-mediated cytotoxic action. 
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The above postulation is further confirmed by the results of the experiments in 
which pertussus toxin (PTX) was used to activate the formation of intracellular 
cAMP level in L-929 cells in the presence of rhTNF.. PTX (20 to 100 ng/ml) can 
potentate the cytotoxic effect of TNF (Fig. 5.3). We have also tried to use another 
toxin, cholera toxin (CTX), to stimulate cAMP content and test the effect of TNF 
on the CTX-treated L-929 cells. Chun and Hoffmann (1987) have demonstrated 
the potentiating effect of CTX on TNF activity in their extremely TNF-sensitive L-
cells (in their system, 10'^  ng/ml of rhTNF exhibited 50% inhibition in L-cell 
survival). We could not find the expected potentiating effect of CTX in our system 
(Fig. 5.2). This discrepancy may be due to the fact that our L-929 cells are less 
sensitive towards rhTNF action (In our system, 10 ng/ml level of rhTNF is needed 
to produce 50% inhibition of survival of our L-929 cells, Fig. 5.2) and we have 
shorter incubation period [we used 20 hours versus 48 hours in Chun and 
Hoffmann (1987)] 
We further tested whether cAMP-depenclent protein kinase (protein kinase A, 
PKA) plays any role in rhTNF-mediated cytotoxicity in L-929 cells. By using two 
specific PKA inhibitors, H-8 and H-9, we demonstrated that PKA may not be 
involved in the TNF action in L-929 cells (Fig. 5.7 - Fig. 5.10). 
In conclusion, in this chapter, we have demonstrated that (1) rhTNF cannot induce . 
accumulation or formation of cAMP inside L-929 cells; (2) increasing intracellular 
cAMP level (by 10 / iM Sp-cAMPS or 20-100 ng/ml PTX) results in potentiation 
of rhTNF-mediated cytotoxicity in L-929 cells; (3) decreasing cAMP level (by 10 
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/ iM Rp-cAMPS) causes suppression of rhTNF's cytotoxic effect on L-929 cells; 
(4) PKA is not involved in rhTNF-mediated cytotoxicity in L-929 cells. The exact 
mechanism of intracellular cAMP in potentiating the TNF cytotoxic effect on 
tumor cells are of therapeutic importance and awaits further studies. 
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Chapter 6. Role of intracellular free calcium ions and calcium dependent 
responses in rhTNF-inediated cytotoxicity in L-929 cells 
6,1 Introduction 
6.1.1 Inositol trisphosphates and intracellular free calcium ions 
Inositol trisphosphate is a second messenger that controls many cellular events by 
generating internal calcium signals. In response to many stimuli, the G-protein is 
activated and causes the activation of the enzyme, phosphoinositol-specific 
phospholipase C (PLC). This enzyme hydrolyzes the phosphatidylinositol-4,5-
bisphosphate (PIP2) to give inositol-!,4,5-trisphosphate (Ins-1，4，5-P3) and 
diacylglycerol (DAG) (Berridge and Irvine, 1984; Majerus, 1992; Catt et al, 1991; 
Berridge, 1987; Berridge and Irvine, 1989; Berridge, 1993; Tsunoda, 1993). 
Besides PIP2， PLC can also hydrolyze phosphatidylinositol (PI) and 
phosphatidylinositol-4-mono-phosphate (PIP). 
PLC exists in multiple distinct isoforms. At least nine isoforms of PLC are found 
and can be categorized into 4 immunologically distinct groups and designated as a 
(MW 60-70 Kda), p 1-3 (MW 100-150 Kda), y 1-2 (MW 140-148 Kda) and 6 1-3 
(MW 85-88 Kda) (Rhee et al, 1989). Of the four classes of PLC, the p, 丫 and 6 
groups are isolated from bovine brain and their substrates are located in the 
membrane bilayer, therefore these PLC must bind to the membrane before they can 
hydrolyze the phosphatidylinositols. In these three isoforms, they contain two 
domains of 150 and 120 amino acids (named X and Y) with 54% and 42% identity, 
respectively. These conserved domains are possibly involved in the catalytic site of 
the enzymes or their interactions with receptor and/or regulatory proteins 
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controlling enzyme activity. The a type of PLC is isolated from liver, seminal 
vesicle and uterus (Ryu et a I, 1987a). It has been found that PLCy can couple 
with a protein tyrosine kinase without mediation of G-protein and P L C 5 can 
couple with the pertussis toxin sensitive G-protein. They share a dependence of 
[Ca^+ji and have a substrate specificity of PI, PIP and PIP2. The tissue specific 
distribution and divergent sequences of PLCs together with the different modes of 
modulation of enzymatic activity suggest that different isoforms may couple to 
distinct G-proteins. This may provide cells with a capacity to elicit diversified 
responses to a variety of stimulating signals. 
PLC can also be activated by influx of Ca2+ but this PLC may be different from that 
activated by G-protein. For PLC activated by Ca""" influx，the IPs-induced release 
of Ca2+ from intracellular stores represents a positive feedback system. It seems 
that Ca2+-activated PLC acts on phospholipids on cell membrane or membrane of 
other organelles. Other PLCs may also be functional in cytoplasm and can be 
activated by various nucleotide trisphosphates in a non-specific manner (Lo, 1988). 
One of the products of PLC activity, inositol-l，4，5-trisphosphate (Ins-1，4，5-P3)，is 
well known for its role as a second messenger. The synthesis and metabolism of 
phosphoinositide in agonist-stimulated target cells are outlined in Fig. 6.1. 1ns-
1，4，5-P3 was found to be rapidly hydrolyzed by a specific 5-phosphatase to give 
lns-l,4-P2 (Downes el al, 1982). This hydrolysis occurs near the plasma 
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Fig. 6.1 Outline of phosphoinositol synthesis and metabolism pathway in an 
agonists-stimulated system. upon stimulation of receptor by agonist, 
phospholipase C hyclrolyzes the phophoinositides (PIP and PIP2) to give 
diacylglycerol and Ins(l,4,5) trisphosphale. Ins(l’4，5) trisphosphate activates • 
intracellular calcium ions and are rapidly hyclrolyzes to other products which may 
be recycle back to the membrane or used in other control mechanisms. 
Diacylglycerol is responsible for protein kinase C activation. Dashed line shows 
the lithium-sensitive pathway and signal molecules are boxed. (Catt el al, 1990). 
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membrane as 5-phosphates, except in platelets, where it takes place near cell 
membrane. As the production and elimination site of Ins-1，4，5-P3 is adjacent to 
cell membrane, it was suggested that Ins-1,4,5-P3 functioned as a second 
messenger. The proposal was confirmed by the demonstration that Ins-1，4，5-P3 
can mobilize Ca^^ from an ATP-ase loaded non-mitochondrial Cn^^ pool in 
permeabilized cell and subcellular membrane preparations (Prentki el a I, 1984). 
Similar observations in a wide variety of cells and cell-free system clearly -
established the key role of Ins-1,4,5-P3 in the coupling of receptor-activated 
phosphoinositide hydrolysis to Ca^^ signal generation. 
Hydrolysis of PIP2 gives two phos pho inositol lipids, besides Ins-1,4,5-P3, its cyclic 
derivative Ins-l,2-cyclic,4-5-P3 is also formed. The 1-phosphate of Ins-1,2-
cyclic,4-5-P3 forms a phosphodiester bond with the 2-hydroxyl group (Willocks et 
I 
al, 1989; Wong et a I, 1988). At normal pI—I and at physiological environment, the 
cyclic form exists only in small amount. It is not clear what determines the ratio of 
cyclic versus noncyclic phosphates produced upon stimulation of cells with various 
agonists. In general, prolonged stimulation of cells or tissues tends to produce 
higher levels of cyclic phosphates. This may be a result of the fact that the cyclic 
phosphate is metabolized and so can accumulate to levels thai eventually approach 
those of Ins-1，4’5-P3. The relatively slow kinetics of Ins-l,2-cyclic,4-5-P3 in 
metabolism suggest that it is unlikely to function as a Ca" -mobilizing signal 
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(Dixon and Hokin, 1987; Lee and Hokin, 1989) and as a quantitatively minor 
product of PLC activity, it contributes little to the inositol metabolism and signal 
transduction involved. However, the level of Ins-1,2-cyclic,4-5-P3 is higher than 
Ins-1’4，5-P3 in tumor cells when compared to the normal counterparts (Graham et 
a l 1987). 
There are two independent pathways involved in the metabolism of Ins-1，4，5-P3， 
both of which produce compounds that do not release Ca^ "^  from intracellular 
stores. The first one is the dephosphorylation of Ins-1,4,5-P3 to Ins-1,4-P2 which 
is inactivated in Ca^^ metabolism (Hanson et a I, 1987). The other pathway 
converts Ins-1,4,5-P3, to Ins-1,3,4,5-P4, again, with the reactions of two enzymes 
working independently. Polyphosphate 5-phosphatase is involved in the first 
pathway. It can act on three substrates: namely lns-l,4,5-P3, Ins-l,2-cyclic,4-5-P3 
and Ins-1，3’4，5-P4 (Majerus, 1992). lns-l,4,5-P3 is phosphorylated by 
polyphosphate 5-phosphatase to form Ins-1,4,5-P3, which is then converted to the 
inactive form of inositol trisphosphate, Ins-]，3，4-P3 (Irvine et a I, 1984). Two 
forms of cytosolic polyphosphate 5-phosphatase are found (Connolly et al, 1985; 
Michel 1 et a I, 1989). Type I polyphosphate 5-phosphatase has a molecular weight 
of 45 Kda and requires Mg2+. The Km of type I polyphosphate 5-phospliatase for 
Ins-1,3,4,5-P4 is 0.5 /y.M, much lower than that of Ins-],4,5-P3, (Kin=7.5 "M). 
The Vniax for Ins-1,3,4,5-P4 is only 2% of that obtained by using lns-l,4,5-P3 as 
126a 
substrate (Connolly ei al, 1987). Thus, a small amount of Ins-1，3，4，5-P4 can 
inhibit the breakdown of Ins-1，4，5-P3 and Ins-l,2-cyclic，4-5-P3. This implies that 
the cellular level of Ins-1，4，5-P3 may be sustained in the presence of Ins-1,3,4,5-
P4. The type I polyphosphate 5-phosphatase can be phosphorylated and activated 
by protein kinase C (King and Rittenhous, 1989). Thus, it seems that protein 
kinase C tends to turn off signal transducted by Ins-1，4，5-P3. 
Type I I polyphosphate 5-phosphatase (MW=75 KDa) hydrolyzes the same 
substrates as type I polyphosphate 5-phosphatase but with different kinetic 
parameters (Km values for Ins-1，4，5-P3 is 24 /^M, and for Ins-1,3，4，5-P4 is 7.5 
/^M). However, type I I enzyme is not phosphorylated and activated by protein 
kinase C (Michell ei al, 1989). Antibodies directed against type I I enzyme shows 
no cross-reactivity against type I enzyme, indicated that this two enzymes are 
structurally distinct. 
Although Ins-1,3，4，5-P4 is ineffective to release Ca^^ from intracellular store, it can 
act in conjunction with Ins-1，4，5-P3 to mimic fertilization in sea urchin eggs (Irvine ‘ 
and Moor, 1986) and to increase Ca^'^-dependent K^-conductance in lacrimal gland 
cells (Morris et a I, 1987) due to enhanced Ca"^ influx. It has been suggested that 
Ins-1，3，4，5-P4 induces Ca^^ mobilization in a way different from that induced by 
Ins-1,4,5-P3 (Ely el al, 1990). 
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Another enzyme responsible for the breakdown of Ins-1,4,5-P3 is Ins-1，4，5-P3 3-
kinase. This enzyme converts Ins-1,4,5-P3 (K„i=0.2 to 1.5 "M)，but not Ins-1,2-
cyclic,4-5-P3, to Ins-1,3,4,5-P4 in the presence of Mg" ' and ATP (Connolly et al, 
1987; Irvine et al, 1988; Ryu et al, 1987a; Shears, 1991)). In most tissues, the Ins-
1，4，5-P3 3-kinase is regulated by Ca-^-calmodulin (Biden et al, 1987; Ryu et a I, 
1987b; Takezawa et al, 1988). This would accelerate the removal of Ins-1,4,5-P3 
by its conversion to Ins-1,3，4，5-P4 during agonist-induced elevation of cytoplasmic 
free Ca "^". Addition of phorbol esters to intact platelets or to a malignant T-cell 
induced a two-fold increase in the Ins-1,4,5-P3 3-k:inase activity, indicates that this 
enzyme is regulated by phosphorylation (King and Rittenhouse, 1989). The 
enzyme can also be phosphorylatecl by cAMP-dependent protein kinase (PKA) and 
protein kinase C, the former increases its activity while the later suppresses it in 
vitro (Sim et al, 1990). Whether this regulation system operates in vivo is not 
clear. 
Besides the above mentioned phosphoinositols, several highly phosphorylatecl ‘ 
inositols are found in mammals. They are the InsP4 and InsPs. Among all these 
phosphoinositols, several InsP and InsP] were identified as intermediates produced 
during breakdown of highly phosphorylatecl inositols and their metabolites by 
enzymatic reactions. Fig. 6.2 shows the metabolism of higher inositol 
polyphosphosphates. There is no evidence that these highly phosphorylatecl 
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Fig. 6.2 Metabolism and function of higher inositol polyphosphosphates. 
Ins(l,3,4,5)P4 has been proved to promote calcium influx in plasma membrane. 
Ins(l，3，4)P3 is a poor calcium mobilizing agent. Higher membranes of inositol 
phosphates such as IP5 and 1?6 have been shown to regulate neuronal exilability in 
central nerves system (Vallejo et al, 1987). 
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inositols are directly involved in Ca^^ mobilization in cellular signaling but they 
seem to be effective in acting as extracellular regulators in central nervous system. 
They are also found to reduce heart rate and blood pressure (Vallejo et a I, 1987). 
Ins-1,4,5-P3 works as second messenger by triggering the release of Ca^ "^  from 
intracellular stores (Berridge and Irvine, 1989; Taylor and Richardson, 1991; Henzi 
and MacDermott, 1992; Ferris and Synder, 1992b). When Ins-1,4,5-P3 is 
administered to permeabilized cells, a transient release of Ca^^ from ATP-
dependent intracellular store was observed. This Ins-1，4，5-P3 induced Ca""^  release 
is originated from non-mitochondria 1 organelle as isolated microsomal vesicles are 
still sensitive to this response and that the response is insensitive to mitochondrial 
inhibitors (Berridge and Irvine, 1984; Burgess el a I, 1984). 
The release of Ca""^  from intracellular stores of Ca""^  by Ins-1,4,5-P3 involves the 
binding of Ins-1,4,5-P3 to specific receptor (Ferris and Synder, 1992a). The 
existence of IPg-receptors (IP3-R) was demonstrated by specific IP3 binding sites 
in permeabilized cells (Spat et al, 1986; Guillemette et al, 1988; Spat ct al, 1987; 
Challiss et al, 1990). A family of IP3-R was identified (Furuichi et al, 1989; 
Mignery et al, 1990), with molecular diversity arising from both alternative splicing 
and existence of separating genes (Sudnof el al, 1991; Ross et al, 1992). The C-
terminal of the IP3-R contains typical membrane-spanning domains which anchor 
the receptor to the membrane. Four units of the receptors are needed to form a 
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functional unit, which is responsible for IP3-sensitive calcium channel. The N-
terminal lies in the cytoplasm and contains the IP3 binding site, is far away from the 
calcium channel forming C-terminal. Upon binding with IP3, conformational 
change takes place, and activates the calcium channel (Mignery and Sudnof, 1990). 
The IP3-R can be phosphorylated by cAMP-dependent protein kinase (PKA), 
resulting in 10-fold decrease in ability to release Ca'^ when stimulated by I P 3 
(Supattapone et a I, 1988). This provides a cross-link between PKA and 
IP3/calcium signal transduction. In addition, IP3-R can also be phosphorylated and 
its activity is suppressed by PKC and Ca-camodulin dependent protein kinase 
(Ferris and Synder, 1992b; Ferries el a I, 1992). In general, PLC hydrolyze PIP2 to 
give both I P 3 and diacylglycerol (DAG). The DAG further stimulates PKC 
activity, together with the Ca-camodulin-depenclent protein kinase activated by 
I P 3 , the end product of the stimulation form a feedback control to the signal 
transduction system. Two factors controlled the sensitivity of I P 3 induced Ca^ "^  
release. The first one is the amount of calcium stored in the calcium pool of the 
cell (Missiaen el al, 1991; 1992a; 1992b; Tregear el al, 1991) and the second is the ‘ 
heterogeneity of the receptor (Ferris et al, 1992). 
The intracellular calcium store from which calcium is released upon stimulation • 
have to depend on the existence of three components. The first one is the pump to 
sequester calcium. The second is the presence of binding proteins to hold the 
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calcium, and the last one is the presence of specific receptors. One of the 
organelles that functions as calcium store is the endoplasmic reticulum (Meldolesi 
etal, 1990). 
6.1.2 Diacylglycerol 
Diacylglycerol (DAG) is another substance produced from the hydrolysis of PIP2. 
DAG appears to be of critical importance in the control of cell growth and 
differentiation. This may be related to its ability to activate protein kinase C (PKC) ‘ 
which is a uniquitous enzyme found in all eukaryotic cells (Nishizuka, 1988; 
Blackshear et al, 1988; Rando, 1988; Azzi ei al, 1992). Phorbol ester is commonly 
used as a DAG analogue to activate PKC (Nishizuka, 1985; Go et al, 1987). 
Another source of cellular DAG comes from the turnover of phosphatidyl-choline 
by phospholipase D (Rosoff et al, 1988; Bass et al, 1989). It has been shown that 
phorbol ester can induce translocation of DAG-kinase from cytosol to membrane. 
The observation that DAG can be phosphorylated by PKC (Kamoh et a I, 1989) 
illustrated a feedback mechanism in this pathway. 
(U.3 Protein Kinase C (PKC) 
PKC was first reported in 1977 (Inoue el al, 1977; Takai et a I, 1977) only as a ‘ 
group of enzymes that regulated biological activities but not as a signaling 
molecule. Workers began to realize the significance of role of PKC in signal 
transduction when they discovered that PKC activity was related to Ca "^" and was 
phospholipid dependent (Takai et al’ 1979a). They also found that DAG increases 
the affinity of PKC for calcium (Takai el al, 1979b), thereby activating the PKC. 
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PKC is a serine/threonine-containing peptide of 77-83 Kda . The serine/threonine 
are considered to be phosphorylation site. PKC can be classified into two major 
groups: the conventional PKC and novel PKC (nPKC) (Osada et al, 1990). The 
nPKC is similar to that of conventional PKC except that it is independent of Ca^ "^ . 
This indicates that an alternative signaling pathway involving nPKC may exist. 
Several isoenzymes of PKC are found. They are believed to be result of multiple 
genes and alternative splicing of a single gene. By studying the cDNA sequences, 
nine members of the PKC family are defined (ICikkawa et al, 1988; Tsukuda et al, 
1988; Beyer el al, 1988; Sekiguchi et al, 1988). Initially, 4 isoenzymes are 
defined. They were designated as a, Pi, Pn and y. They all belong to the 
conventional PKC. The genes of a-, (3- and y-PKC were found to come from 
different chromosomes. However, Pi and Pn seem to originate from a single RNA 
transcript by alternative splicing (Coussens et al 1986). Another 3 members of the 
PKC family come from the nPKC. They include the b-, e- and 与-PKC which were 
all isolated from rat brain cDNA library (Ono el al, 1988). The last two 
isoenzymes were isolated from the cDNA library of mouse epidermis and human 
keratinocyte, they were designated as ” - and L-PKC respectively (Osada et al, 
1990; Bacher et al, 1991). L-PKC has been found to be the human homologue of . 
ri-PKC. These two isoenzymes are closely related to the 6-，e- and 与-isoenzymes 
of P K C 
Most of the PKC isoenzymes are tissue specific (Shearman et al, 1988) and have 
restricted subcellular distribution (Kiss cH a I, 1988) except a-PKC which can be 
found in a wide variety of tissues (Kosaka et a I, 1988). 丫-PKC is apparently 
expressed only in brain and spinal cord but not in other tissues (Shearman el al, 
1987). pi and Pn are found differentially in the brain and other tissues (Coussens et 
a I, 1987) Of all the isoenzymes, r|-PKC is mainly found in lung and only slightly in 
brain (Osada et al, 1990). Different isoenzymes of PKC family may express in the 
same cells. This indicates that different PKC isoenzymes may mediate different 
response, namely phosphorylating different proteins. This also explains the 
diversity of PKC mediated responses. However, the role of high heterogeneity and • 
differences in expression of PKC in various tissues is not well understood. 
Though nine isoenzymes are found in PKC family, they all show conserved motifs 
with a high degree of sequence homology. Most of them have four conserved 
polypeptide chains (designated as Ci to Q ) and five variable regions (designated as 
V i to V5). However, the nPKCs lack the C2 region. The regulatory domain that 
interacts with Ca^ "^ , phospholipids, DAG or pliorbol ester was made up from the N-
terminal of Ci, C2, Vi , V2 and part of V3. The C-terminal of C3, C4 and V4 form 
the catalytic site of PKC (Coussens ei al’ 1986). 
Aiitoinhibitory domains have been found in many protein kinase. They are believed , 
to interact with the catalytic site of the protein kinase (Soderling el a I, 1990). In 
PKC, a pseudo-autoinhibitory domain has been found between residue 19 to 36 
(House and Kemp, 1987; Pearson et a I, 1988). An analogous sequence has been . 
found in all isoenzymes of PKC family. This sequence contains one or more basic 
residue(s) that resemble the natural substrates but they lack the phosphorylation 
site (serine or threonine residue). Synthetic peptide of tlie pseudo-autoinhibitory 
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domain was made and antibody against this peptide was effective in activating 
PKC, even in the absence of calcium and phospholipids (Makowske and Rosen, 
1989). This indicates that auto-inhibition domain is present in PKC at the 
suggested location. Two ATP-binding sites were found in the catalytic region of 
PKC. Though the function of these conserved ATP-binding sites is unknown, 
deletion of these binding sites completely deactivate the PKC (Ohno et a I, 1990). 
A number of intracellular lipids, such as sphingolipid and lysosphingolipid, have 
been shown to down-regulate PKC activities (Bell et al, 1988). These lipids may 
counteract under the action of DAG and together with DAG, may act as a control 
mechanism of PKC. 
PKC plays an important role in signal transduction especially in those involved with 
PLC. The target proteins of PKC phosphorylation cover a wide range of biological 
responses. Upon stimulation, DAG activates the PKC which can effectively cause 
phosphorylation of target protein. In vitro studies have shown that DAG produced 
by PLC and PLD are very different in that they are more effective in activating 
PKC. It is found that PLD can generate DAG for a prolonged period of time, 
without mobilization of calcium, indicated that DAG produced by PLD may act 
differently as DAG produced by PLC (Azzi et a I, 1992). 
6.1.4 Intracellular Free calcium ions and protein kinase C 
Activation of PKC by calcium or DAG is believed to involve the redistribution of 
PKC from cytosol in resting cells to membrane-associated in stimulated cells (Kraft 
and Anderson, 1983) or to nuclear membrane of the cell (Masmoudi et a I, 1989). 
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A rise of intracellular calcium level is enough to cause translocation of PKC 
(Melloni et a I, 1985). It has been found that the distribution of cytosolic and 
membrane-bound PKC is controlled by the free calcium level in the cell (Phillips et 
a I, 1989). Free calcium level may not only control the location of PKC but also 
the activity of PKC. It has also been reported that redox changes can affect PKC 
activity (Gopalakrishna and Anderson, 1989). An activated-PKC receptor, named 
RACK (Receptor for Activated C Kinase), has been identified and is believed to be 
involved in the translocation of PKC from cytosol to membrane (Mochly-Rosen el 
al, 1991). Binding of PKC to RACK is specific and saturable, dependent on 
calcium and phosphatidylserine, and enhanced by DAG. 
Activated PKC is translocated to membrane where proteolytic degradation takes 
place. Calpain, a calcium dependent proteinase, releases the catalytic domain of 
PKC，yielding the calcium (Inoue et al, 1977; Takai et al, 1977) and a catalytic 
fragment, known as PKM (Kishimoto et al, 1983; Pontremoli et al, 1988; Melloni 
et al, 1988). When the PKM is released from the membrane to cytoplasm or 
nucleoplasm, it is ready to phosphorylate other cellular component. PKC 
isoenzymes in different cells undergo different down-regulation processes because 
of their difference in susceptibilities. 
6.1.5 Effect of intracellular free calcium ions and protein kinase C on TNF-
inecliatecl cytotoxicity 
There are not many studies concerning these aspects. TNF cannot induce the 
intracellular free calcium level in inflammatory cells (Richter el al, 1989). The 
effect of TNF on PKC seems to be cell-specific: PKC activation occurs in myeloid 
156a 
and lymphoid cell lines (Schutze et a I, 1990; Meichle et al, 1990) but not in 
fibroblasts (Schutze et al, 1990). Whether increasing intracellular free calcium or 
activating PKC in tumor cells can change the sensitivity of the cells towards TNF 
action is not known. 
6.1.6 Tyrosine kinase induced release of IP3 
The release of I P 3 can also be induced by tyrosine kinase activity (Berridge, 1993). 
The tyrosine kinase receptors are related to the 丫-forni of PLC. Upon tyrosine 
kinase activation, PLCy is activated which further starts the I P 3 turnover system. 
Upon stimulation, cytosolic PLC^ moves towards the membrane. This action not 
only brings the PLCy close to its substrates on the membrane but also brings it to 
the tyrosine kinase domains of the receptors (Renard el a I, 1992). The activation 
of PLCY differs from the other activation mechanisms in that its response is slower, 
and the resulting calcium response is smaller but last for longer latency. 
6.1.7 Calcium Channels 
The intracellular free calcium ion level is controlled by the action of calcium 
channels on the cell membranes. In non-excitable cells, the channels are receptor- ‘ 
operated channels (Neher, 1987; Rink, 1988) while in excitable cells, the channels 
are voltage-operated calcium channels (Tsien el a I, 1988; Rosenthal et al, 1988a; 
1988b). The receptor in the receptor-operated calcium channels forms an integral ‘ 
part of the channels (Meldolasi and Pozzan, 1987). The mechanism of the 
receptor-operated calcium channel is a fascinating and unprecedented phenomenon 
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as it is possible that multiple channels can be modulated by one single type of 
receptor (Fasolato et al, 1994). 
Voltage-operated calcium channels not only control the flux of calcium ion in 
neurons system, but also in nearly all other cell types and thereby affecting a wide 
variety of cellular functions. In 1985, Tsien and colleagues (Nilius el a I, 1985; 
Nowyck el a I, 1985) classified voltage-operated calcium channel as (Transient) T-
type, (Long lasting ) L-type; and (Neither) N-type. Other types of voltage-
operated calcium channels included (Background) B-type and (Purkinje) P-type 
which can only be found in neurons. The B-type and P-type calcium channels are 
rarely found and not so well studies (Tsien et a I, 1991； Mori et al, 1991; Mintz et 
al, 1992)， 
The current induced by the L-type voltage-operating calcium channels is generally 
10 times more than that induced by T-type voltage-operated calcium channels 
(Nilius el al, 1986). Also, the number of L-type voltage-operated calcium 
channels is 10-20 times more abundant than T-type voltage-operated calcium 
channels (Rose el a I, 1992). L-type voltage-operated calcium channels rapidly 
disappear from excised membrane, indicating the dependence of channel activity on 
intracellular activity. The L-type voltage-operated calcium channel can be blocked 
by 1,4-dihydrophridines which is specific for the channels. 
Other types of calcium channels are also found，such as G-protein-opemted 
calcium channel, in which the channel is associated with G-protein. The number of 
channel types actually exist in mammalian cells is not known yet. However, the 
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classification of calcium channels into receptor-operated calcium channel and 
voltage-operated calcium channel, and that 4 major types of voltage-operated 
calcium channels has been widely accepted (Terence et al 1994; Miller, 1992). 
As N-type and P-type voltage-operated calcium channels are rare and usually 
found only in neural cells, their effect on rhTNF mediated cytotoxicity on L-929 
cells is not studied herewith. Also, as L-type voltage-operated calcium channel is 
more abundant and give a higher response in most cells, study of the role of this 
channel on rhTNF mediated cytotoxicity on L-929 cells may shed more insight into 
TNF's action on the cell membrane. 
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6.2 Results 
6.2.1 Effect of rhTNF on intracellular free rCa2+l of L-929 cells 
The role of calcium ions in rhTNF mediated cytotoxicitry in L-929 cells was 
studied. A direct measurement of changes in intracellular tree calcium ions level 
was made by using the fluorescence dye, Fura-2-AM. Fura-2-AM was hydrolyzed 
by esterase in the cells to give Fura-2 after taken up by the cells. Fig. 6.3 shows 
the fluorescence tracing of a typical experiment. rhTNF ranged from 12.5 ng/ml to 
125 ng/ml was added to different samples of L-929 and the intracellular free . 
calcium ions level was calculated from their fluorescence tracings and plotted on 
Fig. 6.4. The difference in calcium ions level before and after rhTNF 
administration was insignificant. It seems that the intracellular free calcium ions 
level is not affected by treatment of rhTNF in L-929 cells, at least not in nM level. 
The intracellular free calcium ions level was also measured by confocal 
microscopy. In the previous experiment, only the total intracellular free calcium 
ions was measured but not the distribution of the calcium ions in the cells. 
Confocal microscopy has an advantage over normal fluorescence 
spectrophotometry in that single cell image can be obtained and thus the 
distribution of the studying material can be located. In this experiment, L-929 cells , 
were loaded with another fluorescence probe, calcium green-1/AM (AM ester of 
calcium green-1). Calcium green-1 was used in this experiment because it is more 
stable and resistant to laser induced photo bleaching. Cells were first loaded with . 
calcium green-1/AM and mounted to the confocal microscope. Suitable cells were 
placed at the center of the field. A minimal amount of laser light source was 
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Fig. 6.3. A typical fluorescence tracing of Fura-2-AM loaded L-929 cells. 2x10^ 
L-929 cells were loaded with Fura-2-AM as described in 'materials and methods'. 
rhTNF was added when the tracing was stable. SDS was added to lysis the cells to 
obtain a maximum reading and Mn "^^  was added to displace all the calcium from the 
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Fig. 6.4. Changes in intracellular free calcium level in L-929 treated with rhTNF. 
2x10*^  L-929 cells were used for each sample. L-929 cells were loaded with Fura-
2-AM and subjected to fluorscence spectrophotometer as described in'materials . 
and methods'. Various amount of l i iTNF were administered and the fluorscence 
intensity recorded by computor. The graph shows the changes in calcium level as 
calculated values. Calculation was based on equatiom described in 'materials and 
methods'. In the graph,(〇）indicated the calcium level before addition of rhTNF 
while ( • ) indicated the calcium level after administration of rhTNF. 
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would end up in photo-bleaching. The images recorded by the computer was 
showed on Fig. 6.5. Each picture was taken at 2 minutes interval at the same 
population of cells, from the images, it can be found that the brightness and 
distribution of fluorescence signal of the cells has no observable changes. This 
means that the intracellular free calcium ions concentration does not change in 
response to rhTNF in this short incubation period. 
In another experiment, L-929 cells were treated with rhTNF for various periods of 
time before the loading of calcium green-AM. Cells were examined under confocal 
microscope and the fluorescence images of L-929 treated with rhTNF for various 
period of time were recorded by computer. The amount of laser energy input, the 
time of incubation for fluorescence dye, the sensitivity of the sensor in the confocal 
microscope and washing procedure were kept constant to avoid alternations in 
energy detected by the computer. Fig. 6.6 shows the result of this experiment. 
The fluorescence images were taken at a focal plane at the middle of the cells. The 
fluorescence pattern of the control cell was turned down so as to prevent the over-
shooting of the data. It seems that the fluorescence intensity of the whole cells 
increased especially in the nucleus region. This indicates that intracellular calcium 
ions level of the L-929 cells increased after rhTNF treatment and most of the 
calcium ions were located at the nucleus region as this region also gave high 
fluorescence when acridine orange was added (data not shown). Maximal 
response was observed from 2 to 6 hours after rhTNF administration. The increase . 
in fluorescence intensity is probably not due to increased uptake of calcium green-
1/AM in response to the action of rhTNF on cell membrane. Should this be the 







Fig. 6.5 Fluorescence staining of intracellular free calcium ion in L-929 cells 
treated with 50 ng/ml rhTNF. L-929 cells were grown on glass slip and loaded 
with calcium green-l/AM as described in 'materials and methods'. After selecting . 
one single cell and focus adjusted, rhTNF was added and images of the immuno-
fluorescence staining was recorded by the computer. In this figure, images at 
various time intervals were shown. In the left side, from top to bottom: Control, 8 
minutes, 16 minutes, 24 minutes, after addition of rhTNF; right side, from top to 






Fig. 6.6 Fluorescence staining of intracellular free calcium ion in L-929 cells -
treated with 50 ng/ml rhTNF. L-929 cells were grown on glass slip and loaded 
with calcium green-1/AM as described in 'materials and methods' rhTNF was 
added to the L-929 cells and calcium green-1/AM was added just one hour before 
the incubation period ended. Images are recorded from L-929 cells treated with 50 ng/ml rhTNF for: Left side, from top to b ttom: Control, 1 hr, 2 hr, 3 hr; right side，f om t p to b ttom, 4 hr, 5 hr, 6 hr , 7 hr. ， 
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brightest. Another possible explanation is that rhTNF enhanced the esterases in the 
cell that cause an increase in the concentration of the fluorescence dye. 
However, in most cases, esterase in the cell is in excess and it does not seem 
reasonable to speculate a change in fluorescence intensity as a result of changes in 
esterase activity. Taking the results of the experiments using fluorescence dyes 
together, it seems that there are no transient changes in intracellular free calcium 
ions level. The intracellular calcium ions level rise when L-929 cells were exposed 
to a longer period of rhTNF. The rise in intracellular free calcium ions level last 
for about 6 hours and then starts to stop. In another experiment, L-929 cells were 
treated with rhTNF for 12 hours and examined for intracellular free calcium ions 
level. Fig. 6.7 shows the fluorescence image of that experiment. Highly 
fluorescence region was found at the nucleus indicated that permanent changes 
may take place in the nucleus region. 
To verify the changes in intracellular free calcium ions observed is really due to a 
change in intracellular level but not changes in other factors, radioactive calcium, 
45Ca，was used to perform an uptake experiment. Fig. 6.8 shows the calculated 
result of this experiment. Radioactivity of individual well was compared to the 
mean of the control wells to obtain a percentage and the percentage was plotted. 
From the graph, it can be found that rhTNF at a concentration of about 6 ng/ml 
effectively enhanced the uptake o f ^Ca from the environment by approximately 1.5 
to 3.5 fold. The amount uptake at this concentration of rhTNF increased as the 
time of treatment increased. However, a higher dosage of rhTNF did not furtlier 
increase the amount of 々^Ca uptake but actually the percentage uptake dropped 
gradually, resuming that of the control. It seems that at least two factors are 
1 4 6 
Fig. 6.7. Fluorescence staining of intracellular free calcium ion in L-929 cells 
treated with 50 ng/ml rhTNF. L-929 cells were grown on glass slip and loaded 
with calcium green-1/AM as described in ‘materials and methods'. The L-929 cells 
shown in the image had been incubated with 25 ng/ml rhTNF for 12 hours. 
Calcium green-l/AM was added just one hour before the end of incubation. 
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Fig. 6.8. ^^Calcium uptake in L-929 cells treated with rhTNF. L-929 cells were 
grown in wells of 24-well plate. One ml of rhTNF ranged from 50 ng/ml to 3.125 
ng/rnl in two fold serial dilutions were added to the cells. Radioactive calcium 
(^^Calcium) in 100 volume was added fifteen minutes before the end of 
incubation. After incubation, cells were washed three times with cold PBS and the 
cells were lysed with sodium hydroxide. The percentage of radioactivity was 
calculated by comparing the radioactivity of each sample with the mean of the 
4 5 
control wells. Calcium uptake was determined at 1 hour (A), 2 hours (o) and 4 
hours ( • ) after rhTNF treatment. Result was determined by four individual 
readings and S.E.M. of the readings were plotted as error bar in tlie graph. 
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involved in controlling the movement of '^ '''Ca across the membrane. One possible 
explanation is that a high dosage of rhTNF may over-stimulate the cell and 
suppress the normal calcium ions metabolism. Calcium ions gradients across 
cellular membrane are maintained by energy expenditure and re-equilibration is 
driven mainly in two ways. They include an ATP-dependent mechanism which 
pumps the calcium ion across the membrane with direct utilization of energy; and 
also by membrane potential or Na+ZCa!. exchanger activity in plasma membrane 
(McBurnet and Neering, 1987). This mechanism, together with the calcium ions 
storage pool in the cell and calcium ions flux due to second messengers, will 
control the calcium level in the cells and hence all the calcium ions dependent 
responses (Carafoli, 1987). 
6.2.2 Effect of calcium ion channel blockers on rhTNF-mediated cytotoxicity 
on L-929 cells 
From the above results, it seems that calcium ions may enter the L-929 cells when 
the cell is exposed to rhTNF. The entrance does not take place in a rapid manner, 
but rather in a delay manner. To study the role of calcium in rhTNF mediated 
cytotoxicity, calcium channel blockers were used to examine whether calcium ion 
in the environment play a role. Cinnarizine was the first calcium ion channel 
blocker used for this study. This is a non-specific calcium channel blocker that 
inhibits calcium ions uptake. Fig. 6.9 shows the result of an experiment in which 
the L-929 cells were treated with various concentrations of cinnarizine for 4 hours. . 
The cinnarizine was removed by washing and replaced with rhTNF diluted with 
medium containing no cinnarizine. From the result, it seems that there are no 
change in the survival curve of cells treated with or without cinnarizine. As the 
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Fig. 6.9 Effect of cinnarizine on rhTNF mediated cytotoxicity on L-929 cells. L -
4 
929 cells at a population of 4x10 /well were seeded on wells of %-wel l plate. The 
cells were treated with 10 " M cinnarizine (〇)，50 " M cinnarizine (•)，100 " M 
cinnarizine ( • ) and culture medium without cinnarizine ( • ) for 4 hours before the 
administration of rhTNF. rhTNF at a concentration of 33.3 ng/ml to 0.26 ng/ml in 
two-fold serial dilutions were added and further incubated at 37°C in a hunidified 
CO2 incubator for 20 hours. Viability of cells was determined by neutral red 
uptake assay. Percentage survival was defined as the percentage ratio of O.D. 540 
nm reading of individual well compared to the wells treated with medium without 
rhTNF. Results were means of six individual readings and S.D. of the readings 
were plotted as the error bars in the graph. 
1 5 0 
result of previous experiment showed that the changes in intracellular free calcium 
ions concentration does not take place immediately after rhTNF administration, 
removal of the calcium channel blocker may also remove that effect. Hence, 
another experiment was done to study the effect of cinnarizine on rhTNF mediated 
cytotoxicity. In this experiment, rhTNF was diluted with medium containing 
various concentrations of cinnarizine and incubated with the cells. Fig. 6.10 shows 
the result of such experiment. From the graph, it can be found that at high 
concentration of rhTNF (33.3 ng/ml) percentage survival increased each by about 
10% as the concentration of cinnarizine went up from control to 10 juM and from 
50 / /M to 100 juM, respectively. Comparing the dose-dependent curve of 
cinnarizine at 100 /^M versus that of control, it is quite sure that cinnarizan at this 
concentration could suppress rhTNF-mediated cytotoxicity on L-929 cells. From 
the results of these two experiments (Fig. 6.9 and Fig. 6.10), it seems that the 
uptake of external calcium ions has a close relationship with rhTNF mediated 
cytotoxicity, either as a course of cell damage or as a result of cell damage. 
To have a better understanding of the mechanism of calcium intake, three 
commonly used slow calcium channel (L-type calcium channel) blockers were used 
to investigate the effect of blocking the calcium channel on rhTNF mediated k i l l i ng . . 
The name slow calcium channel is used to distinguish this type of calcium channels 
from the rapid Ca^VNa"" exchange channel. Diltiazen, nifedipine and verapamil 
were employed in these experiments. They are effective blockers of slow calcium . 
channel and they act on different locations of the channel. Diltiazen is a synthetic 
benzothiazepine that binds to benzothiazepine receptors on cell surface with 
moderately high affinity (ICD=80 nM at 20°C) (Garcia el al, 1986; Rosales and 
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Fig. 6.10 Effect of cinnarizine on the rhTNF mediated cytotoxicity on L-929 cells. 
4 -
L-929 cells at a population of 4x10 /well were seeded on wells of 96-well plate for 
the assay. RhTNF at a range of 33.3 ng/ml to 0.26 ng/ml in two-fold serial 
dilutions in medium containing 10 /^M cinnarizine (〇)，50 " M cinnarizine (•)，100 
jtiM cinnarizine ( • ) and no cinnarizine(^). The cells were kept at 37°C in a 
humidified CO2 incubator for 20 hours. Viability of L-929 cells were determined 
by neutral red uptake assay. Percentage survival was defined as the ratio of O.D. 
540 nm reading of individual well compared with the wells treated with no rhTNF 
but only culture medium or culture medium containing cinnarizine. Results are 
means of at least six individual measurements and S.D. of the measurements are 
plotted as error bars in the graph. 
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Browa, 1992; Dagani et al, 1989). The ability of cliltiazen to affect rhTNF 
mediated killing was also done in two ways: firstly, with diltiazen added to the L-
929 cells and removed by washing before adding rhTNF and secondly, diltiazen 
added with rhTNF together to the L-929 cells. The results are shown in Fig. 6.11 
and 6.12 respectively. In Fig 6.11，it was found that there are no significant 
difference in the survival of L-929 cells pretreated with 100 " M cliltiazin. 
However, when rhTNF was added to L-929 cells with 10 /^M diltiazen, the 
survival percentage increased from about 30% to 60% at a dose of 33.3 ng/ml 
rhTNF. This indicates that significant inhibition of the killing action of rhTNF was 
obtained. At low concentrations of rhTNF (-0.25 ng/ml rhTNF), an increase in 
about 10% of survival was also observed, indicates that diltiazen was also effective 
at low dosage of rhTNF. 
Nifedipine is a 1,2-dihydropyridine type and relatively selective blocker of cellular 
voltage-operated channels (VOCs) for calcium or slow calcium channels (Tabrizchi 
and Triggle, 1989). It blocks the same calcium channels as diltiazen but at 
different binding site. Nifedipine was also added to L-929 cells to test their effect 
on rhTNF mediated killing as diltizaen. Fig. 6.13 shows the effect of rhTNF on L-
929 cells treated with nifedipine for 4 hours before addition of rhTNF. From the 
graph, it can be found that L-929 cells pretreated with 10 / 遍 nifedipine shows no 
significant difference to those not treated with nifedipine. However, when the 
concentration of nifedipine was increased to 100 /^M, the survival percentage 
increased about 20% at a dosage of 33.3 ng/ml rhTNF. In another experiment, 
nifedipine was applied together with l i iTNF on L-929 cells, similar pattern was 
observed. As shown in Fig, 6.14，it can be seen that there was still an increase in 
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Fig. 6.11 Effect of diltiazen on rhTNF mediated cytotoxicity on L-929 cells. L -
4 
929 cells at a population of 4x10 /well were seeded on wells of 96-well plate. The 
cells were treated with 1 0 0 " M diltiazen (•)，and culture medium without diltiazen 
( • ) for 4 hours before the administration of rhTNF. rhTNF at a concentration of 
33.3 ng/ml to 0.26 ng/ml in two-folcl serial dilutions were added and further 
incubated at 37°C in ahumidified CO2 incubator for 20 hours. Viability of cells 
was determined by neutral red uptake assay. Percentage survival was defined as 
the percentage ratio of O.D. 540 nm reading of individual well compared to the 
wells treated with medium without rhTNF. Results were means of six individual 
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Fig. 6.12 Effect of diltiazen on the rhTNF mediated cytotoxicity on L-929 ce l l s . ‘ 
4 
L-929 cells at a population of 4x10 /well were seeded on wells of 96-well plate for 
the assay. RhTNF at a range of 33.3 ng/rnl to 0.26 ng/ml in two-fold serial 
dilutions in medium containing 10 " M diltiazen (〇）and no diltiazen ( • ) . The cells 
were kept at 37°C in a humidied CO2 incubator for 20 hours. Viability of L-929 
cells was determined by neutral red uptake assay. Percentage survival was defined 
as the ratio of O.D. 540 nm reading of individual well compared with the wells 
treated with no rhTNF but only culture medium or culture medium containing 
diltiazen. Results were means of at least six individual measurements and S.D. of 
the measurements were plotted as error bars in the graph. 
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Fig. 6.13 Effect of nifedipine on rhTNF mediated cytotoxicity on L-929 cells. L -
929 cells at a population of 4xl0'^/well were seeded on wells of 96-well plate. The 
cells were treated with 10 ^ M nifedipine (〇)，100 / iM nifedipine ( • ) and culture 
medium without nifedipine ( • ) for 4 hours before the administration of rhTNF. 
rhTNF at a concentration of 33.3 ng/ml to 0.26 ng/ml in two-fold serial dilutions 
were added and further incubated at 37°C in a humidified CO2 incubator for 20 
hours. Viability of cells was determined by neutral red uptake assay. Percentage 
survival was defined as the percentage ratio of O.D. 540 nm reading of individual 
well compared to the wells treated with medium or nifedipine. Results were means 
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Fig. 6.14 Effect of nifedipine on the rhTNF mediated cytotoxicity on L-929 cells. 
4 
L-929 cells at a population of 4x10 /well were seeded on wells of 96-well plate for 
the assay. rhTNF at a range of 33.3 ng/ml to 0.26 ng/ml in two-fold serial dilutions 
in medium containing 10 / /M nifedipine (〇)，50 / /M nifedipine ( • ) and no 
nifedipine ( • ) . The cells were kept at 37°C in a humidified CO2 incubator for 20 
hours. Viability of L-929 cells was determined by neutral red uptake assay. 
Percentage survival was defined as the ratio of O.D. 540 nm reading of individual ‘ 
well compared with the wells treated with no rhTNF but only culture medium or 
culture medium containing nifedipine. Results were means of at least six individual 
measurements and S.E.M. of the measurements were plotted as error bars in the 
graph. 
157a 
survival percentage but the concentration needed to give similar enhancement in 
survival percentage is 50 " M . One common finding in using this calcium channel 
blocker is that it does not give significant increases in survival percentage at low 
dosage. 
The last calcium channel blocker used is verapamil. Verapamil is also capable of 
inhibiting calcium entry through voltage-dependent calcium channel and slow 
calcium channel (Morris and Bradford, 1985). It binds to aralkylamine receptor on 
the channels and deactivates the calcium channel. Fig. 6.15 shows that when L-
929 cells were treated with verapamil for 4 hours before the addition of rhTNF, the 
toxicity of rhTNF was reduced by 10% when 5 " M verapamil was applied before 
addition of 33.3 ng/ml rhTNF to the cells. From the graph, it can be found that an 
overall enhancement of survival was obtained when L-929 cells were pre-treated 
with verapamil. Fig. 6.16 further shows that when L-929 cells were treated with 
rhTNF in the presence of verapamil, an increase in survival percentage was also 
observed. In this graph, it can be seen clearly that the effect of verapamil was 
more significant at low dosage of rhTNF and higher dosage of verapamil. The 
percentage of survival nearly leveled off when rhTNF at a range of 2.6 ng/ml to 4 
ng/ml was added to L-929 cells in the presence of 25 " M verapamil. 
The above three calcium channel blockers are known to be effective in blocking 
slow calcium channel by binding to different receptors and hence should induce 
different response in the calcium channel. It was found that they are all effective in 
suppressing the cytotoxicity induced by rhTNF on L-929 cells especially in co-
treatment with rhTNF. This indicates that the movement of calcium ion from 
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Fig. 6.15 Effect of verapamil on rhTNF mediated cytotoxicity on L-929 cells. L -
929 cells at a population of 4xlo'^/well were seeded on wells of 96-well plate. The 
cells were treated with 5 / i M verapamil and culture medium without verapamil ( • ) 
for 4 hours before the administration of rhTNF. rhTNF at a concentration of 33.3 
ng/ml to 0.26 ng/ml in two-fold serial dilutions were added and further incubated at 
37°C in a humidified CO2 incubator for 20 hours. Viability of cells was determined 
by neutral red uptake assay. Percentage survival was defined as the percentage 
ratio of O.D. 540 nm reading of individual well compared to the wells treated with 
medium without rhTNF or medium containing verapmil. Results were means of six 
individual readings and S.E.M. of the readings were plotted as the error bars in the 
graph. 
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Fig. 6.16 Effect of verapamil on the rhTNF mediated cytotoxicity on L-929 c e l l s . . 
L-929 cells at a population of 4xl0'^/well were seeded on wells of 96-well plate for 
the assay. rhTNF at a range of 33.3 ng/ml to 0.26 ng/ml in two-fold serial dilutions 
in medium containing 5/zM verapamil (0)，25 verapamil (V),and no verapamil 
( • ) . The cells were kept at 37°C in a humidified CO2 incubator for 20 hours. 
Viability of L-929 cells was determined by neutral red uptake assay. Percentage 
survival was defined as the ratio of O.D. 540 nm reading of individual well 
compared with the wells treated with no rhTNF but only culture medium or culture 
medium containing verapamil. Results were means of at least six individual 
measurements and S.E.M. of the measurements were plotted as error bars in the 
graph. 
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extracellular environment into the cytosol plays a major role in the killing 
mechanism induced by rhTNF on L-929 cells. 
6.2.3 Effect of protein kinase C (PKC) on rliTNF-inecliated cytotoxicity on L-
929 cells 
A lot of intracellular responses depend on intracellular free calcium level. A 
change in intracellular calcium level would bring along changes in the cellular 
functions. One of the most important cellular components that depends on calcium _ 
level is protein kinase C (PKC). PKC is a calcium dependent protein kinase that 
regulates a wide range of cellular activities. In an attempt to study whether PKC 
plays any role in rhTNF mediated cytotoxicity on L-929 cells, a potent PKC 
inhibitor, staurosporine, was used. Staurosporine was isolated from Strcpiomyces 
sp. first as an antibiotic. This microbial alkaloid had later been identified as a PKC 
inhibitor (Tamaoki et a I, 1986). L-929 cells were subjected to rhTNF treatment in 
the presence of 2 ng/ml staurosporine. As staurosporine is one of the most potent 
PKC inhibitors known, it is usually used in ng/ml level. It has been reported that a 
high dose of staurosporine is not only toxic to the cells, but also it would affect 
other calcium metabolism, either as a direct action or indirectly through PKC 
inhibition (Tamaoki et a I, 1986). The survival percentage of L-929 cells treated . 
for 20 hours was shown on Fig. 6.17. When 33.3 ng/ml rhTNF was applied to L -
929 cells, 2 ng/ml staurosporine increased the survival by about 30% survival. 
In another experiment, a PKC activator was used to study the role of PKC on 
rhTNF mediated cytotoxicity. SC-10, [N-(n-Heptylyl)-5-chloro-l-
naphthalenesulfonamide], is a synthetic compound that can activate PKC in a 
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Fig. 6.17 Effect of staurosporine on the rhTNF mediated cytotoxicity on L-929 
cells. L-929 cells at a population of 4xlo'^/well were seeded on wells of 96-well 
plate for the assay. RhTNF at a range of 33.3 ng/ml to 0.26 ng/ml in two-fold 
serial dilutions in medium containing 2 ng/ml staurosporine (〇 )and no 
staurosporine ( • ) . The cells were kept at 37。C in a humidified CO2 incubator for 
20 hours. Viability of L-929 cells was determined by neutral red uptake assay. 
Percentage survival was defined as the ratio of O.D. 540 nm reading of individual 
well compared with the wells treated with no rhTNF but only culture medium or 
culture medium containing staurosporine. Results are means of at least six 
individual measurements and S.D. of the measurements are plotted as error bars in 
the graph. 
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calcium dependent manner (Ho el a I, 1986). Fig. 6.18 shows that when rhTNF 
diluted with 10 / iM SC-10 was added to L-929 cells and incubated for 20 hours, 
there was no significant difference in the survival percentage in the L-929 cells. 
However, when 50 " M of SC-10 was applied to the L-929 cells for 4 hours before 
administration of rhTNF, there was a slight increase in survival when high dosage 
of rhTNF was used (Fig. 6.19). One possible explanation is that an incubation of 
L-929 cells with high concentration of PKC activator may over-stimulate the PKC 
and cause a exhaust of the PKC (Ho et a I, 1986). • 
6.2.4 Iminiino-nuorescence stainine of PKC in rhTNF-treated L-929 cells. 
Activation of PKC is associated with the movement of cytosolic PKC towards the 
plasma-membrane (Kraft and Anderson, 1983). A monoclonal antibody against 
PKC was used to locate the distribution of PKC inside the rhTNF-treated L-929 
cells. The distribution of cytosolic PKC and membrane-bound PKC shows the 
activity of PKC. Fig. 6.20 shows the immuno-fluorescence image-graph of L-929 
cells stained with monoclonal antibody against PKC. The anti-PKC antibody was 
visualized by FITC-labelecl goat anti-mouse-IgM antibody. From the results, it can 
be found that the cells without rhTNF treatment are palely stained and the staining 
is rather evenly distributed over the cytoplasm. However, in rhTNF-treated L-929 
cells, the staining is brighter and locate around the nucleus. After 3 hours of 
incubation, the fluorescence pattern of rhTNF-treated L-929 cells drops but the 
fluorescence intensity is still higher than that of the control. L-929 cells treated 
with rhTNF for 4 hours shows similar result as that of L-929 cells treated for 3 
hours. From this result, it seems that PKC is activated by rhTNF treatment in L-
929 cells. The activity of PKC reached maximum at one hour after addition of 
165 
100 r . , 
90 -
I 二： : 
I 50 - N d ^ 
I 40 - 2 
^ 30 - -
^ 2 0 -
10 - : 
0 t ^ — — ‘ i ； 
0.2 0.5 1.0 2.0 5.0 10.0 20.0 
rhTNF (ng/ml) 
Fig. 6.18 Effect of SC-10 on the rhTNF mediated cytotoxicity on L-929 cells. L-
929 cells at a population of 4 x l o V e l l were seeded on wells of 96-well plate for 
the assay. RhTNF at a range of 33.3 ng/ml to 0.26 ng/ml in two-fold serial 
dilutions in medium containing 10/ /M SC-10 and no SC-10 ( • ) . The cells were 
kept at 37°C in a humidified CO2 incubator for 20 hours. Viability of L-929 cells 
was determined by neutral red uptake assay. Percentage survival was defined as 
the ratio of O.D. 540 nm reading of individual well compared with the wells treated 
with no rhTNF but only culture medium or culture medium containing SC-10 • 
Results are means of at least six individual measurements and S.D. of the 
measurements are plotted as error bars in the graph. 
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Fig. 6.20 Immunofluorescence staining of PKC in L-929 cells treated with 50 
ng/ml rhTNF for various periods of time. L-929 cells treated with rhTNF were 
fixed and stained after incubation as described in 'materials and methods，. The 、 
energy of the laser been and the sensitivity of the detector of the confocal . 
microscope was unchanged throughout the experiment. In this figure, image of L-
929 cells treated for different incubation time was shown. Upper left: Control; 
upper right: treated for 1 hour; lower left: treated for 3 hours; lower right: treated 
for 4 hours. 
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Fig. 6.19 Effect of SC-10 on rhTNF mediated cytotoxicity on L-929 cells. L-929 
cells at a population of 4xlo'^/well were seeded on wells of 96-well plate. The 
cells were treated with 50 / iM SC-10 (V) and culture medium without SC-10 ( • ) 
for 4 hours before the administration of rhTNF. rhTNF at a concentration of 33.3 
ng/ml to 0.26 ng/ml in two-fold serial dilutions were added and further incubated at 
37°C in a humidified CO2 incubator for 20 hours. Viability of cells was determined 
by neutral red uptake assay. Percentage survival was defined as the percentage 
ratio of O.D. 540 nm reading of individual well compared to the wells treated with 
medium or medium containing SC-10. Results were means of six individual 
readings and S.E.M. of the readings were plotted as the error bars in the graph. 
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rhTNF to the L-929 cells. PKC activation by FCS was compensated in the control 
group as the cells were kept in medium containing 5%FCS before and throughout 
the experiment. 
6.2.5 Effect of calmodulin and calmodulin sensitive calcium ATPase on 
rhTNF-mediated cytotoxic effect on L-929 cells 
Another regulatory protein that is highly influenced by calcium ions level is 
calmodulin. Calmodulin is a heat-stable calcium binding protein that can activate ‘ 
nucleotide phosphodiesterase in the presence of calcium (Sawamura el al, 1985； 
Inagaki et al, 1983). It also affects adenylate cyclase, calcium-dependent ATP-ase, 
and other kinases (Krebs, 1993). To test whether calmodulin takes part in rhTNF 
mediated killing in L-929 cells, W-7 was added together with rhTNF to L-929 cells 
and assessed for their ability to kill L-929 cells. W-7, N-(6-Aminohexyl)-5-chIoro-
l-naphthalenesulfonamicle, is a calmodulin antagonist that binds calmodulin and 
inhibits all Ca-'^-calmodulin-regulated activities (Inagaki et al, 1983) Fig. 6.21 
shows the result of the survival of L-929 cells treated with rhTNF diluted with or 
without W-7. From the graph, it can be seen that there is no significant difference 
between the survival curve of L929 cells treated with or without W-7 while the 
cells are exposed to rhTNF. Noted that a rather high concentration of W-7 was ‘ 
used. This results indicate that calmodulin is not involved or the role played by 
calmodulin is not important in the rhTNF-mediated cytotoxicity on L-929 cells. 
Another inhibitor, TMB-8, was employed to study the role of calmodulin in rhTNF 
mediated cytotoxicity on L-929 cells. TMB-8, 8-(Diethylamino)-octyl 3,4,5-
trimethoxybenzoate, is a synthetic intracellular calcium antagonist that can inhibit 
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Fig. 6.21 Effect of W-7 on the rhTNF mediated cytotoxicity on L-929 cells. L_ 
929 cells at a population of 4 x l o V e l l were seeded on wells of 96-well plate for 
the assay. RhTNF at a range of 33.3 ng/ml to 0.26 ng/ml in two-fold serial 
dilutions in medium containing 200 W-7 ( • ) and no W-7(«). The cells were 
kept at 37°C in a humidified CO2 incubator for 20 hours. Viability of L-929 cells 
was determined by neutral red uptake assay. Percentage survival was defined as 
the ratio of O.D. 540 nm reading of individual well compared with the wells treated 
with no rhTNF but only culture medium or culture medium containing W-7 . 
Results are means of at least six individual measurements and S.D. of the 
measurements are plotted as error bars in the graph. 
1 6 7 
calmodulin-sensitive calcium ATPase activity (Savvamura et al, 1985). Fig, 6.22 
shows the effect of applying TMB-8 to L-929 cells 4 hours before the addition of 
rhTNF. TMB-8 treated L-929 cells were washed with plain medium before 
. addition of rhTNF. From the graph, it can be found that L-929 cells pre treated 
with 5 jug/ml TMB-8 behaved as they have not been treated with TMB-8. Similar 
result was obtained in another experiment in that TMB-8 was added to L-929 cells 
together with low dosage of rhTNF (Fig. 6.23). As shown in this graph, only at 
high dosage of rhTNF, a slight increase in survival was observed when 1 / ig/ml of -
TMB-8 was added together with rhTNF. In case of applying TMB-8 with rhTNF 
together to L-929 cells, it was expected TMB-8 should have an effect on L-929 
cells. 
Hence, as evidenced from the results of experiments using W-7 and TMB-8, it 
seems that calmodulin or calmodulin-sensitive calcium ATPase may play a minor or 
an indirect role in rhTNF mediated cytotoxicity on L-929 cells. 
6.2.6 Role of inositol trisphosDhate in rhTNF-ineclinted cytotoxicity on L-929 
ceils 
The ability of rhTNF to induce inositol lipid metabolism in L-929 cells was studied ‘ 
by direct measurement of inositol phosphate turnover profile in L-929 cells treated 
with rhTNF. Simple ion exchange column was used in this experiment as the aim 
was not to identify the structure and details of the inositol phosphate members in 
this pathway. Lithium chloride was added to the reaction mixture to inhibit the 
activities of two enzymes, namely the inositol monophosphate 
phosphomonoesterase and inositol polyphosphate 1-phosphate 
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Fig. 6.22 Effect o fTMB-8 on rhTNF mediated cytotoxicity on L-929 cells. L-929 
4 
cells at a population of 4x10 /well were seeded on wells of 96-well plate. The 
cells were treated with 5 /^g/ml TMB-8 (o) and culture medium without TMB-8 
( • ) for 4 hours before the administration of rhTNF. rhTNF at a concentration of 
33.3 ng/ml to 0.26 ng/ml in two-fold serial dilutions were added and further 
incubated at 37°C in a humidified CO2 incubator for 20 hours. Viability of cells 
was determined by neutral red uptake assay. Percentage survival was defined as 
the percentage ratio of O.D. 540 nm reading of individual well compared to the 
wells treated with medium without rhTNF. Results were means of six individual 
readings and S.D. of the readings were plotted as the error bars in the graph. 
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Fig. 6.23 Effect o fTMB-8 on the rhTNF mediated cytotoxicity on L-929 cells. L-
929 cells at a population of 4xl0'^/well were seeded on wells of 96-well plate for 
the assay. rhTNF was added at a concentration of 33.3 ng/ml to 0.26 ng/ml in 
two-fold serial dilutions in medium containing 1 jug/m\ TMB-8 (〇）and no TMB-8 
( • ) • The cells were kept at 37°C in a humidified CO2 incubator for 20 hours. 
Viability of L-929 cells was determined by neutral red uptake assay. Percentage 
survival was defined as the ratio of O.D. 540 nm reading of individual well 
compared with the wells treated with no rhTNF but only culture medium or culture 
medium containing TMB-8. Results are means of at least six individual 
measurements and S.D. of the measurements are plotted as error bars in the graph. 
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phosphomonoesterase. This mainly prevented the conversion of inositol 
monophosphate back to myoinositol so as to enhance the signal. Fig. 6.24 shows 
the inositol turnover profiles of L-929 cells stimulated with 5% FCS. The fractions 
containing inositol monophosphate had an increased radioactivity after 5% FCS 
was added and incubated with the cells from 1 to 4 hours. Table 6.1 showed the 
percentage of radioactivity in the inositol phosphate members, including inositol 
mono-phosphates, inositol di-phosphales and inositol tri-phosphates, in the eluent 
compared to the total radioactivity eluted from the column. It could be seen that 一 
the amount of labeled inositol phosphates reached about 11% of the total eluted 
inositol lipids within 2 hours. Fig. 6.25 shows the effect of rhTNF on the inositol 
phosphate turnover in L-929 cells in the presence of 5% FCS. There were no 
significant changes in the profiles. The radioactivity of labeled inositol phosphates 
was also compared to the total radioactivity of the eluent and result was shown in 
table 6.2. It was found that around 10% of the total eluent contains inositol 
phosphates. The amount of inositol phosphate was similar to that in cells without 
rhTNF treatment. In another experiment, inositol profiles were obtained from L-
929 cells treated with 50 ng/ml rhTNF in the absence of FCS. Fig. 6.26 showed 
the profiles obtained at different time intervals and table 6.3 showed the amount of 
radioactivity in the eluent that was contributed by inositol phosphates. From the ‘ 
profiles, it seems that there was no change in the pattern of the profile but there 
was a slight but fluctuated increase in the radioactivity contributed by the inositol 
phosphates. This slight but non-linear increase had been observed in many 
experimental trials. 
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Fig. 6.24 Inositol phosphate turnover profiles in L-929 cells treated with 5% FCS. 
L-929 cells were depleted for FCS and incubated with 4 "Ci /ml ^H-myo-inositol 
for 18 hours. After incubation, the L-929 cells were washed 3 times with Na- . 
HEPES (pH 7.4). Li CI was added in the experiment to enhance the signal. 
Members of inositol phosphates were measured as described in 'materials and 
methods'. Inositol phosphate turnover profiles were obtained at different time 
intervals, (A) control, no FCS was added, (B) 1 hour after 5% FCS was added, (C) 
2 hours after 5% of FCS was added, (D) 3 hours after 5% of FCS was added, (E) 
4 hours after 5% FCS was added. 
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Time/hours No rhTNF 1 2 3 4 
% of Total 2.74 7.63 11.37 12.2 11.27 
Table 6.1 Percentage of inositol phosphates in L-929 cells treated with 5% FCS. 
Table showing the percentage of inositol phosphates, including inositol mono-
phosphate, inositol bisphosphate and inositol trisphosphate, in the total sample 
eluted from ion exchange column. The percentage is calculated by comparing the 
total count of inositol phosphates with that of the total count of the whole profile. 
During the loading of ^H-myo-inositol, the cells were depleted for FCS. The data 
was obtained in one typical experiment. 
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Fig. 6.25 Inositol phosphate turnover profiles in L-929 cells treated with rhTNF. 
3 
L-929 cells were incubated with 4 "Ci/ml H-myo-inositol overnight at 37°C in a 
moisted CO2 incubator. After incubation, cells were washed 3 times with Na-
HEPES and cell number adjusted to IxlO^/ml. 50 ng/ml rhTNF was added in the 
presence of LiCl. Members of the inositol phosphate family were collected as 
described in 'materials and methods'. Medium supplemented with 5% FCS was 
used throughout the experiment. Inositol phosphate turnover profiles measured at 
different time intervals were presented: (A) control profile, no rliTNF; (B) treated 
for 30 minutes; (C) treated for 60 minutes; (D) treated for 90 minutes; (E) treated 
for 120 minutes; (F) treated for 150 minutes; (G) treated for 180 minutes; (H) 
treated for 210 minutes; (I) treated for 240 minutes; (J) treated for 270 minutes. 
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Time /hour Control 0.5 1.0 1.5 2.0 2.5 ~ ^ ” ~ ~ “ 
% of Total 10.24 10.78 9.34 10.16 9.99 10.33 10.69 9.99 10.57 10.31 
Table 6.2 Percentage of inositol phosphates in L-929 cells treated with 50 ng/ml 
rhTNF in I he presence of FCS. Table showing the percentage of inositol 
phosphates, including inositol mono-phosphate, inositol bispliosphate and inositol 
trisphosphate, in the total sample eluted from ion exchange column. The 
percentage is calculated by comparing the total count of inositol phosphates with 
that of the total count of the whole profile. The data was obtained in one typical 
experiment. 
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Fig. 6.26 Inositol phosphate turnover profiles in L-929 cells treated with 50 ng/ml 
3 . 
rhTNF. L-929 cells were incubated with 4 "Ci /ml H-myo-inositol overnight at 
37°C in a moisted CO2 incubator. After incubation, the cells were washed 3 times 
with Na-HEPES (pH 7.4) and cell number adjusted to l x l O % i l . The cells were 
depleted for FCS for 18 hours and LiCl was added to prevent the hydrolysis of I P 3 . 
Details of experimental procedure were described in 'materials and methods'. (A) 
Control curve, no FCS and no rhTNF, (B) control curve, 5% FCS and no rhTNF, 
(C) treated for 30 minutes, (D) treated for 60 minutes, (E). treated 90 minutes, 
(F). Treated for 120 minutes, (G) treated for 150 minutes, (H) treated for 180 
minutes, (I) treated for 210 minutes, (J) treated for 240 minutes, (K) treated for 
270 minutes. 
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Time /hour 0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 
% of Total 3.640 3.772 4.506 5.587 3.947 4.851 3.839 4.588 5.146 5.198 
Table 6.3 Percentage of inositol phosphates in L-929 cells treated with 50 ng/ml 
rhTNF in the absence of FCS. Table showing the percentage of inositol . 
phosphates, including inositol mono-phosphate, inositol bisphospliate and inositol 
trisphosphate, in the total sample eluled from ion exchange column. The 
percentage is calculated by comparing the total count of inositol phosphates with 
that of the total count of the whole profile. In sample with FCS and no rhTNF the 
percentage of total inositol phosphate gave a value of 11.195. The data was 
obtained in one typical experiment. 
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Neomycin sulphate is a common agent to inhibit cellular events involved with 
inositol phospholipid as it is an inhibitor of phospholipase C. In an experiment to 
study the effect of neomycin sulphate on rhTNF mediated killing in L-929 cells, it 
was found that there was no significant change in the sensitivity of L-929 cells 
towards the cytotoxicity of rhTNF. Fig. 6.27 shows that the percentage of survival 
in L-929 upon rhTNF treatment in the presence of neomycin sulphate was very 
close to that of the one without neomycin sulphate and no significant difference 
was observed. ‘ 
6.2.7 Role of Tyrosine kinase activity in the rliTNF-mccliated cytotoxicity on 
L-929 cells 
Tyrosine kinase activation can induce the turnover of inositol-phosphates and thus 
it is interesting to investigate whether rhTNF has the ability to activate tyrosine 
kinase. Fig. 6.28 shows the result of Western blotting against phosphorylated 
tyrosine residue in protein isolated from L-929 cells treated with rhTNF for various 
periods of time. As shown from the image of the Western blotting, two bands 
were found, with Rf value of 47 and 81 respectively and the molecular weight 
estimated to be 33 and 17 Kda respectively. As the monoclonal antibody used is 
highly specific for phosphorylated tyrosine residue, the result indicates that a ‘ 
protein with 33 kda is highly phosphorylated by tyrosine kinase and another protein 
with molecular mass 17 Kda is also phosphorylated by tyrosine kinase but the 
amount of protein is not so abundant as the former one. 
From the results showed on different lanes, it can be seen that these two proteins 
shown similar staining intensity as compared to the control. This indicates that L-
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Fig. 6.27 Effect of neomycin sulphate on rhTNF mediated cytotoxicity on L-929 
cells. 4x10 L-929 cells in 100 /i\ volume of culture medium were seeded onto 
wells of 96-well plates. After incubation at 37。C in a moisted CO: incubator for 
12 hours, various dilutions of rhTNF in medium containing no neomycin sulphate 
(•)，0.5 mg/ml neomycin sulphate (〇)，1 mg/ml neomycin sulphate ( • ) and 5 mg/ml 
neomycin sulphate (A) were added. Viability was determined by neutral red uptake 
assay after 20 hours incubation at 37°C in a humidified CO2 incubator. Amount of 
neutral red was measured by plate reader at a wavelength of 540 nm. Percentage 
survival was defined as the percentage ratio of O.D. reading of individual well 
compared to wells without rhTNF but only the corresponding culture medium. 
Data points were measurement of at least six individual wells and S.E.M. of the 
measurements were plotted as error bars. 
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Result of comparison of Rf values between standard and unknown protein 
Standards Unknown estimated molecular weight 
Rf MWs Rf MWs 
4 94000 47 33000 





Stardards obtained from Pharmacia LKB AB and the composition, from top to bottom in 
lane 1, consisted of phosphorylase b (94000); bovine serum albumin (67000); ovalbumin 
(43000); carbonic anhydrase (30000); soybean trypsin inhibitor (20100) and a-lactalbumin 
(14400). 、. 
！ 
Fig. 6.28 Image of Western blotting using antibody against phosphorylated tyrosine 
residues in protein. The samples were isolated from L-929 cells treated with or 
without rhTNF. In the top panel, the image of the nitrocellulose filter was shown. 
Lane 1 shows the molecular weight markers; lane 2 and lane 3 show the control 
samples; lane 4-7 show the result of L-929 cells treated with 50 ng/ml rhTNF for 1 
to 4 hours respectively. The lower panel shows the Rf values of the standard and 
the calculated molecular weight of the sample stained. 
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929 cells treated with 50 ng/ml rhTNF show no significant response towards 
tyrosine kinase activity. However, the result obtained from this experiment is 
limited by the sensitivity of the experimental setup. 
Using the same antibody, an immuno-fluorescence imagegraph of L-929 cells 
treated with rhTNF can be obtained. L-929 cells were treated with rhTNF for 
various periods of time followed by fixing and staining as described in 'materials 
and methods'. Precautions which had been made were similar to that in staining of -
PKC. Fig. 6.29 shows the staining of phosphorylated tyrosine residues in proteins 
located in the L-929 cells. An even distribution of fluorescent dyes in the 
cytoplasm was observed in L-929 cells not treated with rhTNF. The amount of 
fluorescent dye increases in rhTNF-treated L-929 cells and the intensity reaches 
maximum in 3 hours. The result indicates that tyrosine kinase activity was 
enhanced by the treatment of 50 ng/ml rhTNF on L-929 cells. 
Genistein, a tyrosine kinase inhibitor, was used to investigate the role of tyrosine 
kinase in rhTNF-mediated cytotoxicity on L-929 cells. Genistein has been shown 
to reduce the cytotoxic effect of rhTNF on L-929 cells as shown in Fig. 6.30. The 
effect was rather significant when 3 or 10 f M genistein were used. When 30 " M ‘ 
genistein was applied together with rhTNF to L-929 cells, over 50% increase in 
survival was observed at a concentration of 33.3 ng/ml rhTNF. This gives strong 
indication that by suppressing the activity of tyrosine kinase, the cytotoxic effect of • 
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Fig. 6.29 Immunofluorescence imagegraph of rhTNF treated L-929 cells stained 、 
with fluorescence labeled antibody against phosphotyrosine. L-929 cells were 
treated with or without rhTNF for various periods of time, followed by fixing and 
staining as described in 'materials and methods'. The energy of the laser bean and 
the sensitivity of the detector of the confocal microscope was unchanged 
throughout the experiment. In this figure, images of L-929 cells treated for 
different incubation times were shown. Upper left: Control; upper right: treated 
for 1 hour; lower left: treated for 2 hours; lower right: treated for 3 hours. 
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Fig. 6.30. Effect of gen is te in on rhTNF mediated cytotoxicity on L-929 cells. L-
4 
929 cells at a population of 4x10 /well were seeded on wells of 96-well plate for 
the assay. rhTNF at a range of 33.3 ng/ml to 0.26 ng/ml in two-fold serial dilutions 
in medium containing 3 / iM genistein (〇)’ 10 /^M genistein (V), 30 /zM genistein 
( • ) and no genistein ( • ) . The cells were kept at 37°C in a humidified CO2 
incubator for 20 hours. Viability of L-929 cells was determined by neutral red 
uptake assay. Percentage survival was defined as the ratio of O.D. 540 nm reading 
of individual well compared with the wells treated with no rliTNF but only culture 
medium or culture medium containing genistein. Results are means of at least six 
individual measurements and S.E.M. of the measurements are plotted as error bars 
in the graph. 
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6.3 Discussion 
By using the calcium ions sensitive fluorescence dye, Fura-2/AM, we found that 
rhTNF could not stimulate a rapid and transient enhancement of intracellular 
[Ca2十]in L-929 cells (Fig. 6.1). This finding was confirmed by using another 
fluorescence probe, calcium green-l/AM, and examined the cells under confocal 
microscopy (Fig. 6.3-6.5). However, we found that when L-929 cells were treated 
with rhTNF for 2-6 hours, intracellular [Ca^+J increased significantly in the whole 
cell especially in the nucleus (Fig, 6.6). By using radioactive "^ Ca "^^  uptake assay, ‘ 
we found that L-929 cells treated for 1 to 4 hours by rhTNF at 6 ng/ml could 
effectively enhance the Ca"^ uptake from the extracellular medium into the cells by 
approximately 1.5 to 3.5 folds comparing with the control (Fig. 6.8) 
In our study, we further use Ca'^ channel blockers to elucidate the function of Ca"^ 
in our system. Both the non-specific Ca"^ channel blocker, cinnarizine, and other 
three specific L-type Ca^^ channel blockers, diltiazen, nifedipine and verapamil, 
when added together with rhTNF on the treatment media in L-929 cells and treated 
for 20 hours, could decrease the cytotoxic effect of rhTNF (Fig. 6.10, 6.12 and 
6.14, 6.16). For the same blockers, pre-treatment for 4 hours before the 
administration of rhTNF could exhibit some effect in decreasing TNF's sensitivity -
in L-929 cells (Fig. 6.9，6.11，6.13 and 6.15). Al l the above mentioned result 
clearly demonstrated that intracellular free calcium ions level plays a role in rhTNF-
mediated cytotoxicity in L-929 cells. • 
Since Ca^^ can activates the Ca"^ dependent protein kinase C (PKC) and 
calmodulin activities, we investigated whether rhTNF can affect PKC or 
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calmodulin activities in L-929 cells. We found that PKC inhibitor, staurosporine, 
but not PKC activator, SC-10 can suppress the cytotoxic effect of rhTNF on L-929 
cells (Fig. 6.17, 6.18 and 6.19). By using immuno-fluorescence staining technique, 
it was found that there is translocation of PKC towards the nucleus membrane 
(Fig. 6.20). The PKC activity, reflected in their translocation, reaches maximum in 
the cells at about 1 hour after addition of rhTNF. On the other hand, antagonists 
of calmodulin, W-7 and TMB-8, did not affect the sensitivity of L-929 cells 
towards rhTNF (Fig. 6.21，6.22, 6.23). At present, we do not know what exact 一 
function of intracellular Od^^  wi l l exerts after rhTNF treatment in L-929 cells. 
Inositol trisphosphate is also a major component in Ca"^ related signal transduction 
system. In L-929 cells treated with rhTNF in the presence of 5%FCS, no 
significant difference was found in the relative amount of radioactivity contributed 
by inositol trisphosphate members extracted from the L-929 cells (Table 6.2). 
However, the result was different in another experiment in which the experimental 
condition was FCS free. In this experiment，it is found that there is a slight 
increase in the percentage of radioactivity contributed by inositol trisphosphates in 
L-cells treated with 50 ng/ml rhTNF (Table 6.3). In this two experiments, L i . was 
added to prevent hydrolysis of inositol trisphosphates so as to amplify the signal. ‘ 
Tyrosine kinase has been reported to be one of the inducers of inositol 
trisphosphate. Tyrosine kinase is not so potent as other stimulators but its effect • 
can last longer. From the results in inositol trisphosphates, inositol trisphosphate 
turnover induced by tyrosine kinase is implied. Thus we also investigated the 
effect of rhTNF on tyrosine kinase in L-929 cells. By using an immuno-
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fluorescence staining assay, it was found that tyrosine kinase activation occurred in 
L-929 cells treated with rhTNF and the response increased within the experimental 
period of 3 hours (Fig. 6.25). By using a tyrosine kinase inhibitor, genistein, it was 
found that the cytotoxic effect of rhTNF was suppressed in the presence of this 
tyrosine kinase inhibitor. From this results, it seems that tyrosine kinase is involved 
in rhTNF-mediated cytotoxicity on L-929 cells. Tyrosine kinase probably mediates 
the response by activating the inositol triphosphate related calcium action which 
may be responsible for PKC activity. ‘ 
Whether TNF can stimulate intracellular Ca"^ depends on different cell types. In 
inflammatory cells, TNF does not increase the intracellular concentration of Ca'^ 
(Laudenn el al’ 1990; Richten et a I , 1989). However, TNF can induce increase in 
] in neutrophils (Richten el a I , 1989). In our present study, we found that 
prolonged treatment of rhTNF (2-6 hours) can enhance intracellular in L-
929 cells. 
Scffus et al (1987) reported that inhibitors of phospholipase C or of diacyglycerol 
lipase do not prevent TNF-mediated cytotoxicity in L-929 cells. Phospholipase C 
is the enzyme required to activate protein kinase C (PKC). However, in our ‘ 
experiment, we found that PKC inhibitor can suppress the cytotoxicity of rhTNF 
towards L-929 cells. This result seems not consistent with other groups. In our 
study, it seems that PKC activation by rhTNF is mediated by a cascade led by ‘ 
tyrosine kinase dependent inositol liisphosphate turnover mechanism and it is 
possible that it may by-pass the phospholipase C pathway. Actually, several 
reports indicate that TNF can activate PKC activity in some myeloid and lymphoid 
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cell lines (Schutze et al, 1990; Meichle el al, 1990) but not in fibroblasts (Schutze 
el a I , 1990). Though L-929 is originated from fibroblasts, variations may still 
occurs because mutation in signaling pathway is common in tumor cell lines. As 
the role of Ca^^and PKC in TNF-mediated cytotoxicity is untriggered, it seems that 
further studies are needed to get a clear understanding of the underlying 
mechanism. 
195 
Chapter 7. Effect of antioxidants on abrogation of rhTNF -mediated cytotoxicity on 
L-929 cells 
7.1 Introduction 
Oxygen free radicals as mediators ot TNF-indiiced tumor cell necrosis: 
Several lines of evidence implicate oxygen radicals (oxyradicals) as mediators of TNF-
induced cell necrosis in vitro: 
(1) Malondialdehyde (MDA), a measure of peroxidation of cell membrane after oxyradical 
damage, increase in L-929 cell after TNF treatment (Matthews, 1987); 
(2) TNF can generate hydroxy 1 radical (OH.) (Zimmerman et a I , 1989a) resulting in cell 
necrosis (Wong and Goeddel, 1988) in TNF-sensitive tumor cell lines; whereas no 
increase in OH- can be observed in human embryonic lung fibroblasts known to be 
insensitive to TNF (Yamauchi el a I , 1989). 
Until present, there is still some uncertainty that oxyradicals are absolutely involved in 
direct TNF-mediated tumor killing. For example, there are data indicating that some 
scavengers (compounds or enzymes which trap the free radicals) protect tumor cells from 
TNF-mediated killing but some other scavengers do not (Palombella and Vilcek, 1989). 
In one study, dimethyl sulfoxide (DMSO) suppressed TNF cytotoxicity in L-929 cells 
(Watanbe et a l , 1988). In another study no suppression of TNF killing was noted with 
DMSO, vitamin E, thiourea, mercaptoethanol, or methimazole treatment (Matthews, 
1983), and limited effect was observed with bu try la ted hydroxytoluene (Watanbe et a l , 
1988). However, the data that spin trap (TEMPOL) scavenges superoxide radicals (CV.) . 
in TNF-treated L-929 cells resulting in protecting from TNF cytotoxicity (Pogrebniak el 
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a l , 1991)，and findings that iron chelator (desferrioxamine) inhibits killing (Matthews, 
1983)，are consistent with a role of oxyradical for TNF-induced damage in tumor cells. 
The reason why only some antioxidants can inhibit TNF's cytotoxic effect on tumor cells 
is not known. We hypothesize that the difference in the abilities of antioxidants to enter 
the cell may be one of the reasons. In present study, we tested the effects of some potent 
antioxidants, namely Trolox (which is a more polar vitamin E analogue), superoxide 
dismutase (SOD) and cysteine on the change of cytotoxicity of rhTNF on L-929 cells. ‘ 
Trolox (6-hydroxy-2,5,7,8-tetramethyl-chroman-2-carboxylic acid, is the more polar 
derivative of vitamin E (a-tocophenol) and was found to have higher antioxidant activity 
than the parent compound both in vitro arid in vivo (Dean et a I, 1991; Thirior et a I, 1987; 
Rubinstein et a I , 1992; Wu et a l , 1993) in various systems. Fig. 7.1 shows the structures 
of two antioxidants, namely trolox and cysteine, used in the study. It is suggested that 
Trolox is soluble in lipid membrane of the cells and can enter the cells and discharge its 
antioxidant effect better than vitamin E. Since vitamin E cannot exert any effect on the 
TNF-mediated cytotoxicity on L-929 cells (Matthews, 1983), we tried to study the effect 
of Trolox in this system. 
Thiol-containing compounds such as cysteine have been reported to attenuate 
postischaemic contractile dysfunction that occurs following relatively short periods of 
ischaemia (so-called myocardial stunning) when administered immediately prior to 
reperfusion (Rice-Evans and Diplock, 1993). The mechanism is believed to be mediated 
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Fig. 7.1 The structures of two antioxidants: cysteine and trolox 
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through their scavenging free radical properties and their ability to donate sulphydryl 
group to an impaired glutathione defense system. Thiol-containing compounds, e.g. 
cysteine, have good intracellular access. Since it has recently been reported that treatment 
of mouse hepatocytes with inhibitors of glutathione biosynthesis can enhance cytotoxic 
sensitivity of TNF on these cells (Adamson and Billings, 1992), it is reasonable to test 
whether cysteine which is a sulphydryl group donor can alleviate TNF's cytotoxic effect 
on L-929 cells. 
Superoxide dismutase (SOD) is capable of catalyzing dismutation of superoxide anion free 
radicals. It has been used in situations in which increased superoxide generation is to be 
controlled (Reilly et al, 1991). Wong and Goeddel (1988) reported that TNF resistance in 
certain cells may correlate with the TNF induced SOD biosynthesis in the mitochondria. 
However, it has also been reported that overexpression of SOD in the mitochondria of the 
cells can only partially abrogate TNF-mediated cytotoxicity (Wong and Goeddel, 1988). 
We therefore tested whether direct addition of SOD in the assay system can suppress the 
cytotoxic effect of TNF on L-929 cells. 
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7.2 Results 
Fig. 7.2 shows that rhTNF exhibited cytotoxicity on L-929 cell in a dose-dependent 
manner. Trolox at 5 juM or 50 " M could not change the cytotoxic effect of rhTNF at this 
concentration range (0.26-33.3 ng/ml). 
On the other hand, Fig. 7.3 shows that cysteine at 5 mg/ml (i.e. 20.8 mM) could 
significantly abrogate the cytotoxic effect of rhTNF. Low concentration of cysteine (0.5 
mg/ml i.e. 2.08 mM) could exhibit some slight effects. • 
Fig. 7.4 shows the effects of exogenous addition of SOD (purchased from Sigma, an iron-
containing enzyme isolated from Escherichia coll) at 100 U/ml could abrogate the 
cytotoxic effect of rhTNF on L-929 cells whereas SOD at lower concentrations, namely, 
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Fig. 7.2 Effect of trolox on the rhTNF mediated cytotoxicity on L-929 cells. L -
4 
929 cells at a population of 4x10 /well were seeded on wells of 96-well plate for 
the assay. rhTNF at a range of 33.3 ng/ml to 0.26 ng/ml in two-fold serial dilutions 
in medium containing 5 / /M trolox (〇)，50 / /M trolox ( • ) and no trolox ( • ) . The 
cells were kept at 37°C in a humidified CO2 incubator for 20 hours. Viability of L -
929 cells was determined by neutral red uptake assay. Percentage survival was 
defined as the ratio of O.D. 540 nm reading of individual well compared with the 
wells treated with no rhTNF but only culture medium or culture medium 
containing trolox. Results are means of at least six individual measurements and 
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Fig. 7.3 Effect of cysteine on the rhTNF mediated cytotoxicity on L-929 cells. L-
929 cells at a population of 4xlo'^/well were seeded on wells of 96-well plate for 
the assay. rhTNF at a range of 33.3 ng/ml to 0.26 ng/ml in two-fold serial dilutions 
in medium containing 0.5 mg/ml cysteine (〇)，5 mg/ml cysteine ( • ) and no cysteine 
( • ) . The cells were kept at 37°C in a humidified CO2 incubator for 20 hours. • 
Viability of L-929 cells was determined by neutral red uptake assay. Percentage 
survival was defined as the ratio of O.D. 540 nm reading of individual well 
compared with the wells treated with no rhTNF but only culture medium or culture 
medium containing cysteine. Results are means of at least six individual 
measurements and S.D. of the measurements are plotted as error bars in the graph. 
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Fig. 7.4 Effect of SOD on the rhTNF mediated cytotoxicity on L-929 cells. L-929 
cells at a population of 4 x l o V e l l were seeded on wells of 96-well plate for the 
assay. rhTNF at a range of 33.3 ng/ml to 0.26 ng/ml in two-fold serial dilutions in 
medium containing 10 U/ml SOD (〇)，50 U/ml SOD (•)，100 U/ml SOD ( • ) and • 
no SOD ( • ) . The cells were kept at 37。C in a moistened CO2 incubator for 20 
hours. Viability of L-929 cells was determined by neutral red uptake assay. 
Percentage survival was defined as the ratio of O.D. 540 nm reading of individual 
well compared with the wells treated with no rhTNF but only culture medium or 
culture medium containing SOD. Results are means of at least six individual 
measurements and S.D. of the measurements are plotted as error bars in the graph. 
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7.3 Discussion 
Results from other workers indicated that some known antioxidants can inhibit TNF's 
cytotoxic effect in vitro but most antioxidants cannot (Matthews, 1983). Since the most 
lipophilic antioxidant vitamin E exhibits no inhibition of TNF killing of L-929 cells 
(Matthews, 1983), we tested the effect of a more polar derivative of vitamin E - trolox 
(which may possess a better intracellular access to the tumor cells) on the cytotoxic effect 
of TNF. We found that trolox at 5-50 " M could not abrogate the cytotoxic effect of 
rhTNF on L-929 cells. We have not tried the effect of higher concentration of trolox 
because of its low aqueous solubility. 
We have also tested the effect of Cysteine (which is known to be an effective antioxidant 
in other systems) on the cytotoxic effect of rhTNF on L-929 cells. Cysteine at higher 
concentration (5 mg/ml i.e. 20.8 mM) could significantly abrogate the rhTNF cytotoxic 
effect whereas Cysteine at low concentration (0.5mg/ml, i.e. 2.08 mM) did not affect the 
TNF's cytotoxicity on L-929 cells. Since Cysteine possesses potent intracellular access in 
cells and is an effective donor of sulphydryl group (Rice-Erans and Diplock, 1993), it is 
reasonable to speculate that Cysteine inhibited the rhTNF-mediated cytotoxicity in L-929 
cells by recovering the impaired glutathione defense system in these cells. 
Our results on testing the effect of SOD on rhTNF-mediated cytotoxicity also indicate that 
superoxide anion free radicals (CV.) may be involved in rhTNF-mediated cytotoxicity on 
L-929 cells. SOD at 100 U/ml could significantly alleviated the cytotoxic effect of rhTNF 
on L-929 cells. 
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In conclusion, from the results of the experiments performed using two antioxidants -
Cysteine and SOD in the present study, it is quite certain that free radicals, at least 
superoxide anion free radicals (O〗'.) are involved in the rhTNF-mediated cytotoxicity in L-
929 cells. Indeed, it has been reported that the tumor cell lines that are among the most 
sensitive to TNF are those with the lowest radical scavenging capacity and after exposure 
to TNF, they show the highest oxidative damage (Zimmerman et a l , 1989b). We 
speculate that L-929 cells which are sensitive to rhTNF may contain low antioxidant ‘ 
enzyme systems. Exogenous SOD or addition of cysteine can increase the antioxidant 
status of the cells and therefore abrogates the oxyradical induced lysis of the cell when 





General Discussion , 
In the past few years, a number of experimental studies have been made that 
J 
provide insight into the biochemical mechanisms of TNF cytotoxic action. 
However, the exact effect of TNF on the signaling pathway is not clear. We have 
studied the biochemical changes in rhTNF-treated L-929 cells, especially on the 
signal transduction pathway. By studying these changes, a better understanding of 
TNF-mediated cytotoxicity on tumor cells can be obtained and this information -
may be useful for the future design on the clinical use of rhTNF as, an anti-tumor 
agent. Though rhTNF had been used for phase I and II clinical trial, results are not 
very satisfactory. The most significant drawback of clinical trial of rhTNF is that 
TNF induces a lot of side effects which resemble bacterial shock. An 
understanding of the mechanisms of rhTNF mediated cytotoxicity towards tumor 
cells can help to suppress the side effects, and gives a direction of using other 
agents in combination with rhTNF in treatment of cancer. 
It was found that rhTNF is capable of inducing translocation of nucleolar protein, 
nucleophosmin, in L-929 cells (Fig. 3.1 and Fig. 3.2). Nucleophosmin is a 
nucleolar protein that is associated with the structural assembly of ribosome and ‘ 
plays an important role in cell proliferation. Translocation of nucleophosmin is 
believed to be associated with a damage to the ribosomal structure. A number of 
anti-cancer drugs have been shown to induce nucleophosmin translocation in • 
various tumor cell lines (Yung et al, 1985a; 1985b; 1986; Huang el al, 1983; 1985; 
Chan et al, 1987; 1988). Hyperthermia treatments that cause death of tumor cell 
also induce nucleophosmin translocation in these cells (Lui et al, 1993). It seems 
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that stronger anti-tumor agents can induce a higher degree of nucleophosmin 
translocation in tumor cells. We found that rhTNF alone can induce 
nucleophosmin translocation in L-929 cells but not as effective as actinomycin D. 
However, it is known that actinomycin D is more toxic than rhTNF towards 
normal cells. By using actinomycin D and rhTNF together in our experiments, we 
found that they are much more effective than used individimlly in inducing 
nucleophosmin translocation in L-929 cells. This gives an experimental 
background that actinomycin D and rhTNF can be used together to treat tumor and -
by doing so, the dosage used in each agent can be reduced. This may be a possible 
way to reduce the side effects induced by rhTNF treatment in patients suffering 
from malignant diseases. 
Translocation of nucleophosmin in response to rhTNF treatment is most probably 
occurred before the death of L-929 cells. By studying the time needed to induce 
cell death in L-929 cells by rhTNF and actinomycin D, it was found that 
nucleophosmin translocation takes place before any significant cell death occurs 
(Fig. 3.4). However, it is possible that the translocation of nucleophosmin is one 
of the early stages in rhTNF mediated killing in L-929 cells. 
Other workers reported that DNA synthesis is stopped in tumor cells treated with 
rhTNF before cell death occurs (Miyazaki et a I , 1985) and TNF works 
synergistically with drugs targeting at topoisomerase II (Alexander et al, 1987). It • 
seems that TNF mediated cytotoxicity probably involves attack on nucleus. The 
translocation of nucleophosmin after TNF treatment in L-929 cells may be one of 
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the events that resulted from nucleus damage. However, the exact mechanism and 
the pathway leading to nucleophosmin translocation is not known. 
We also tested whether free radicals are involved in rhTNF-mediated cytotoxicity 
in L-929 cells. In a preliminary study, we cannot measure detectable changes in 
superoxide anion radical production in L-929 cells (data not shown). This may be 
due to the fact that L-929 cells are originated from fibroblasts which are not 
effective in producing superoxide anion radical or other high energy oxidative -
agents. It has been reported that these high energy oxidants play a role in cell 
death induced by TNF (Adamson et a I, 1992). In TNF-resistant tumor cells, there 
are a high level of manganese superoxide dismutase (Mn-SOD) being induced in 
their mitochondria when treated with TNF (Wong el al, 1988). Mn-SOD is an 
antioxidant enzyme that can scavenge superoxide anion free radical. In the present 
study, we used L-929 cells which are TNF-sensitive cell type with low Mn-SOD 
activity. It seems that if there are any increase in free radicals level in L-929 cells 
treated with rhTNF, exogenous antioxidants could suppress this free radical-
mediated cytotoxicity. To verify our view, several antioxidants were used for 
studying the role of free radicals in TNF-mediated cytotoxicity on L-929. 
Superoxide dismutase (SOD) is a commonly used agent that works as an 
antioxidant in many assay systems. In our study, it was found that SOD can 
effectively reduce the cytotoxic effect of rhTNF towards L-929 cells (Fig. 7.5). • 
The results indicate that superoxide anion free radicals are involved in rhTNF 
mediated cytotoxicity. This finding is supported by the results of another set of 
experiment, in which another non-specific antioxidant, cysteine, was found to 
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protect L-929 cells from rhTNF mediated cytotoxicity (Fig. 7.4). To our surprise, 
trolox which is a polar derivative of vitamin E and has been proved to be more 
potent than the parent molecule, shows little protective effect on L-929 cells 
towards rhTNF treatment. This may be due to the low aqueous solubility of trolox 
(5 to 50 juM in our experiment) and hence the effective dosage had not been 
reached in our experiment. From other results, we have proved that free radicals 
are involved in rhTNF-mediated cytotoxicity in L-929 cells. The use of antioxidant 
to abrogate the rhTNF's cytotoxic effect seems not of therapeutic interest in view ‘ 
that drugs should be searched to help TNF killing tumor cells. However, 
antioxidants may be useful in helping the normal cells to tolerate at a higher level of 
TNF which may be required to eliminate the more susceptible tumor cells. We are 
now in the progress of studying the effect of rhTNF on normal cells in this aspect. 
TNF-specific receptors (TNF-R) have been found in various cell lines and it is 
widely accepted that binding of TNF to its receptor is necessary but not sufficient 
to induce cell killing. Normal cells also possess TNF-R and when they are treated 
with TNF, they would not suffer from cell death. This indicates that the signal 
transduction pathway induced by the TNF-R upon TNF binding may be different in 
tumor cells and normal cells. In an attempt to study the signal transduction ‘ 
pathway induced by TNF, we used two bacterial toxins, cholera toxin (CTX) and 
pertussus toxin (PTX). We found that there are no changes in the susceptibility of 
L-929 cells towards rhTNF in the presence of CTX (Fig. 5.2)，but the cytotoxic • 
effect of rhTNF was enhanced in PTX-treated L-929 cells (Fig. 5.3). This 
indicates that TNF-R may most probably activate it's signal pathway through a 
PTX-sensitive pathway and one of the possible candidate is the PTX-sensitive G-
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protein, G,,. As both toxins can induce accumulation of cAMP, the role of cAMP 
was also studied. Our studies indicate that cAMP does not play a major role in 
rhTNF mediated cytotoxicity on L-929 cells. cAMP may be involved in a minor 
pathway or secondary to other pathways. By direct measurement of cAMP level, it 
was found that rhTNF cannot change cAMP level in L-929 cells. However, by 
treating the L-929 cells with Sp-cAMP and Rp-cAMP, stimulator and suppresser 
of cAMP action respectively, it was found that the sensitivity of the cells towards 
rhTNF increase and decrease respectively (Fig. 5.4-5.6). ‘ 
Other inhibitors of cAMP-dependent protein kinase (PKA) were used to 
investigate the role plays by PICA in rhTNF-mediated cytotoxicity on L-929 cells. 
Both H-8 and H-9 foiled to alter the sensitivity of L-929 cells towards rhTNF-
mediated cytotoxicity (Fig 5.7-5.10). This indicates that PKA is not involved in 
rhTNF-mediated cytotoxicity in L-929 cells. 
Free intracellular calcium level and calcium-dependent signal transduction pathway 
are both very important in the control of cellular function. The most widely 
studied pathway is the signal transduction pathway initiated by hydrolysis of 
phosphoinositol phosphates by phospholipase C. We have found several positive ‘ 
results indicated that cytosolic free calcium ions play a major role in signal 
transduction induced by TNF and that these signals are closely related to the 
cytotoxic effect of TNF towards L-929 cells. The first phenomenon was that TNF- ‘ 
mediated cytotoxic effect was mediated by a PTX-sensitive agent, most probably 
the Gp,G-protein which control the activities of phospholipase C. However, we 
foiled to demonstrate an increase in cytosolic calcium ion concentration in L-929 
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cells treated with rhTNF for short period of time (in term of minutes) with 
fluorescence techniques (Fig. 6.2). In other experiments using ''"'^ Ca"^ , we were 
able to show an increase in ''^ Ca '^^  accumulation in cells treated with rhTNF for 1 
hour (Fig. 6.6). Taking together with the fluorescence image-graph of single cell 
measurement of intracellular calcium, it can be found that there are changes in free 
calcium ion levels but changes take place hours after rhTNF addition and that the 
calcium ion are found to localize on the nucleus region. 
Several calcium channel blockers were used in our experiments to investigate the 
effect of blocking the movement of calcium ion movement on TNF-mediated 
cytotoxicity. Cinnarizine, a non-specific calcium channel blocker and diltiazen, 
nifedipine and verapamil which block L-type calcium channel by blocking different 
specific sites were employed in our study. Similar results were obtained in that all 
these calcium ion channel blockers enhanced the survival percentage of L-929 cells 
exposed to rhTNF (ranged from 0.2 to 33.3 ng/ml, Fig. 6.7-6.14). As the changes 
in calcium ions distribution mainly occurred near the nucleus, it is possible that 
rhTNF may alter the calcium level across the nuclear membrane. 
Cytosolic free calcium ions affect a wide range of responses in the cell and one of -
the most important one is protein kinase C (PKC). We used a very potent and 
specific protein kinase C inhibitor, staurosporine, to test whether PKC is involved 
in rhTNF-mediated cytotoxicity in L-929 cells. In the presence of staurosporine, • 
the ability of rhTNF to kill L-929 cells dropped. This is a strong indication that 
PKC is involved in rhTNF-mediated cytotoxicity in L-929 cells. By using immuno-
fluorescence staining, it was found that PKC translocation took place in L-929 
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cells within one to three hours after treatment of rhTNF (Fig. 6.21). An activator 
of PKC, SC-10, was also used to test whether it can alter the sensitivity of L-929 
towards rhTNF mediated cytotoxicity. However, SC-10 seems to have little effect 
on the rhTNF-mediated cytotoxicity on L-929 cells. This may be due to the effect 
contributed by SC-10 used is small because there is already a huge amount of PKC 
activators in the culture medium (stimulated by the growth factors in the serum) 
that may over-ride the effect of SC-10. By using immuno-fluorescence staining 
technique, it was found that rhTNF could activate PKC as indicated by the -
translocation of PKC towards the nuclear membrane. The experiments performed 
to test the involvement of PKC in rhTNF-mediated cytotoxicity indicate that PKC 
plays an important role in rhTNF-mediated cytotoxicity in L-929 cells. 
Several inhibitors of calmodulin and calcium-calmodulin protein kinase were used 
to investigate whether calcium-calmodulin protein kinase are involved in rhTNF-
mediated cytotoxicity on L-929 cells in our experiments. W-7 and TMB-8 both 
show no effect on rhTNF-mediated cytotoxicity on L-929 cells (Fig. 6.18-6.20). 
This indicates that calmodulin or calcium calmodulin protein kinase is not involved 
in this aspect. 
Inositol trisphosphate turnover has also be tested in L-929 cells treated with 
rhTNF. It is found that rhTNF only induce slight increase in inositol triphosphate 
accumulation in L-929 cells. The ability of rhTNF to induce inositol triphosphate 
synthesis is not as potent as FCS. Inositol trisphosphate synthesis induced by 
rhTNF in L-929 cells can only be visualized when the stimulation induced by FCS 
is removed. However, there is still only small amount of inositol triphosphates 
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being synthesized. Tyrosine kinase activity can be demonstrated in L-929 cells 
treated with rhTNF by immuno-fluorescence staining technique. By using 
inhibitors of inositol turnover and tyrosine kinase, we have found that upon 
inhibiting these two mechanisms, the cytotoxic effect of rhTNF towards L-929 
cells is suppressed. The low degree of inositol trisphosphate response meets the 
kinetic of tyrosine kinase related inositol triphosphate turnover. 
It has been known that upon TNF binding to their receptors, internalization occurs. -
It is possible that the internalized ligand complex may undergo degradation inside 
the cells. This may give an explanation to the fact that no immediate signal 
response related to cell death are observed in our experiments. The signal for cell 
death may be generated by fragments generated from degradation of the TNF-
TNF-R complex. As the second messenger system is highly related and each 
member is influenced by other members of the second messenger family, it is not 
surprised that some of the messengers play a very minor role in the rhTNF-
mediated cytotoxicity on L-929 cells. 
As in the case of second messenger, it seems that a very complex and highly inter-
related system is activated when TNF binds to the TNF-R on L-929 cells. It seems ‘ 
that a PTX-sensitive G-protein may be involved. Tyrosine kinase related inositol 
trisphosphates turnover is probably another mechanism related to cytotoxic effect 
of rhTNF on L-929 cells. Change in intracellular calcium ion level and PKC 
activity may be a result of inositol trisphosphate-mediateci calcium release from 
internal calcium stores. It seems that cAMP and protein kinase A may be 
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secondary to the effect of calcium ion change. They only play a minor role in the 
toxic effect of rhTNF on L-929 cells. 
By measuring the membrane potential of rhTNF-treated L-929 cells, we found that 
there was no change in membrane potential when rhTNF are administered to L-929 
cells. Also, an exogenous manipulation of membrane potential failed to alter the 
sensitivity of L-929 cells towards rhTNF. By using potassium ionophores and 
monovalent cation blockers, the internal pH of L-929 cells can be controlled and by ^ 
altering the internal pH of the L-929 cells, we found that an acidic pH would 
decrease the sensitivity of L-929 cells towards rhTNF. When rhTNF was applied 
directly to L-929 cells, no change in internal pH could be found. It seems that 
upon treatment of rhTNF in L-929 cells, a cascade of reaction will be initiated. 
This cascade of reactions may probably not affecting the internal pH but should be 
pH-dependent. 
From the result of this study, it seems that upon treatment of rhTNF, a wide range 
of biochemical changes occur. However, most of these changes were observed 
after several hours of treatment. It seems that rhTNF does not alter the membrane 
potential in L-929 cells and that the cAMP-clependent protein kinase (PKA) is not ‘ 
involved in the signal transduction provoked by the binding of rhTNF on the TNF-
receptors of L-929 cells. However, the result of this study showed that the 
cytotoxic action of rhTNF on L-929 cells was affected by the cAMP level in the ‘ 
cells. The involvement of another well studied signal transduction pathway, the 
protein kinase C and intracellular free calcium ion was also studied. It was found 
that there was a raise in intracellular free calcium, especially around the nucleus, 
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after L-929 cells were treated with rhTNF for 4 hours. Also, protein kinase C 
activity was found to be stimulated by the action of rhTNF on L-929 cells. Other 
calcium dependent activities were also studied and the result indicated that rhTNF 
can stimulate inositol trisphosphate turnover in L-929 cells. However, calmodulin 
and calmodulin dependent protein kinase does not give any response to the action 
of rhTNF on L-929 cells. 
The signal transduction system in L-929 cells provoked by rhTNF differs from ’ 
other signal transduction system in that signal provoked by rhTNF in L-929 cells is 
weak and occurs hours after addition of rhTNF to these cells. This may be related 
to the behavior of TNF-receptor in that upon binding if TNF to the TNF-receptor, 
the TNF/TNF-receptor complex may be internalized and degraded. It seems that 
there is a possibility that the signal induced is provoked by this degraded products. 
Further study on this issue should be done. 
In this study, it was found that upon rhTNF treatment, L-929 cells developed a 
change in the nucleus materials as shown by the result of nucleophosmin 
translocation experiment. Free radicals were also involved in the killing mechanism 
of rhTNF on L-929 cells. This two changes seem to be directly related to the ‘ 
death of the L-929 cells treated with iliTNF. 
From the results of this study," it seems that upon addition of rhTNF, the 
TNF/TNF-receptor complex is internalized and degraded. The signal transduction 
pathway is stimulated hours after addition of rhTNF to the L-929 cells. The 
secondary messengers involved are intracellular free calcium, protein kinase C and 
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inositol trisphosphates. A wide variety of biochemical changes then occurs, which 
are probably pH and cAMP dependent. This changes would lead to the damage 
in ribosomal structure that may end up with the death of the cell. 
From this study, it was found that rhTNF induce nucleophosmin translocation in L-
929 cells. The translocation of nucleophosmin had been shown to be related to the 
stability of the ribosomal particles. The result indicated that rhTNF may affect the 
stability of ribosomal particles in L-929 cells. In this study, it was also shown that -
rhTNF can enhance translocation of nucleophosmin in L-929 cells when L-cells are 
treated together with actinomycin D. From this result, it seems that a lower 
dosage of actinomycin D and rhTNF can be used to obtain a cytotoxic action on 
tumor cells. By using this protocol, the side effects of rhTNF treatment in cancer 
patients may be not so serious as those induced by giving a high dose of rhTNF. 
However, all the work done so far are in in vitro system, the effects of killing 
tumor cells in vivo with a combination of TNF and various antitumor drugs that 
affect ribosomal particles are of interest to investigate. 
This study also confirms the involvement of free radical(s) in rhTNF mediated 
cytotoxicity in L-929 cells. As L-929 cell is fibroblast in nature, it is a poor ‘ 
producer of free radical in normal condition. However, the ability of cysteine and 
SOD to enhance the survival of L-929 cells upon rhTNF treatment gives strong 
evidence demonstrating that free radical is generated in L-929 cells treated with ‘ 
rhTNF. However, we found that trolox was unable to affect the cytotoxic action 
of rhTNF on L-929 cells. This may be due to only low concentration of trolox can 
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be used. It seems that more studies should be done on both the site of free radical 
generation and the site of action of these free radicals. 
In this study, it was found that there are changes occurring around the nucleus. 
One is the nucleophosmin translocation and the other is the accumulation of free 
calcium ion around the nucleus. As the detailed function of nucleophosmin is still 
uncertain, it seems that further study in the relation between calcium ion level and 
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